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Chapter 1
General introduction to the structural features and 
transport mechanisms of ABC importers
Part of this chapter is based on: Lotteke J. Y. M. Swier, Dirk-Jan Slotboom & Bert 
Poolman (2016) Chapter 1: ABC Importers, ABC transporters – 40 years on, Anthony M. 




ATP-binding cassette (ABC) transporters
ATP-binding cassette (ABC) proteins serve many functions, including the 
transport of nutrients into the cell, transport of compounds across organellar membranes, 
the secretion of proteins, antigen (peptide) presentation, cell volume regulation, regulation 
of protein synthesis, detoxification and antibiotic resistance. The vast majority of ABC 
proteins, known as the ABC transporters, are part of complexes that mediate transport 
of molecules across cellular or organellar membranes. A smaller group of ABC proteins 
is associated with soluble (supra)molecular complexes and involved in DNA repair, 
recombination, chromosome condensation and segregation, and translation elongation. 
Regardless of whether the ABC proteins are found in membrane transport or soluble 
(supra)molecular complexes, they provide a power-stroke in which chemical energy is 
converted into work, for example for a translocation or dislocation event. 
ABC transporters are subdivided in importers and exporters (Figure 1A). The 
core of both importers and exporters consists of two transmembrane domains (TMDs) 
and two cytoplasmic nucleotide-binding subunits (NBDs, also called ATPases), which 
power the transport through hydrolysis of ATP. Together, the TMDs and NBDs form 
the translocator of the transporter. Whereas the structural organization of the TMDs is 
different among different types of ABC transporters (see below), the NBDs share the same 
fold and form the hallmark of the ABC transporters. Each NBD consists of a RecA-like 
domain and a helical domain,1 and within the NBD dimer, the monomers are arranged in a 
head-to-tail like conformation (Figure 1B). Additionally, the NBD can have a C-terminal 
domain which is involved in the dimerization of the NBDs or functions as a regulatory 
domain.
Both the RecA-like domain and the helical domain contain conserved motifs 
that are involved in ATP binding and hydrolysis (Figure 1B-C). The A-loop contains a 
conserved aromatic residue, which engages in a π-π interaction with the adenine ring of 
the ATP molecule.2,3 The glycine-rich Walker A motif (GXXGXGK(S/T)) has interactions 
with the phosphate groups of ATP, especially via hydrogen bonds formed by the amino 
group of a highly conserved lysine residue. The Walker B motif (φφφφDE, with φ being 
a hydrophobic residue) contains a conserved aspartate that coordinates the Mg2+ ion 
required for hydrolysis, and is therefore involved in ATP hydrolysis. The Walker B motif 
also contains a conserved glutamate residue, which serves as general base in the ATP 
hydrolysis mechanism by polarizing the attacking water molecule.2,4–6 Directly behind 
the Walker B motif lies the D-loop. The D-loops of opposing monomers are in close 
proximity in the NBD dimer, and the conserved aspartate residue at the end of the D-loop 
of one monomer, participates in the ATP binding site of the opposite monomer, where 
it interacts with residues of the Walker A motif and with the conserved histidine in the 
H-loop.7–9 Conformational changes in these D-loops affect key residues in the active 
sites, thereby forming or breaking the ATP hydrolysis sites during the catalytic cycle. The 
conserved histidine of the H-loop interacts with the conserved aspartate of the D-loop, the 
general base at the end of the Walker B motif and the γ-phosphate group of ATP, and is 
proposed to be involved in positioning of the general base, the Mg2+ ion and the attacking 
water molecule.7,8,13,14 The ABC signature sequence LSGGQ is involved in phosphate 
binding and this sequence is the characteristic feature of the ABC superfamily. Finally, 
the Q-loop includes a conserved glutamine residue, which interacts with the Mg2+ ion.
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Figure 1: The architecture of the superfamily of ABC transporters. A) Crystal structures 
of proteins belonging to the Type I (MalFGK2: PDB 2R6G
6), II (BtuCDF: PDB 4FI310) and III 
importers (ECF FolT2: PDB 5D3M11), and exporters (McjD: PDB 4PL012) of the ABC transporter 
family. The TMDs are shown in cyan and slate, the NBDs in two shades of red, the C-terminal 
domains of the NBDs in wheat and the SBPs/S-component in yellow. The predicted borders of 
the membrane are indicated by the black lines, with the cytoplasmic and extracytoplasmic sides 
indicated by the words “In” and “Out”. B) Side view (left) and top view (right) of the ATP-bound 
NBD dimer of the maltose transporter MalFGK2 (PDB 1Q1213), with the RecA-like domain colored gray and the helical domain colored white. The bound ATP molecule is shown in sticks with the 
following color code; C atoms in gray, O atoms in red, N atoms in blue and P atoms in orange. This 
color code for O atoms, N atoms and P atoms in maintained throughout this thesis. The conserved 
domains in the NBDs shown in the following colors; A-loop: magenta, Walker A: dark green, 
Q-loop: slate, LSGGQ signature motif: red, Walker B: yellow, D-loop: orange, H-loop: cyan. C) 
Close-up of one of the two ATP binding and hydrolysis sites in the NBD dimer of MalFGK2, with the conserved residues involved in ATP binding and hydrolysis shown in sticks.
ABC importers
This chapter focusses on the ABC importers, which on structural and mechanistic 
grounds are subdivided in Type I, II and III importers (Figure 1A).15 The Type I and II 
importers employ a soluble substrate-binding protein (SBP) to capture the substrate and 
12
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donate the molecule to the translocator. The SBP can be a soluble periplasmic protein or 
tethered to the membrane via a lipid moiety or protein anchor, or fused to the translocator. 
The latter has been observed for hetero- and homodimeric TMDs, and thus results in one 
or two substrate-binding domains (SBDs) per functional complex.16 In some cases, two or 
even three SBDs fused in tandem are linked to the TMDs and these systems have a total 
of four or six extracytoplasmic substrate-binding sites, which can even have different 
substrate specificities. The mechanism of transport of Type I and II ABC importers 
involves the binding and release of substrate from the dedicated SBP or SBD to the 
translocator domain, as well as alternating access of the substrate-binding pocket in this 
latter domain.
Type III importers, also named energy-coupling factor (ECF) transporters, 
capture their substrate via so-called S-components, which are small integral membrane 
proteins that associate with a transmembrane coupling protein and two NBDs to form a 
full transporter. The latter three subunits form the eponymous ECF module, which fuels 
substrate transport. Based on the chromosomal location of the genes encoding the four 
subunits, the ECF transporters are subdivided in group I and group II (Figure 2). In the 
first group, the genes encoding all four subunits are present in one operon and under 
the control of a single promotor, resulting in the formation of a dedicated transporter. 
In case of the group II ECF transporters, the genes encoding the ECF module are still 
located in one operon under a single promotor, while the genes encoding S-components 
with different substrate-specificities are scattered around the genome, under the control 
of different promotors. All these S-components can interact with the same ECF module; a 
modularity analogous to the promiscuity of a subset of Type I importers that can interact 
with different SBPs or have multiple different SBDs fused to their TMD.4  The mechanism 
of transport of Type III importers involves substrate translocation by toppling of the 
S-component rather than alternating access of the translocator domain. In this chapter, the 
structural features of the Type I, II and III importers known to date, as well as the current 
status of their mechanisms of transport, is presented.
Group I Group II
ecfA ecfA’ ecfT S ecfA ecfA’ ecfT




Figure 2: Division of the ECF transporters into two groups. Schematic representation of group 
I and group II ECF transporters, showing both the chromosomal location of the genes at the top, 
as well as the architecture of the transporters at the bottom. The colors of the different subunits are 
the same as in Figure 1.
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Structural features of ABC importers
Type I importers
Crystal structures of Type I importers for four different substrates are available: 
the molybdate/tungstate transporter ModB2C2 from Archaeoglobus fulgides and 
Methanosarcina acetivorans,17,18 the maltose transporter MalFGK2 from Escherichia 
coli,6,9,14,19–21 the methionine transporter MetN2I2 from E. coli,22,23 the transporter for 
basic amino acids Art(QN)2 from Thermoanaerobacter tengcongensis,24 and the alginate 
transporter AlgM1M2SS from Sphingomonas sp. A1.25 MalFGK2 is by far the most studied 
transporter. The different crystal structures are listed in Table 1.
The crystal structure of MalFGK2 in the inward-facing, apo state is likely 
representing the resting state of the transport cycle (Figure 3A).19 The two TMDs of 
MalFGK2, MalF and MalG, are not identical. They consist of eight and six transmembrane 
helices, respectively, from which TM3-8 of MalF are related to TM1-6 of MalG. These 
helices form the core region of the TMDs with pseudo-twofold symmetry. In the inward-
facing state, the interface between MalF and MalG creates a translocation cavity, which 
is accessible from the cytoplasm. On the periplasmic end, this cavity is closed by 
a periplasmic, hydrophobic gate that is composed of four loops, each at the kink of a 
transmembrane helix (TM5 and TM7 from MalF, TM3 and TM5 from MalG, Figure 3C). 
Both MalF and MalG have a coupling helix, which is located in loop L6 between TM6 
and TM7 of MalF and in loop L4 between TM4 and TM5 of MalG. Both coupling helices 
dock into a groove on the surface of each of the two NBDs (MalK subunits). These 
grooves are lined by two helices from the helical subdomain of MalK, the helix following 
the Walker A motif and residues from the Q-loop. The interactions between the coupling 
helices and the MalK subunits transduce conformational changes upon ATP binding and 
hydrolysis to MalF and MalG and allow alternate access of the binding pocket in the 
TMDs.
Within the MalF-MalG dimer, an occluded maltose-binding pocket is formed 
about halfway the membrane. In the structures showing maltose-bound MalFGK2 in a 
pretranslocation state, this pocket is closed at the periplasmic side by a hydrophobic gate.9 
On the cytoplasmic side, the pocket is closed by a network of vanderWaals interactions. 
The binding pocket is lined by residues from MalF only, and the binding mode resembles 
that of the maltose-binding protein (MBP, the SBP of the maltose transporter) in terms of 
aromatic stacking of binding site residues with the sugar rings, as well as a hydrogen bond 
network involved in sugar recognition. Within the TMD dimer of the alginate transporter 
AlgM1M2SS from Sphingomonas sp. A1, a substrate-specific binding pocket lined by 
charged residues from only one TMD (AlgM1) has been found as well.25
A crystal structure of nucleotide-free MalFGK2-MBP in the pretranslocation 
state with maltoheptaose bound, has shed light on the selectivity of sugar transport.21 
MalFGK2 imports linear malto-oligosaccharides of a length from two to seven glycosyl 
units, linked through α-1,4 glycosidic bonds, with an unmodified reducing end. In the 
crystal structure, four glycosyl units from the reducing end of maltoheptaose are bound in 
the groove between the N-terminal and C-terminal lobe of MBP. A conserved glutamine 
in the periplasmic L5 loop of MalG is also inserted into this groove and forms hydrogen 
bonds with the first glycosyl unit at the reducing end. There is no clear electron density 
found for the glycosyl units at the non-reducing end of maltoheptaose. In a different 








































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Figure 3: Crystal structures of MalFGK2-MBP. A) Cartoon representation of MalFGK2 in the inward-facing conformation (PDB 3FH6)19, with MalF colored from the N-terminus in blue to the 
C-terminus in red, and the other subunits colored as in Figure 1. The cytoplasmic part of MalF 
is not resolved in this structure. The periplasmic gate, cytoplasmic gate and the coupling helices 
are indicated. B) MalFGK2 in complex with MBP in the outward-facing conformation (PDB 
2R6G)6, shown as in panel A. C) Top view of the closed (left) and open (right) conformation of 
the periplasmic gate as adopted in panel A and B, respectively. D) Top view of the open (left) and 
closed (open) conformation of the cytoplasmic gate as adopted in panel A and B, respectively.
three glucosyl units from the non-reducing end of maltoheptaose are bound in the MalF 
binding site.21 Aromatic stacking interactions and five direct protein-sugar hydrogen 
bonds within this binding site indicate specificity for α-1,4 linkage of the glycosyl units. 
The other glucosyl units of maltoheptaose are not visible, probably because they do not 
have specific interactions with the transporter. Overall, it seems that the size-exclusion 
limit of transport by MalFGK2 is determined by the size of the cavity in the occluded state, 
which is about 2400 Å, just large enough to fit a maltoheptaose molecule.
Five crystal structures of the transporter for basic amino acids Art(NQ)2 from T. 
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tengcongensis in the apo-, arginine-, histidine-, ATP- and ATP plus arginine-bound state 
all show an inward-facing conformation, with the nucleotide binding domains (ArtNs) 
in a semi-open state.24 The transmembrane domains (ArtQs) contain five transmembrane 
segments, which correspond to TM4-8 of MalF and TM2-6 of MalG, and form a 
homodimer with twofold symmetry. Together, the ArtQs form a highly negatively charged 
tunnel reaching from the periplasmic side to the cytoplasmic side of the membrane, which 
allows positively charged amino acids to pass through. Halfway across the predicted 
membrane, each ArtQ subunit has a highly negatively charged substrate-binding pocket, 
lined by highly conserved residues that are involved in specific binding of both arginine 
and histidine. Remarkably, two amino acids are present in the ArtQ dimer of the crystal 
structure with arginine or histidine, which raises question on the transport mechanism 
as one amino acid at a time is transferred from the substrate-binding protein ArtI to 
Art(NQ)2. A crystal structure of ArtI in the arginine bound state shows only one binding 
site. We therefore consider it more likely that the two amino acids have accessed the 
binding-pocket when the protein was trapped in the inward-facing conformation, and that 
the structures do not reflect a true translocation intermediate.
Capturing MalFGK2 in an ATP-bound state was achieved by mutating the 
catalytic glutamate in the ATP hydrolysis site to a glutamine (E159Q).6 In the outward-
facing conformation, the translocation cavity is now open to the bound MBP, which is in 
a substrate-free state (Figure 3B).6,9,14 On the cytoplasmic side, the translocation cavity is 
closed by a tightly packed helix bundle of TM6 and TM7 from MalF and TM4 and TM5 
from MalG (Figure 3D). In the pretranslocation, occluded state, only four residues from 
these TMs are forming the gate. In the closed, nucleotide-bound MalK dimer, two ATP or 
AMP-PNP molecules are sandwiched at the dimeric interface, where they interact with 
residues from the Walker A and Walker B motif of one MalK subunit and residues from 
the LSGGQ signature sequence of the other subunit. Compared to the pretranslocation, 
occluded state, the helical domains have rotated another 15°, thereby breaking the 
intersubunit hydrogen-bond network of the MalK dimer. Overall, when comparing the 
inward-facing and outward-facing conformations, the structure of the core helices TM4-7 
in MalF and TM2-5 in MalG are maintained as rigid bodies during the transport cycle. 
The other helices, TM2, TM3 and TM8 of MalF and TM1 and TM6 of MalG, move 
together with the core helices of the other TMD subunit. The helical domains of the 
NBDs, as well as the coupling helices, rotate over an angle of about 30° upon closure of 
the MalK dimer, which allows the conformational change in the MalFG dimer.
MalFGK2 has been crystallized in complex with the MBP, maltose and ADP 




- or BeF3-, which has provided insight in the 
mechanism of ATP hydrolysis within the MalK dimer.14 The overall structures show the 
same outward-facing conformation as described above, suggesting that ATP hydrolysis 
does not force the transporter in a different conformation. Even the conserved residues 
within the ATP hydrolysis site are superimposable in all four structures. The hydrolysis 
of ATP proceeds by the attack of the γ-phosphate of ATP by a water molecule, which is 




- bound structures 
show a trigonal bipyramidal and octahedral geometry, respectively, which represent the 
transition state of the hydrolysis. Three of the four oxygen atoms of VO
4
- or the fluorides 
of AlF
4
- lie in the equatorial plane, while the fourth oxygen of VO
4
- or the attacking water 
molecule in case of the AlF
4
- bound structure and the oxygen connecting the β-phosphate 
group are found at the axial positions. This transition state supports the catalysis-by-a-
general-base model, where the attacking water molecule is activated by the conserved 
glutamate (E159) by polarizing the water molecule. The conserved histidine (H192) in the 
18
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H-loop positions the γ-phosphate group, the attacking water molecule and the conserved 
glutamate, while the conserved glutamine (Q82) in the Q-loop is involved in coordination 
of the Mg2+ ion.
In the final step before returning to the resting state, the SBP is released from the 
transporter and the inorganic phosphate and ADP are released from the NBDs. Intermediate 
states of this step are observed in the crystal structure of the molybdate/tungstate 
transporter ModB2C2 from A. fulgides, which is in the inward-facing conformation in 
complex with its substrate-binding protein ModA,17 and two crystal structures of ADP-
bound MetN2I2 in the inward-facing conformation without the substrate-binding protein 
MetQ bound.23 The structure of the ModB2C2-A complex is similar to that of MalFGK2 
in the resting state, with the NBDs (ModCs) in an open, nucleotide-free conformation 
and the TMDs (ModBs) in an inward-facing conformation. The ModC dimer adopts a 
post-hydrolysis conformation and two molecules of inorganic phosphate are bound at the 
position of the β-phosphate groups of ATP in the ATP-bound structure of MalFGK-MBP,6 
suggesting that binding of a phosphate group at this position is probably the strongest 
compared to the position of the α- or γ-phosphate group.
Two pairs of crystal structures of the methionine transporter MetN2I2 from E. 
coli are available, with the NBDs (MetN) spaced differently between the nucleotide-free 
and the ADP-bound structures.22,23 Similar to the structure of MalFGK2 in the resting 
state, the MetN dimer is held together by dimerization of the C-terminal domains. Each 
TMD contains five transmembrane segments, which correspond to TM4-8 of MalF and 
TM2-6 of MalG. The region of highest sequence and structure similarity is found at the 
region of the coupling helices and TM3 and TM4 located on either side of them. Similar 
to the maltose transporter, a network of salt bridges between the coupling helices of MetI 
and the helical subdomain of MetN relay the conformational changes between the TMDs 
and NBDs. The gate that closes the translocation cavity at the periplasmic side of MetN2I2 
is structurally conserved and also found in the ModB2C2 transporter.
Type II importers
The Type II importers facilitate the uptake of metal chelates including vitamin 
B12, heme and oxanions.26 For this group of ABC importers, seven crystal structures of 
complete transporters are available (Table 2). These structures correspond to five different 
states, which represent the major steps of the transport cycle. Five crystal structures are 
of the vitamin B12 transporter BtuCD from E. coli,10,27–30 which is the most studied Type 
II importer. The two other crystal structures are of the molybdate/tungstate transporter 
MolB2C2A from Haemophilus influenza and the heme transporter HmuUV from Yersinia 
pestis.31,32
In 2002, the vitamin B12 transporter BtuCD from E. coli was crystallized in an 
outward-facing conformation, forming a cavity accessible from the periplasmic side 
(Figure 4A).27 No substrate or nucleotides are bound and this outward-facing conformation 
probably represents the resting state of the transport cycle. The BtuC subunit consists of 
ten transmembrane helices, of which TM2-5 and TM7-10 are related by a pseudo-twofold 
rotation axis. Within the BtuC dimer, there is a two-fold symmetry axis running down 
the translocation pathway. This translocation pathway is lined by residues from TM5, 
TM5a (small transmembrane helix following TM5) and TM10 of each BtuC, and the 
loops preceding TM3 and TM8. In this outward-facing conformation, the translocation 
cavity stretches out two-thirds into the predicted membrane and is closed by cytoplasmic 
19
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Table 2: Crystal structures of type II ABC importers.
Name (organism) Remarks Ligand Resolution (Å) PDB ID
Vitamin B12 transporter BtuCD (E. coli)
Outward-facing 
conformation, no BtuF V4O12
4- 3.20 1L7V27




Vitamin B12 transporter BtuCD in complex 
with BtuF (E. coli)
Intermediate occluded 
state, BtuF in open state – 2.60 2QI9
28
E159Q mutation, 
BtuC in asymmetric 
conformation
 – 3.49 4DBL29
Intermediate state AMP-PNP 3.47 4FI3
10
Putative metal-chelate-





conformation, no SBP – 2.40 2NQ2
31
Heme transporter 
HmuUV (Y. pestis) Outward-facing - 3.00 4G1U
32
gate I (Figure 4D).
 Given the millimolar ATP concentration in the cell, the resting state of the 
transporter will be short lived. The BtuDs will quickly bind ATP and the transporter 
will convert into an outward-facing, nucleotide-bound state as represented by the 
recently solved crystal structure of BtuCD in complex with two molecules of the non-
hydrolyzable ATP analogue AMP-PNP and two Mg2+ ions.30 Like in the resting state, the 
BtuC dimer is in an outward-facing conformation with a translocation cavity open to the 
periplasmic side but closed at the cytoplasmic side by a second cytoplasmic gate, known 
as cytoplasmic gate II. The BtuDs form a closed dimer with the AMP-PNP molecules 
and Mg2+ ions bound at the ATP hydrolysis site; in this state, the two coupling helices of 
the BtuCs are about 9.5 Å closer to each other than in the resting state. Apparently, the 
binding of AMP-PNP promotes closure of the BtuD dimer, which is coupled to opening 
of cytoplasmic gate I and closure of cytoplasmic gate II in BtuC.
In the next step of the transport cycle, the substrate-binding protein BtuF binds 
vitamin B12 and subsequently docks onto the periplasmic side of the BtuC dimer. A study 
with BtuCD reconstituted in proteoliposomes has shown that ATP-binding promotes 
docking of BtuF onto the BtuCD complex, rather than simulating BtuF release to 
scavenge vitamin B12.30 Upon docking of BtuF onto the BtuCD complex, the N-terminal 
and C-terminal lobe of BtuF are spread apart while making interactions with periplasmic 
loops of BtuC. TM5a of BtuC sticks into the vitamin B12 binding site of BtuF, and this 
distortion forces vitamin B12 to move into the translocation cavity. Rearrangements within 
the BtuC dimer will then result in a substrate-bound, occluded state, which has been 
obtained in the presence of AMP-PNP.10 In this state, the BtuD dimer closely resembles 
the previous state, but TM5 and TM5a of both BtuC subunits have now closed the 
translocation cavity from the periplasmic side, while cytoplasmic gate II is still closed 




























Figure 4: Crystal structures of BtuCDF. A) Cartoon representation of BtuCD in the outward-
facing conformation (PDB 1L7V)27, with one BtuC subunit colored from the N-terminus in blue 
to the C-terminus in red, and the other subunits colored as in Figure 1. The periplasmic gate, 
cytoplasmic gates I and II, and the coupling helices are indicated. B) BtuCD in complex with BtuF 
in the occluded conformation (PDB 4FI3)10, shown as in panel A. C) Top view of the open (left) 
and closed (right) conformation of the periplasmic gate as adopted in panel A and B, respectively. 
D) Bottom view of the conformations of the cytoplasmic gates I and II as adopted in panel A (left) 
and B (right), respectively.
is wide enough to host the molecule with only minor steric hindrance. The interior of 
the cavity does not resemble the substrate-binding pocket of BtuF, rather it forms a low 
affinity chamber.
After hydrolysis of ATP, the cytoplasmic gate II in the BtuD dimer will open 
to release inorganic phosphate and ADP. The substrate may then be squeezed out by a 
peristaltic-like movement. The state after substrate release is visualized by the crystal 
structure of the molybdate/tungstate transporter MolB2C2 from Heamophilus influenza.31 
The transporter was crystallized in a nucleotide-free, inward-facing conformation in the 
absence of the substrate-binding protein MolA. The arrangement of the transmembrane 
helices of MolB is similar to that of BtuC. In MolB2C2 only the TM5a of each subunit 
contributes to the formation of the periplasmic gate. EPR and selective crosslinking 
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studies show that this gate offers a narrower opening upon nucleotide binding compared 
to the periplasmic gate in BtuCD, which is in agreement with the much smaller substrates 
molybdate or tungstate as compared to vitamin B12.33
To return to the outward-facing resting state, BtuF should dissociate and 
cytoplasmic gate I should close while the periplasmic gate needs to open up. A 
post-translation, intermediate state was crystallized in two different asymmetric 
conformations.28,29 While the two non-identical lobes of BtuF interact with the periplasmic 
loops of the BtuC subunits, a slight asymmetry is introduced in the loops, resulting in 
an asymmetric arrangement of the transmembrane helices. Especially the orientation of 
TM3-5a is thought to control on which side of the membrane the translocation cavity 
is opened. The closure of the periplasmic gate and cytoplasmic gate I ensures that no 
continuous channel is formed, while switching from the inward-facing to the outward-
facing conformation. Once the transporter reaches the outward-facing conformation by 
opening the periplasmic gate, BtuF will be released and the transporter is back in the 
resting state.
Type III importers
Compared to the Type I and Type II importers, the structure information on 
the Type III importers/ECF transporters is limited. To date, crystal structures of nine 
different S-components,11,34–41 two NBD dimers,42,43 and four complete transporters are 
available (Table 3).11,44–46 The nine substrate-bound S-components are RibU for riboflavin 
from Staphylococcus aureus and from Thermotoga maritima,36,39 ThiT for thiamin from 
Lactococcus lactis and Listeria monocytogenes,35 BioY for biotin from L. lactis,34 NikM2 
for Ni2+ for T. tengcongensis,38 FolT for folate from Enterococcus faecalis and Lactobacillus 
delbrueckii (Chapter 5 of this thesis)11,40 and YkoE for thiamine from Bacillus subtilis.41 
RibU, BioY, FolT and ThiT from L. lactis and L. monocytogenes are associated with group 
II ECF transporters and despite a sequence identity of only 16-34%, these S-components 
share a common structural fold of a six transmembrane helical bundle (Figure 5A). The 
N-terminal parts consisting of transmembrane helices (TM) 1-3, are structurally the most 
conserved and were predicted to be involved in the interaction with the ECF module. TM1 
often contains a ΦxxxΦ motif, with Φ being a small, hydrophobic residue. This motif is 
important for complex formation and thiamin transport by ECF ThiT from L. lactis and 
in biotin transport by the group I transporter BioMNY from Rhodobacter capsulatus.35,47 
TM4-6 in the C-terminal parts of the S-components are structurally more different and 
are the main contributors to the substrate-binding site. This combination of a structurally 
conserved part and a highly divergent part explains how different S-components can 
interact with one and the same ECF module and maintain a high specificity for chemically 
diverse substrates (dissociation constants in the sub-nanomolar to nanomolar range). 
The substrate-binding pocket is located on the predicted extracytoplasmic side of the 
S-component and closed by the loop L1 connecting TM1 and TM2, which lies over the 
pocket in a lid-like manner. EPR studies on thiamin-specific ThiT from L. lactis have 
shown that the main structural difference between thiamin-bound and substrate-free ThiT 
is the conformation of this loop L1, covering the substrate-binding pocket in the liganded 
state, while exposing it to the environment in the unliganded state.48 In all structures of 
the group II S-components, one or more residues in this L1 loop interact with the bound 
substrate molecules. In case of RibU from T. maritima, the conserved aromatic Y130 at 
the extracellular end of T5 plays a role in closing off the substrate-binding pocket from 
the environment too, together with the F128 and L129 of the conserved PLY motif.36 A
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Table 3: Crystal structures of type III ABC importers.
Name (organism) Remarks Ligand Resolution (Å) PDB ID
RibU,  S-component for 
riboflavin (S. aureus) substrate bound riboflavin 3.60 3P5N
39
RibU, S-component for 







ThiT, S-component for 
thiamine (L. lactis) substrate bound thiamine 2.00 3RLB
35
ThiT, S-component for 
thiamine
(L. monocytogenes)
substrate bound thiamine pyrophosphate 3.00 4TKR
37
YkoE, S-component for 
thiamine (B.  subtilis) substrate bound thiamine 1.95 5EDL
41
BioY,  S-component for 
biotin  (L. lactis) substrate bound biotin 2.10 4DVE
34
NikM, S-component for 








FolT, S-component for 
folate (E. faecalis) substrate bound folate 3.19 4Z7F
40
FolT1, S-component for 
folate (L. delbrueckii) substrate bound folate 3.01 5D0Y
11
CbiO homodimer
(T. tengcongensis) nucleotide free - 2.30 4MKI
42
EcfAA’ heterodimer
(T. maritima) nucleotide bound ADP 2.70 4HLU
43
ECF FolT transporter
(L. brevis) substrate free - 3.00 4HUQ
44
ECF HmpT transporter
(L. brevis) substrate free - 3.53 4HZU
45
ECF PanT transporter




substrate free - 3.00 5JSZ11
nucleotide bound AMP-PNP 3.30 5D3M11
conserved aromatic residue at a similar position, probably fulfilling a similar role, have 
been found in ThiT from L.lactis (W133), ThiT from L. monocytogenes (W139) and FolT 
from E. faecalis (Y129).
NikM2 is the S-component of the NikM2N2OQ transporter from T. 
tengcongensis, which is a metal transporter belonging to the group I ECF transporters.38 
Compared to the six vitamin-specific S-components, NikM2 has an additional N-terminal 
α-helix (Figure 5B). The highly conserved extracellular N-terminus inserts into the center 
of the S-component and occupies a space that corresponds to the substrate-binding pocket 
in the vitamin-specific S-components. Within this space, Ni2+ or Co2+ is bound in a square-
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Figure 5: Crystal structures of S-components and a full ECF transporter. A) Crystal structure 
of ThiT from L. lactis (PDB 3RLB)35, as seen from the plane of the membrane (left) or from the 
top of the membrane (right). The loop L1 is colored in pale yellow and thiamine is shown in sticks 
with its C atoms in yellow. B) Crystal structure of NikM as seen from the plane of the membrane 
(4M5B)38. The loop L1 is shown in pale orange and the Ni2+ cation is represented by the black ball. 
C) Crystal structure of ECF FolT from L. brevis, which EcfT colored from the N-terminus in blue 
to the C-terminus in red, while the other subunits are colored as in Figure 1 (4HUQ).44 D) Close-up 
of the interactions between the coupling helices of EcfT and FolT, which the helices involved being 
indicated.
planar geometry by four nitrogen atoms. The nickel-binding residues are stabilized and 
oriented by a network of hydrogen bonds. YkoE is the S-component of the YkoEDC 
transporter from B. subtilis, which also belongs to the group I ECF transporters.41 The 
overall fold of this S-component resembles that of the vitamin-specific S-components 
belonging to the group II ECF transporters in the sense that it has a six-helical bundle 
in which the substrate-binding site is located on the extracytoplasmic site, but there are 
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also some striking differences. The six-helical bundle is followed by a highly-charged, 
seventh α-helix, which protrudes into the cytosol and is proposed to be involved in 
maintaining the up-right orientation of the S-component in the membrane. Besides, helix 
1 is extended and is connected by helix 2 via a sharp turn only, so the long L1 loop of 
the group II S-components is absent and the substrate-binding site is not closed off from 
the extracytoplasmic side. Within the substrate-binding pocket, the thiamine molecule is 
located much deeper into the pocket compared to thiamine in ThiT from L. lactis, and 
also harbors a reverse orientation, while the conformation of both molecules are almost 
identical.
The structures of the complete Type III transporters all show the same 
conformation, in which the EcfAA’ heterodimer adopts an open conformation and the 
substrate-free S-components lie in the membrane with the helical axis perpendicular to 
the plane of the membrane (Figure 5C). Three out of four structures are of transporters 
from the same organism, L. brevis, which use the same ECF module in complex with 
three different S-components: FolT for folate,44 PanT for pantotenate,46 and HmpT.45 
The latter has shown to bind pyridoxamine and should therefore be named PdxU2.49 The 
fourth structure is of the ECF FolT2 transporter for folate from a different organism, L. 
delbrueckii, but also belongs to the group II ECF transporters (Chapter 5).11 The NBDs in 
these four structures, as well as in the two structures of lone NBD dimers, have the same 
structural fold as in Type I and Type II importers, including the RecA-like domain, the 
helical domain and a C-terminal domain. All the conserved features (Walker A, Walker 
B, LSGGQ signature motif, A-, D-, H- and Q-loop) are present. A C-terminal extra 
domain provides the basis for dimerization.42,43 Like the NBDs of the Type I and Type II 
importers, each dimer has two grooves at the interface of the RecA-like domain and the 
helical domain within one ATPase subunit, which can form the anchor points of eventual 
coupling helices. These acidic and highly conserved grooves are followed at the end of 
the Q-loop by a short 310 helix, which seems to be conserved among the ECF transporters. 
This Q-helix has a conserved xPD/ExQφ (φ is a hydrophobic residue) motif, in which the 
conserved acidic residue and the conserved glutamine point to opposite sides of the helix. 
The later points into the groove and is therefore thought to play a role in interaction with 
the transmembrane domains.
The structures of the complete transporters revealed a L-shaped structure for 
EcfT, consisting of eight α-helices, of which five are transmembrane helices (TM1-
4 and TM8) (Figure 5D). Helix 5 (CH1) lies at the cytoplasmic side of EcfT almost 
perpendicular to the transmembrane helices, and helix 6 and 7 form two cytoplasmic 
coupling helices (CH2 and CH3, respectively), which stick with their C-terminal ends 
into the grooves at the surface of EcfA’ and EcfA, respectively. Together these coupling 
helices form a X-shaped bundle, which is stabilized by extensive hydrophobic interactions. 
The C-terminal end of these helices are formed by a conserved XRX motif, in which the 
first X is usually an alanine and the second a glycine or serine.50 This signature motif is 
participating in the interaction with the NBDs, and the interaction network is probably 
used to transfer conformational changes upon ATP binding and hydrolysis in the EcfAA’ 
dimer to the transmembrane domains of the transporter.
In the transmembrane part of the transporter, the S-components bind in the 
cleft of the L-shaped EcfT, being separated from the EcfAA’ dimer only by the coupling 
helices CH2 and CH3 (Figure 5D). TM1, TM2, the C-terminal end of TM3 and the 
C-terminal end of TM6 of all four S-components show a common surface, through which 
they interact with the coupling helices. CH2 of EcfT mainly interacts with TM1 and TM3 
of the S-components via hydrophobic interactions and the ΦxxxΦ motif in TM1. CH3 
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lies in a hydrophobic groove formed by TM1, TM2 and the C-terminal end of TM6 of the 
S-components. A similar groove is found in RibU, ThiT and BioY. TM1, TM2 and the 
C-terminal ends of TM3 and TM6 contain several small hydrophobic residues that form 
an extensive hydrophobic interaction network with small hydrophobic residues in the 
coupling helices. This interaction network is important for the formation and stabilization 
of the whole transporter.46 A second interaction site is formed by residues in the L3 and L5 
loop of the S-components and residues in TM1, TM3 and TM4 in EcfT.
Mechanism of transport
Type I importers
The maltose transporter MalFGK2 from E. coli is the best-studied Type I 
importer.4,6 In fact, a lot of what we know of full-length Type I ABC transporters comes 
from crystal structures of MalFGK2-MBP, elucidated by the Davidson and Chen labs. 
Currently, structures of the maltose transporter in the inward-facing apo-state without 
the maltose-binding protein (MBP) [SV in Figure 6];19,20 in the outward-facing state with 
maltose, nucleotides and MBP bound [SIV in Figure 6];6,14 and a pretranslocation state 
between the inward-facing and outward-facing state, with maltose and MBP bound and 
in the presence [SIII → SIV in Figure 6]9 and absence of nucleotides [SIII → SIV in Figure 
6]21 are available. However, there is not yet a crystal structure of the nucleotide-bound 
inward-facing conformation (SI-SIII in Figure 6).
In growing cells, the levels of ATP (typically millimolar) are well above the KD 
for binding of ATP to the NBDs and this primes the translocator for import (Figure 6, 
SV → SI). In SI, the translocator is in the nucleotide-bound inward-facing conformation. 
Upon substrate capture via induced fit, the SBP changes conformation from open to 
closed (SII) and, subsequently, docks onto the translocator (SIII). Through the binding of 
the SBP in the closed, liganded state to the TMDs and Mg-ATP bound in the NBDs, the 
so-called pre-translocation state is formed (SIII), that is, the NBDs come closer together, 
forming a tipping for the access of the binding site in the TMDs. The binding energy of 
both ATP and the SBP is used to transit the translocator from an inward to an outward-
facing conformation (SIII → SIV), which allows the transfer of the substrate from the 
SBP to the TMD (SIV). Subsequent hydrolysis of ATP and release of ADP and inorganic 
phosphate (Pi) completes the reaction cycle and releases the substrate on the other side of 
the membrane (SIV → SV).
In another model of a Type I importer, based on biochemical studies of the maltose 
transporter, the open state of the SBP interacts with the TMDs in the outward-facing 
conformation, which then allows the binding of maltose.51 Upon subsequent hydrolysis of 
ATP, the transporter converts to the inward facing conformation and releases the maltose 
into the cytoplasm. This model finds little support in the work on other Type I ABC 
importers, and the initiation of translocation through binding of the SBP in the open state 
is controversial. In fact, this model of the Duong lab is based on studies in nanodiscs in 
which the coupling between maltose-MBP binding and ATP hydrolysis is relatively poor 
compared what others measure,52 and MalFGK2-MBP may not have been in a fully native 
conformation.
 An outstanding question is whether substrate recognition (selectivity) by ABC 
importers is counted for solely by the SBP or whether the TMDs also contribute. For 
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Figure 6: Model of the transport mechanism for Type I ABC importers. The subunits of the 
schematic transporter are coloured as in Figure 1.
the maltose system, there is data suggesting that part of the selectivity originates from 
the TMDs.53–55 For instance, mutants that function independent of the maltose-binding 
protein still transport no sugars other than maltodextrins.54 In a recent structural study by 
the Chen lab,21 it was shown that the transmembrane subunit MalF binds three glucosyl 
units from the non-reducing end of the sugar, suggesting that both MBP and the TMDs 
contribute to the selectivity of the transporter. 
Another point of discussion is the stoichiometry of the transport reaction, 
which is technically challenging to determine. Many ABC transporters display poor 
coupling between ATP hydrolysis and translocation when purified and reconstituted in 
lipid vesicles, that is, significant amounts of ATP are hydrolysed even in the absence of 
substrate. Another difficulty is that the substrate and ATP need to be present on opposite 
sides of the membrane, and the affinity of the TMDs for the SBP is low.56–58 The Type I 
ABC importer OpuA transports glycine betaine and is gated by ionic strength. It has the 
SBD covalently linked to the TMD, which facilitates the membrane reconstitution and the 
ability to perform functional assays. Importantly, below threshold levels of ionic strength, 
there is hardly any ATP hydrolysis provided the lipid composition is “physiological” (>25 
mol % of anionic lipids, 40-50% non-bilayer lipid).59,60 Under these conditions and upon 
activation of the transporter, the experimental ATP/glycine betaine ratio was 2.0 ± 0.5,61 
suggesting a mechanistic stoichiometry of 2. At present this is probably the best estimate 
of the ATP/substrate ratio for any ABC transporter.
A subset of ABC importers has additional domains fused to the NBDs, which 
serve to control the activity of the transporter. MalFGK2-MBP from E. coli and OpuA 
27
General introduction to the structural features and transport mechanisms of ABC importers
Chapter 1
from Lactococcus lactis are the best-studied systems in terms of regulation of transport. 
The C-terminal domain of MalK of the maltose transporter is involved in carbon catabolite 
repression, which determines the hierarchy of sugar utilization and is also known as an 
inducer exclusion mechanism.62  The C-terminal domain of MalK can interact with IIAglc, 
a component of the bacterial phosphoenolpyruvate-dependent sugar phosphotransferase 
system (PTS). IIAglc can be in the unphosphorylated and phosphorylated state, depending 
on the availability of PTS sugars.63,64 In the unphosphorylated form, that is, when a PTS 
sugar such as glucose is present, IIAglc binds to MalK and thereby prevents uptake of 
maltose, the inducer of the maltose operon. It has been recently shown that IIAglc stabilizes 
the inward-facing conformation of the maltose transporter by wedging between the NBD 
of one MalK and the regulatory domain of the opposite MalK.20 Herewith, the closure 
of the NBDs and thus the formation of the outward-facing conformation are prevented, 
which are key steps for ATP hydrolysis and maltose translocation. The inhibition is 
relieved when glucose is exhausted and IIAglc becomes phosphorylated.
The activity of OpuA increases with the osmolality of the medium, which is 
signaled to the protein as an increase in the cytoplasmic electrolyte concentration (gating 
by ionic strength). Two cystathionine-β-synthase (CBS) domains fused in tandem (CBS 
module) to the C-terminus of the NBD and an anionic membrane surface are central to 
the gating of the transporter by ionic strength.65,66 CBS2 is involved in electrolyte sensing, 
whereas the CBS1 domain merely serves as linker between the nucleotide-binding domain 
(NBD) and the CBS2 domain.67 In one model, the interaction of the CBS module with an 
anionic membrane surface locks the transporter in an inactive conformation. Increasing the 
intracellular ionic strength beyond threshold levels screens the electrostatic interactions 
of oppositely charged surfaces and activates the transporter. Alternatively, the ionic 
gating of OpuA could involve two like-charged surfaces, such as the anionic membrane 
and anionic protein residues, in which case a high ionic strength would promote their 
interaction. The verdict is not yet out, but it is evident that screened electrostatic forces 
and an anionic membrane surface are intrinsic to the gating mechanism of OpuA.
For a number of Type I ABC transporters, it has been observed that trans-
accumulated substrate inhibits the translocation. In L. monocytogenes and Lactobacillus 
plantarum, the transport of glycine betaine and carnitine is inhibited by pre-accumulated 
(trans) substrate at 0.1 M or above.68,69 Upon raising the medium osmolality, the 
corresponding ABC transporters are rapidly activated through a diminished trans-
inhibition. Once cellular osmostatic conditions are restored, the transporters are switched 
off. This so-called trans-inhibition serves as a control mechanism to prevent the 
accumulation of the compatible solutes glycine betaine and carnitine to too high levels and 
thereby prevents the turgor pressure from becoming too high. Although the physiological 
effect is the same, trans-inhibition is mechanistically different from the ionic strength 
gating observed in OpuA. The ABC transporter OpuA is not inhibited by trans-substrate 
up to at least 400 mM.61 For two Type I ABC transporters, the structural basis for trans-
inhibition has been elucidated, that are the methionine transporter MetN2I2 from E. coli 
and the molybdate transporter ModB2C2 from M. acetivorants. In both cases, the NBD 
subunits have a C-terminal regulatory domain albeit with distinct folds.18,23 The MetN2I2 
system is inhibited when cytoplasmic levels of methionine reach threshold values,70 
and the binding of methionine to the C-terminal domain stabilizes the transporter in the 
inward-facing conformation, similar to what IIAglc does to the maltose transporter. The 
ModB2C2 system is inhibited by the binding of molybdate or tungstate to its C-terminal 
regulatory domain.
In summary: In recent years, we have obtained enormous insight into the 
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energetics and mechanism of transport and selectivity for ligands, as well as the gating 
of a subset of Type I importers. The regulation of ABC transporters is typically affected 
through one or more additional domains, linked to the NBD, which allow the transporter 
to be fully switched off under certain nutrient or osmotic conditions, even if substrate and 
ATP are available.
Type II importers
Type I and Type II importers differ in their architecture of the SBP and TMDs, but 
also mechanistically these transporters appear to operate differently.4,71–73 The mechanism 
of transport by a Type II importer presented in Figure 7 is based on crystal structures of 
each of the states.30 The vitamin B12 transporter BtuCDF from E. coli is the best-studied 
Type II importer,27 and most of the states are based on structures of this transporter, 
except for state SIII, which is based on the structure of MolB2C2 from H. influenza.31 
The structural analysis suggests two cytoplasmic and one periplasmic gate(s), depicted 
as vertical (brown) and horizontal (gray) bars, respectively (Figure 7). SI represents the 
nucleotide-bound, outward-facing conformation. The ligand-bound SBP docks onto 
the translocator and this results in an occluded state (SII), following the diffusion of the 
ligand from the SBP to the TMDs. Next, ATP is hydrolysed and inorganic phosphate 
and ADP are released, which opens the cytoplasmic gate II and the substrate diffuses 
into the cytoplasm (SIII). The SIII → SIV transition is only possible after the substrate has 
been released, as in the case of BtuCDF the cavity in the TMDs has become too small 
to accommodate vitamin B12. Korkhov and colleagues speculate that SIV may prevent the 
back-reaction or non-specific solute transport through the translocation pathway.30 Next, 
the SBP dissociates from the translocator and the TMDs rearrange to form an outward-
facing conformation (SV). Given the high intracellular concentrations of ATP, SV is rapidly 
converted into SI; the ATP binding closes the cytoplasmic gate II and the system is reset 
for another translocation cycle.
The BtuCDF system has a very high apparent ATP/substrate stoichiometry 
in the order of 50 to 1,74 which may reflect a high rate of ATP hydrolysis of SI or, as 
Korkhov and colleagues propose, SIV to SI-like transitions.30 This results in futile ATPase 
activity and a high apparent ATP/substrate stoichiometry; the mechanistic stoichiometry 
for full translocation is most likely 2. Contrary to the maltose transporter, there are no 
specific interactions between the substrate (vitamin B12) and the TMDs (BtuC subunits). 
The substrate pocket is very hydrophobic and forms a “Teflon-like” wall to prevent 
interactions with the hydrophilic substrate.10 The NBDs of Type II importers discovered 
so far do not have extra domains and gating mechanisms (osmotic, catabolite or product 
control) are not known.
In summary: Although Type I and Type II importers both employ extracytoplasmic 
SBPs or SBDs and operate by alternate access of the binding pockets in the TMDs, the 
mechanism of transport is very different. For instance, in the maltose transporter (Type 
I), the liganded-SBP interacts with the inward-facing TMDs, whereas in the vitamin B12 
transporter (Type II), the liganded SBP interacts with outward-facing TMDs. Accordingly, 
the subsequent steps are different for Type I and Type II importers.
Type III importers
Apart from what has been revealed by the three crystal structures of the complete
29
General introduction to the structural features and transport mechanisms of ABC importers
Chapter 1
Figure 7: Model of the transport mechanism for Type II ABC importers. The subunits of the 
schematic transporter are coloured as in Figure 1, and the periplasmic and cytoplasmic gates are 
indicated by gray and brown bars, respectively.
ECF FolT, ECF PantT and ECF HmptT transporters from L. brevis during the first two years 
of this PhD research, not much was known about the transport mechanism of the Type III 
importers at the onset of this thesis. Unlike the Type I and Type II importers, the Type III 
importers contain a transmembrane domain that binds the substrate specifically without 
the help of a soluble SBP. At least 21 different S-component families are known, which are 
able to bind a wide range of small, chemically different substrates.75,76 Molecular dynamic 
simulation studies on the S-component ThiT for thiamin from L. lactis have shown that 
the six hydrophobic α-helices of the protein zig-zag through the lipid bilayer, with the 
connecting loops being located alternatively on the cytoplasmic and the extracellular side 
of it.48 In the nine crystal structures of the substrate-bound S-components available, the 
substrate-binding site is located near the extracellular surface of the proteins.11,34–41 The 
site is formed by residues in the three C-terminal helices of the S-components together 
with residues in the L1 and L3 loops. These residues create specific, high-affinity binding 
sites with Kd values in the low nanomolar range.11,34,39–41,77,78 The structure of the binding 
site of ThiT from L. lactis has shown to be very robust, suggesting that a substantial 
input of energy, presumably in the form of ATP hydrolysis or conformational changes 
induced upon interaction with EcfT, are needed to accomplish conformational changes 
in the binding site to release the substrate (Chapter 2).79 The N-terminal helices of the 
S-components are structural more similar and provide interaction sites to interact with  the 
EcfT domain. In the substrate-bound S-components, the substrate-binding site is closed 
by the L1 loop. However, in the structures of the complete transporters, the L1 loop has 
moved away, opening the binding site to the cytoplasm.11,44–46 This is in agreement with 
EPR studies performed on ThiT from L. lactis, which showed that the major difference 
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between substrate-bound and substrate-free ThiT is a conformational change of the L1 
loop.48
Based on the three crystal structures of the ECF transporters from L. brevis, a 
model for the transport mechanism was proposed. This model is described in the following 
paragraph. However, new models are proposed in Chapters 5 and 7 after obtaining more 
mechanistic insight.
In the structure of the three complete transporters from L. brevis, the S-component 
adopts a highly unusual orientation, lying almost parallel in the membrane like it has 
toppled over from the orientation of the solitary S-components (SI in Figure 8).44–46 The 
S-component interacts with EcfT, but not with the NBDs, via two interaction sites, with 
the interactions between TM1, TM2 and the C-terminal ends of TM3 and TM6 of the 
S-components and the coupling helices of EcfT forming the largest interaction interface. 
The two coupling helices create a X-shaped structure, of which the C-terminal ends stick 
into the grooves between the RecA-like domain and the helical domain at the surface of 
the EcfAA’ dimer. Via an interaction network of electrostatic interactions and hydrogen 
bonds, these coupling helices are thought to transfer the conformational changes upon ATP 
binding and hydrolysis to the S-component. Like the NBDs in other ABC transporters, the 
EcfAA’ dimer will undergo a tweezer-like closure upon ATP binding (SII in Figure 8).47 
This will probably push the C-terminal ends of the coupling helices together, creating 
a scissor-like conformation. The interactions between the S-component and EcfT are 
mainly hydrophobic (vanderWaals), which allows the subunits to slide along each other. 
ATP binding might allow the S-component to rotate back to the up-right conformation 
in the membrane in order to capture its substrate on the extracytoplasmic side, while 
maintaining the interaction with EcfT.47 It is also possible that in this orientation, the 
interaction between the substrate-free S-component and EcfT is weakened and the two 
will dissociate, allowing another substrate-bound S-component to bind (SIII in Figure 8).80 
Early research has shown that within the group II ECF transporters, multiple S-component 
can compete for the same ECF module and that the affinity of the S-component for the ECF 
module is dependent on the substrate concentration, with substrate-bound S-components 
binding stronger to EcfT than S-component in the absence of their substrate.81 ATP 
hydrolysis and subsequent release of the hydrolysis products will then allow the coupling 
helices to move back to the open-scissor conformation and allow the S-component to 
topple over (SIV in Figure 8). The energy generated by ATP hydrolysis could be used 
to lower the binding affinity for the substrate, so it can be released into the cytoplasm. 
This mechanism would be new form of the moving-carrier mechanism, in which the 
S-component moves as a rigid body like in the elevator mechanism, but topples over 
to expose the substrate binding site to the cytoplasm, rather than making a translational 
movement as in the elevator mechanism.
A 1:1:1:1 stoichiometry was found in the crystal structures of the complete 
transporters and this stoichiometry has been confirmed by light scattering experiments 
performed on the type II ECF transporters from L. lactis.82 On the other hand, a 1:1:2:2 
(A:A’:T:S) stoichiometry was suggested for the group II riboflavin transporter from 
T. maritima,43 and oligomeric EcfT and S-components were suggested for the group I 
biotin transporter from R. capsulatus.83–85 The former result is difficult to reconcile with 
the crystal structures, but in the latter case it is possible that two or more complexes 
oligomerized in the membrane, and that the basic complex has 1:1:1:1 stoichiometry. 
Besides the debate on stoichiometry, rare solitary S-components have been found that 
seem to function independent of the ECF module. These S-components were identified in 
organisms that do not have the genes encoding the ECF module. An example is the biotin 
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Figure 8: Model of the transport mechanism for Type III ABC importers. The subunits of the 
schematic transporter are coloured as in Figure 1.
specific S-component BioY, found in almost all Chlamydia strains, diverse proteobacterial 
and cyanobacterial species.76,86,87 Furthermore, BioY and the cobalt- and nickel-specific 
S-components CbiMN and NikMN from R. capsulatus may facilitate substrate entry into 
the cell in the absence of the ECF module.88,89 Maybe these S-components topple over 
spontaneously in the membrane, a transition that would be energetically unfavorable but 
such rare events may suffice to allow the cell to take up small amounts of micronutrients. 
The S-components could also oligomerize and subsequently assist each other in the 
toppling in the membrane, or they could be assisted by unknown protein(s).
In conclusion: Type I and Type II ABC importers employ extramembranous 
substrate-binding proteins to capture their substrate and deliver the molecule to the 
translocator. Type III ABC importers use an integral membrane protein (S-component) 
for the binding of substrate; transport is thought to take place by reorientation of the 
S-component in the membrane. Whereas full structures of Type I and Type II ABC 
importers with and without SBPs are available, the translocation mechanism by Type III 
importers awaits further biochemical and structural analysis.
Outline of this thesis
This thesis is focusing on the structural features and the transport mechanism 
of the ECF transporters (type III importers). In Chapters 2-4, substrate-binding to the 
S-component ThiT of the ECF ThiT transporter for thiamine from E. coli is studied. ThiT 
binds its natural substrate thiamine with sub-nanomolar affinity (KD = 0.122 nm) and 
the crystal structure of ThiT in complex with thiamine shows that the substrate interacts 
with several residues within the substrate-binding pocket.35,78 In Chapter 2, thiamine 
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derivatives are designed and synthesized in such a way, that various moieties of the 
original thiamine molecule are altered one by one. These derivatives are subsequently 
used to study the contribution of the different interactions between thiamine and ThiT 
to the high binding affinity by determining the binding affinity and investigating the co-
crystal structures of ThiT in complex with these thiamine derivatives. In Chapter 3, a 
second generation of derivatives is designed and synthesized in order to explore a small, 
lipophilic cavity on one end of the substrate-binding pocket of ThiT, and these derivatives 
were docked into the available crystal structure of human thiamine-binding proteins to 
get insight in the selectivity of the compounds. Chapter 4 continues the work of Chapter 
2 making use of new thiamine derivatives as well as binding-site mutants. Besides, other 
new thiamine derivatives are used to explore a large, extended cavity on the other site 
of the substrate-binding pocket, with the goal to trap the S-component in a substrate-
bound state and thereby inhibiting the transport cycle. Molecular dynamic simulations 
were performed to see if conformational changes in ThiT were induced upon binding of 
two thiamine derivatives, and in vivo studies pointed out one derivative that had an effect 
on cell growth.
Chapters 5-7 focus on the ECF FolT2 transporter for folate from L. delbrueckii 
and its mechanism of transport. The organism L. delbrueckii has two S-components for 
folate, FolT1 and FolT2, which both interact with the same ECF module. Chapter 5 reveals 
the crystal structures of folate-bound FolT1 and two crystal structures of the complete 
ECF FolT2 transporter, in the apo state and in complex with the slowly hydrolysable ATP 
analogue AMP-PNP. Together with data on the transport activity, this work results to a 
new working model for the transport mechanism of ECF transporters, which is consistent 
with all available experimental data on these transporters. Chapter 6 describes the 
optimization of the reconstitution of ECF FolT2 and ECF NiaX for niacin from L. lactis in 
phospholipid bilayer nanodiscs, a relatively new membrane model system which is used 
to study the ATPase activity of the ECF transporters. Subsequently, Chapter 7 focusses 
on the dissociation of the S-component from the ECF module during the transport cycle. 
Together with information obtain from the biochemical characterization and mutagenesis 
of ECF FolT2, these results lead to an updated version of the working model proposed 
in Chapter 5. To validate this new model, attempts are made to crystallize ECF FolT2 in 
a nucleotide-bound state. In Chapter 8, the search of druggable pockets on the surface 
of ECF FolT2, followed by a virtual screening study, results in the identification of a 
compound that inhibits folate transport by ECF FolT2 in proteoliposomes. 
Chapter 9 summaries the content of this thesis, giving an overview on where 
we are standing now, and suggests how research on the transport mechanism of ECF 
transporters can proceed from this point.
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Structure-based design of potent small-molecule 
binders to the S-component of the ECF transporter for 
thiamine
This chapter is based on: Lotteke J. Y. M. Swier*, Leticia Monjas*, Albert Guskov, 
Alrik R. de Voogd, Guus B. Erkens, Dirk J. Slotboom and Anna K. H. Hirsch (2015) 
ChemBioChem 16:819-826
(*) Shared first authorship.
Energy-coupling factor (ECF) transporters are membrane-protein complexes that 
mediate vitamin uptake in prokaryotes. They bind the substrate using a specific 
integral membrane subunit (S-component) and power transport by hydrolysis of 
ATP in the three-subunit ECF module. Here, we have studied the binding of thiamine 
derivatives to ThiT, a thiamine-specific S-component. We designed and synthesized 
derivatives of thiamine that bind to ThiT with high affinity, which allowed us to 
evaluate the contribution of the functional groups to the binding affinity. We 
determined six crystal structures of ThiT in complex with our derivatives. The 
structure of the substrate-binding site in ThiT remains almost unchanged despite 
substantial differences in affinity. The work indicates that the structural organization 
of the binding site is robust and suggests that substrate release, which is required for 
transport, requires additional conformational changes in ThiT that may be imposed 
by the ECF module.
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Introduction
 ATP-binding cassette (ABC) transporters are found in all kingdoms of life and 
involved in many crucial processes.1 The recently discovered energy-coupling factor 
(ECF) transporters form a structurally distinct subtype of ABC transporters.2,3 These 
transporters mediate the uptake of a wide variety of substrates, among which are water-
soluble vitamins, cofactors, their precursors and the transition-metal ions Co2+ and Ni2+.4 
ECF transporters are found in prokaryotes, but have not been identified in eukaryotes. 
Within the kingdom of Bacteria, the transporters are found in particular in the phylum 
of the Firmicutes. This phylum includes many human pathogens such as Staphylococci, 
Streptococci, Enterococci and Listeriae.3,5 These pathogens lack enzymes for the de novo 
synthesis of many vitamins and cofactors and are dependent on membrane proteins such 
as the ECF transporters for the uptake of these molecules. Because of their absence in 
humans, ECF transporters are potential targets for the development of novel antibiotics.
 ECF transporters feature the basic architecture of ABC transporters consisting 
of two cytoplasmic nucleotide-binding domains (NBDs) and two transmembrane 
domains (Figure 1A). One of the transmembrane domains is responsible for substrate 
binding and is termed the S-component. The mode of substrate binding is one of the 
defining characteristics of ECF transporters, because other ABC transporters that import 
substrates in prokaryotes invariably make use of soluble extra-cytoplasmic binding 
proteins or domains. The identical or similar NBDs of ECF transporters (EcfA and EcfA') 
bind and hydrolyze ATP. The energy released in this process is hypothesized to induce 
conformational changes within and between the different domains of the transporter, 
which allows transport of the substrate across the membrane. These conformational 
changes are thought to be transduced from the NBDs to the S-component and vice versa 
via the second transmembrane domain called EcfT. EcfA, EcfA' and EcfT together form 
the eponymous energy-coupling factor or ECF module.
 Although the architecture of three ECF transporters has been revealed recently,6–8 
the transport mechanism is not fully elucidated. To investigate this mechanism, we 
focused on substrate binding to the S-component ThiT from Lactococcus lactis. ThiT is 
a 21 kDa protein that binds its natural substrate thiamine (vitamin B1, compound 1) with 
sub-nanomolar affinity.9 Thiamine is a precursor of thiamine diphosphate (TDP), which 
is used as a cofactor in many enzymes that perform decarboxylations and are involved 
in essential cellular processes.10 TDP and its precursor thiamine monophosphate (TMP) 
can bind to ThiT as well, but with lower affinities.9 The crystal structure of ThiT from 
L. lactis in complex with thiamine has been solved in 2011 at 2.0 Å resolution (PDB 
code: 3RLB).11 The structure shows that the protein consists of six transmembrane helices 
(Figure 1B). The substrate-binding pocket is located on the extracytoplasmic side of the 
membrane and formed by residues in helices 4–6, and residues in loops L1 and L3, which 
are located between helices 1 and 2 and helices 3 and 4, respectively. The flexible L1 loop 
shields the substrate-binding pocket from the surrounding solvent in a lid-like manner, 
with W34 playing a major role in the substrate occlusion (Figure 1C).12 The substrate-
binding site is connected to the exterior of the protein via an opening of a diameter of 
7–9 Å, which provides multiple interaction sites for extended small molecules. Thiamine 
interacts with several residues in the binding pocket (Figure 1D and Figure S1A and 
S2A in the Supplemental Information): the aminopyrimidine moiety acts as an anchor 
involved in hydrogen bonds with residues E84, H125, Y146 and N151, as well as a π–π 
stacking interaction with W133. The thiazolium ring is forming π–π stacking and cation–π
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Figure 1: Architecture of an ECF transporter and the structure of thiamine-bound ThiT of L. 
lactis. A) Schematic representation of an ECF transporter in which the nucleotide-binding domains 
EcfA and EcfA' are shown in two shades of red, the transmembrane domain EcfT in cyan, the 
S-component in yellow and the membrane in gray. The cytoplasmic and extracytoplasmic space 
are indicated by the words "In" and "Out", respectively. B) Secondary-structure representation of 
ThiT, colored from the N-terminus in blue to the C-terminus in red. Helices 1–6 are indicated by 
H1–H6. Thiamine is shown in stick representation and colored using the following color code: 
C: dark green, O: red, N: blue, S: yellow. This color code for the oxygen, nitrogen and sulfur 
atoms is maintained throughout the thesis. C) Close-up of the substrate-binding pocket of ThiT 
with surface and secondary-structure representation. The surface of the L1 loop between helices 
1 and 2 is colored light blue, while the remainder of the surface is shown in gray. Residue W34 
is shown in dark blue and stick representation, and thiamine is represented as in Panel B. D) The 
residues involved in the binding of thiamine are shown in stick representation with their carbon 
atoms colored gray, while the other atoms and thiamine are colored as in Panel B. The dashed 
lines indicate electrostatic interactions and hydrogen bonds and the gray spheres represent water 
molecules. Figures 1B-D were generated with Pymol version 1.7.6, using chain A of structure PDB 
3RLB.11
interactions with W34 and H125, and the positively charged nitrogen atom is stabilized 
by an ionic interaction with E84. The hydroxyl group forms a hydrogen bond with Y85.
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Here, we rationally designed derivatives of thiamine such that the various 
moieties of the original thiamine molecule were altered one by one to explore the space 
within the substrate-binding pocket. The aim of this study was to trap the protein in 
previously undetected conformational states, which would provide new insights in the 
mechanism of binding and transport. Furthermore, given that the ECF transporter for 
thiamine is essential for the uptake of this vitamin in some pathogenic bacteria, this 
study can be a first step on the way to develop new antibiotics, which can block thiamine 
transport and thereby interfere with essential cellular processes within these bacteria.
Results
Design of small-molecule modulators.
 Based on the interactions observed between the thiamine molecule and the 
residues of ThiT in the crystal structure, we designed small molecules and tested their 
ability to interact with ThiT in order to determine which functional groups of thiamine 
are crucial for high-affinity binding (Figure 2). MOLOC software was used for molecular 
modeling,13 and the preferred orientation of the molecules in the binding pocket and the 
estimated free energies of binding were obtained with the FlexX docking module14 and 
the scoring function HYDE in the LeadIT suite, respectively.15,16
 It has been previously reported that when the thiazolium ring of thiamine (1) is 
substituted by a pyridinium ring (compound 2), the affinity of the new molecule for ThiT 
is essentially the same as for thiamine (Table 1).9 When the hydroxyl group from the 
hydroxyethyl side chain is mono- or diphosphorylated (compounds 3 and 4), the binding 
affinity decreases by one order of magnitude (Table 1).9 First, we performed docking 
studies for compounds 1–4, for which the KD values had been determined previously, 
to benchmark how well the docking program performs on our target protein and class 
of compounds. According to the estimated Gibbs free energy of binding (ΔGest), we 
could predict that compounds 1 and 2 should have higher binding affinity for ThiT than 
compounds 3 and 4, and this matched with the experimental data retrieved from intrinsic 
fluorescence titration assays (Table 1). In our design, we maintained the aminopyrimidine 
moiety of thiamine in order to preserve the interactions between this part of the molecule 
and ThiT. We explored different modifications in the rest of the molecule: the thiazolium 
ring and the hydroxyethyl side chain. The thiazolium ring was substituted for different 
aromatic moieties, such as a thiophenyl (compound 5) or a phenyl ring (compound 6), to 
evaluate the effect on the π–π stacking interaction of this moiety with residues W34 and 
H125. In order to analyze the importance of the hydroxyethyl side chain of thiamine (1), 
we designed derivatives of 5 and 6 featuring a hydroxymethyl side chain (compounds 7 
and 8) or an aldehyde group (compound 9) to evaluate the importance of the hydrogen 
bond with Y85. The predicted binding poses of the new derivatives are almost identical 
to the one of thiamine, with differences only in the hydrogen bonds formed by the new 
groups introduced instead of the hydroxyethyl substituent of thiamine (Figure S1 in the 
Supplemental Information).
Ligand-binding measurements by an intrinsic fluorescence titration assay.
 By monitoring the intrinsic protein fluorescence upon addition of ligand, we 
determined the KD values for compounds 5–9 (Table 1). Using the same method, the KD
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A
B
Figure 2: Small-molecule binders for ThiT. A) Structure of thiamine (1) with the names of the rings 
and the hydroxyethyl group indicated. B) Structures of pyrithiamine (2), thiamine monophosphate 
(3), thiamine diphosphate (4), and the designed and synthesized small molecules (5–9).
values for compounds 1–4 had been determined in a previous study.9 Replacing the 
positively charged nitrogen atom in the thiazolium ring of thiamine (1) by a carbon atom 
in 5 resulted in an increase in KD to 4.23 nM. Replacing the thiazolium ring of 1 for 
a phenyl ring in compound 6 led to a decrease in binding affinity, resulting in a KD of 
266 nM. Variations of the hydroxyethyl side chain of 5 did not have a significant effect, 
as shown by the KD values of 5.21 and 7.44 nM for compounds 7 and 9, respectively. 
Shortening the hydroxyethyl side chain in compound 6 by one carbon atom in compound 
8, led to an increase in KD up to 528 nM.
Co-crystallization of ThiT with small-molecule binders and structure determination.
To visualize how the small molecules bind to ThiT, we performed co-crystallization 
of substrate-free ThiT, purified in 0.35% (w/v) of n-nonyl β-d-glucopyranoside (NG) and 
in the presence of various concentrations of compounds 2 and 5–9 (Table 2), at 5 °C 
using the vapor diffusion hanging drop method. All crystals were obtained under the 
same conditions as for ThiT with thiamine, using a reservoir solution of 0.15 M NH
4
NO3, 
20% (w/v) PEG 3350. The crystals grew to full size in one to two weeks and had the 
symmetry of space group C2. All structures were solved to 2.0–2.5 Å resolution (Table 2). 
The data processing and refinement statistics are shown in Table S1 in the Supplemental 
Information.
A comparison of the overall crystal structures of ThiT complexed with the 
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Table 1: Binding affinities of ThiT for various small molecules as determined in the ligand-binding 
assay, the experimental and estimated Gibbs free energies of binding (ΔG). The errors indicate the 
standard deviations and the estimated values are based on the scoring function HYDE.15,16
Compound KD ± S.D. (nm) ΔGexp (kJ/mol) ΔGest (kJ/mol)
1 0.122 ± 0.0139 –57 –53
2 0.180 ± 0.0709 –56 –54
3 1.01 ± 0.149 –51 –50
4 1.60 ± 0.009 –50 –52
5 4.23 ± 1.69a –48 –52
6 266 ± 131b –38 –48
7 5.21 ± 3.19c –47 –46
8 528 ± 135c –36 –43
9 7.44 ± 1.67c –46 –40
a The error represents the standard deviation, obtained from four experiments.
b The error represents the standard deviation, obtained from three experiments.
c The error represents the range of the data from two experiments.
synthesized compounds with the structure of ThiT in complex with thiamine, revealed 
very subtle differences only in the spatial orientations of the α-helices. Like for ThiT 
complexed with thiamine, two molecules of ThiT (chain A and B) were present in the unit 
cell binding one small molecule each. Comparison of the binding sites in the different 
chains showed only slight differences in the orientation of water molecules, except for 
the structures with compounds 6 and 8. The superposition of the six structures with the 
corresponding chain of ThiT in complex with thiamine gave RSMD values between 0.274 
and 0.379 Å, indicating that they are almost identical (Table 2).
When zooming in to the residues of ThiT involved in substrate binding, we
Table 2: Conditions for co-crystallization of ThiT with small-molecule binders and diffraction 
results.





2 100 2.1 0.282 0.276
5 10 2.5 0.341 0.322
6 40 2.0 0.310 0.379
7 10 2.2 0.305 0.274
8 10 2.4 0.332 0.361
9 10 2.2 0.287 0.317
a Used during purification and crystallization.
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noticed significant changes in orientation of the side chains only for W34 in the complex 
with compounds 6 and 8. Figures 3A–F show the binding site residues in chain A of 
ThiT co-crystallized with compounds 2 and 5–9, respectively. The binding sites in chain 
B of ThiT are shown in Figure S2 in the Supplemental Information. The π–π stacking 
interactions of the thiazolium ring sandwiched between W34 and H125 are conserved 
in most of the co-crystallized structures as we predicted (Figure S1 in the Supplemental 
Information). In the co-crystallized structures with compounds 6 and 8, W34 has moved 
in the direction of the pyrimidine ring, making a CH–π interaction with this ring. In the 
binding site of compound 6 in chain B of the structure (Figure S2D in the Supplemental 
Information), W34 is located even further away from the pyrimidine ring, making it 
possible for a PEG molecule to bind nonspecifically in the binding pocket. For compound 
8, W34 is in similar position compared to the structure of ThiT in complex with thiamine 
in the binding site in chain A (Figure 3E). However, the electron density for this residue 
extends to the side of the pyrrole moiety of the indole, showing that it could also adopt 
the position shown in the binding site in chain B (Figure S2F in the Supplemental 
Information). Despite the movement of the side chain of W34 and broadening of the 
entrance to the binding pocket in case of these two compounds, the backbone of the L1 
loop maintains its position.
The electrostatic interaction of E84 with the positively charged nitrogen atom in 
the thiazolium ring is only conserved in the complex with compound 2, this being the only 
derivative in which the charged nitrogen atom is maintained. The hydroxyethyl group of 
compound 5 forms water-mediated hydrogen bonds with N29 and Y85. The same group 
of compound 6 forms hydrogen bonds through a single molecule of water with Y85 and 
H72. The hydroxymethyl or aldehyde group of compounds 7 and 9 form water-mediated 
hydrogen bonds with the backbone carbonyl group of E84, the amino group of Lys121 
and the hydroxyl group of Y85. In the case of compound 8, the phenyl ring has turned 
over, relative to its position for compound 6, so as to allow the hydroxymethyl group 
to form a direct hydrogen bond with the backbone carbonyl group of N151. Besides 
the ordered water molecule through which Y146 interacts with the pyrimidine ring of 
the ligands, there are a few other water molecules involved in connecting binding site 
residues with each other. The side chain of K121 is interacting with the backbone of E84 
via an ordered water molecule in all structures, which likely assures proper alignment of 
H125 with the ligand via the interaction between E84 and H125. Besides, the backbone 
of W34 makes interactions with the side chains of Y146 and N151 via ordered water 
molecules, which could help the backbone of loop L1 to keep its position.
Discussion
 We studied the binding of thiamine derivatives to ThiT, the S-component for 
thiamine in L. lactis, by modifying moieties of thiamine in a modular manner. Because the 
crystal structure of ThiT features promising pockets for expansion of thiamine adjacent 
to the thiazolium ring and the hydroxyethyl side chain, we focused on modifications of 
these moieties whilst keeping the pyrimidine moiety intact. The estimated ΔG values 
(ΔGest) from the docking studies correlate very well with the experimental ΔG values 
derived from the KD measurements by intrinsic fluorescence titration assays (ΔGexp). In 
addition, the binding poses observed by X-ray crystallography are in agreement with 
those predicted with computational methods, which highlights the power of docking 
studies when probing protein-ligand interactions. 
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Figure 3: Co-crystal structures of ThiT with small-molecule binders. The residues involved 
in the binding of the small-molecule binders are shown using the same format and color code as 
in Figure 1D. A-F) The carbon atoms of compounds 2, 5–9 are shown in magenta (PDB 4MUU), 
cyan (PBD 4MHW), violet purple (PDB 4MES), lime (PDB 4POV), orange (PDB 4N4D) and deep 
salmon (PDB 4POP), respectively. The figure was created using chain A of the corresponding PDB 
file.
Based on the KD values obtained from the intrinsic-fluorescence titration 
measurements, we conclude that the presence of the positively charged nitrogen atom 
in the central ring contributes to the picomolar binding affinity. Compounds 1 and 2, in 
which the thiazolium ring is replaced by a pyridinium ring, display comparable KD values 
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of 122 pM and 180 pM, respectively. Measuring KD values in the low nanomolar or 
picomolar range with high accuracy is difficult and with a ThiT concentration of 50 nM in 
the intrinsic-fluorescence titration assay, these values cannot be considered significantly 
differently. Replacement of the thiazolium ring by a thiophenyl ring, and thereby 
removing the positive charge, lowered the binding affinity about thirty-fold. Nonetheless, 
derivatives 5, 7 and 9 still bind with high affinity to ThiT (KD values between 4.2 and 
7.4 nM), showing that these analogues are suitable thiamine mimics. Removal of the 
positively charged nitrogen atom and the methyl group in compounds 6 and 8 compared 
to 2 led to a decrease in binding affinity, resulting in KD values in the upper nanomolar 
range. This indicates that the presence of the charged nitrogen in the context of a six-
membered ring provides a bigger contribution to interactions involved in binding than 
in the five membered ring. From the co-crystallization studies we could see that E84 
forms an electrostatic interaction with the positively charged nitrogen atom, which is 
lost when this nitrogen is missing. In addition, the charged nitrogen atom also enables 
cation–π interactions with W34 and H125. In absence of the charged nitrogen, only π–π 
interactions can be formed, which result in a weaker interaction of the substrate between 
W34 and H125. In case of co-crystallization with compounds 6 and 8, W34 moved in 
the direction of the pyrimidine ring, leaving only H125 to form π–π interactions with 
the phenyl ring of the compounds. Both changes decreased the binding affinity with KD 
values of 266 and 528 nM for compounds 6 and 8, respectively. 
 When comparing compounds 5 and 7 featuring a thiophenyl ring with compounds 
6 and 8 with a phenyl ring, the binding affinity is about fifty to seventy-fold lower in the 
presence of the phenyl ring. The difference in affinity could be explained by the sulfur 
atom in compounds 5 and 7, which can make S–π interactions with W34 and His125, 
and the methyl group at C-4, which could also contribute by CH–π interactions with 
Y85. Furthermore, different alignments of the dipole moments of the aromatic moieties 
could also account for the observed difference in affinity. Removing the methyl group 
in compounds 6 and 8 leads to a loss of van der Waals interactions. In case of these two 
compounds, the side chain of W34 adopts different conformations compared to the other 
co-crystal structures, which can also be a reason for the drop in binding affinity.
 Having investigated the importance of the central ring, we next examined the 
importance of the hydrogen-bonding interaction with Y85. To do so, we modified the 
hydroxyethyl group in compounds 7–9. Compound 7 shows that shortening the spacer 
by one carbon atom to a hydroxymethyl group does not change the binding affinity 
significantly compared to compound 5. In case of compounds 6 and 8, the same shortening 
roughly increases the KD value by twofold. In case of compound 8, the interaction with 
Y85 is lost and instead, a new hydrogen bond is formed with the carbonyl group of N151. 
This carbonyl group is in closer proximity than Y85, but the interaction with N151 does 
not seem to contribute to the binding affinity to the same degree as an interaction with 
Y85. In addition, compound 8 also interacts with the backbone carbonyl group of W34 
via an ordered water molecule. The lack of interactions between compound 8 and residues 
E84, Y85 and K121 via an ordered water network may weaken binding, thereby lowering 
the binding affinity to a larger extent compared to the binding affinity of compound 6. The 
interaction of the aldehyde group of compound 9 with Y85 appears to contribute to the 
binding affinity almost as well as the hydroxyethyl group in compound 5, so there is no 
real preference for a hydrogen bond donor or acceptor on this side of the substrate, given 
that most interactions between the ligands and Y85 are water-mediated. Besides, in the 
binding site in chain B of ThiT in complex with thiamine (Figure S2A in the Supplemental 
Information), the hydroxyethyl group of thiamine has turned away from Y85 and is now 
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forming a hydrogen bond with the side chain of E38. This indicates that the interaction 
between Y85 and the ligand is not particularly important and does not make a major 
contribution to the high-affinity binding.
 At the outset of this study, we hypothesized that the designed thiamine derivatives 
could trap ThiT in previously undetected conformational states, which would allow us to 
follow the conformational changes that take place upon substrate binding and release. 
Surprisingly, in spite of differences in the affinity by over three orders of magnitude 
(compounds 1 and 8), the crystal structures of ThiT with the bound thiamine derivatives 
were almost identical. The only difference that we observed in the binding-site residues is 
a rotation of the side chain of W34 located in loop L1 when compounds 6 and 8 are bound. 
The different orientation of W34 slightly opens the entrance to the binding site pocket, 
but the backbone of loop L1 maintains its position, keeping the substrate-binding pocket 
intact. Although this observation is consistent with the EPR studies on ThiT that showed 
that the main structural difference between apo-ThiT and the thiamine-bound protein is 
the conformation of loop L1,12 it does not provide the anticipated mechanistic insight into 
the mechanism of binding. Apparently, the structure of the binding site in the S-component 
is so robust that it stays intact, even if lower-affinity substrates bind. This robustness 
has direct consequences for the transport mechanism employed by the ECF transporter. 
We hypothesize that the S-component “topples” in the membrane only if the loop L1 is 
closed. Interaction with the ECF module might be required for “toppling”, which results 
in the exposure of the binding site to the cytoplasmic side of the membrane, where the 
substrate can be released. Possibly ATP hydrolysis is needed for opening of the binding 
site and substrate release. Indeed, in the context of the entire complex (S-component and 
ECF module) of ECF FolT from Lactobacillus brevis, the substrate-binding site of the 
S-component FolT (for folate) is disrupted and the loop L1 has moved out.6 We speculate 
that substantial input of free energy is required to accomplish the conformational changes 
in the S-component’s binding site, which are necessary for transport and release of the 
substrate. This energy is probably provided by the association with the ECF module and 
by binding and hydrolysis of ATP by the NBDs.
 The observation that the thiamine derivatives bind to ThiT with high affinity is 
very promising for another reason. It suggests that the versatile scaffold of the derivatives 
that lack the thiazolium ring (compounds 5, 7 and 9) could be further modified, which 
is an important step in the design of new derivatives. They can assist not only in the 
elucidation of the transport mechanism but also in the development of novel antibiotics 
against pathogenic bacteria that depend on ECF transporters for their survival.
Experimental Section
Modeling and docking of small–molecule binders.
 The crystal structure of ThiT in complex with thiamine was used for modeling 
(PDB code: 3RLB).11 Thiamine derivatives were designed using the program MOLOC,13 
and the energy of the system was minimized using the MAB force field implemented in 
this software, while keeping the protein coordinates as well as the crystallographically 
localized water molecule (HOH196) fixed. Hydrogen bonds and hydrophobic interactions 
were measured in MOLOC. The designed thiamine derivatives were subsequently docked 
into the binding pocket of ThiT by using the FlexX docking module in the LeadIT suite.14 
During docking, the binding site in the protein was restricted to 8.0 Å around the co-
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crystallized thiamine, and the 30 top-scored solutions were retained and subsequently 
post-scored with the scoring function HYDE.15,16 After careful visualization to exclude 
poses with significant inter- or intramolecular clash terms or unfavorable conformations, 
the resulting solutions were subsequently ranked according to their binding energies.
Expression and purification of ThiT.
 Expression of native ThiT with N-terminal His8-tag was performed as described 
previously with some modifications.9,11 Briefly, L. lactis NZ9000 cells with pNZnHisThiT 
plasmid were grown semi-anaerobically in chemically defined medium without thiamine 
and supplemented with 2.0 % (w/v) of glucose and 5 μg/mL of chloramphenicol in a 10 
L bioreactor at 30 °C and pH 6.5.17,18 At an OD600 of 1.5, expression of ThiT was induced 
by addition of 0.1 % (v/v) of culture supernatant from a nisin A producing strain.17 The 
cells were induced for 3 hours and harvested at a final OD600 of 7–8. After harvesting and 
washing by centrifugation (15 min, 7,446 x g, 4°C), the cells were resuspended in buffer 
A (50 mM potassium phosphate buffer (KPi), pH 7.0), frozen in liquid nitrogen and stored 
at –80 °C.
 The preparation of membrane vesicles was performed as described previously 
with some modifications.9 After the resuspended cells had been thawed, 5 mM of 
MgSO
4
 and 375 µg/mL of DNase were added. The cells were lyzed by high-pressure 
disruption (Constant Cell Disruption Systems Ltd, UK; twofold passage at 269 MPa 
and 4 °C), and the cell debris was separated from the membrane vesicles by low-speed 
centrifugation (30 min, 27,167 x g, 4°C). The membrane vesicles were harvested by high-
speed centrifugation (120 min, 185,677 x g, 4°C) and resuspended in buffer A to a final 
concentration of 10 mg/mL, frozen in liquid nitrogen and stored at –80 °C.
 For the purification of substrate-free ThiT, membrane vesicles were rapidly 
thawed and resuspended in buffer B (50 mM KPi, pH 7.0, 200 mM KCl, 10 % (w/v) 
glycerol) to a final concentration of 6–10 mg/mL. For the co-crystallization experiments 
with ThiT, certain concentrations of compounds 2, 5–9 (Table 2) were added to all buffers 
used during the purification. The membrane vesicles were solubilized using 1 % (w/v) 
of n-dodecyl-β-D-maltoside (DDM, Anatrace), for 1 hour at 4 °C while gently rocking. 
The undissolved material was removed by centrifugation (30 min, 442,906 x g, 4°C). 
The supernatant was incubated with Ni2+-Sepharose resin (column volume = 0.5 mL), 
equilibrated with buffer B, for 1 hour at 4 °C while gently rocking. Subsequently, the 
suspension was poured in a 10 mL disposable column (Bio-Rad) and after collecting the 
flow through, the column material was washed with 20 column volumes of buffer C (50 
mM KPi, pH 7.0, 200 mM KCl, 50 mM imidazole, 0.15 % (w/v) of n-decyl-β-D-maltoside 
(DM, Anatrace)). In case of purifying the protein for crystallization, DM was replaced by 
n-nonyl-β-D-glucopyranoside (NG) (0.35 % (w/v), Anatrace). The protein was eluted in 
three fractions of 350 μL, 650 μL and 500 μL of buffer D (50 mM KPi, pH 7.0, 200 mM 
KCl, 500 mM imidazole, 0.15 % (w/v) DM). Also here, DM was replaced by NG (0.35 
% (w/v)) when purifying the protein for crystallization. To the second elution fraction, 
which contained most of the purified protein, 1 mM of EDTA was added and this fraction 
was purified over a Superdex 200 10/300 gel filtration column (GE Healthcare) using 
buffer E (50 mM KPi, pH 7.0, 150 mM KCl, 0.15 % (w/v) DM). In case of purifying the 
protein for crystallization, buffer F (20 mM HEPES, pH 7.0, 150 mM KCl, 0.35 % (w/v) 
NG) was used for gel filtration chromatography. After gel filtration chromatography, the 
fractions containing ThiT were used directly for further analysis or concentrated using 
a Vivaspin 2 concentrator device with a molecular weight cut-off of 50 kDa (Sartorius 
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stedim) to a final concentration of 6-10 mg/mL and used for crystallization.
 
Ligand-binding measurements by an intrinsic fluorescence titration assay.
 The ligand-binding measurements by intrinsic fluorescence titration 
were performed as described previously using a Spec Fluorlog 322 fluorescence 
spectrophotometer (Jobin Yvon) with some modifications.9 Purified ThiT was diluted in 
buffer E to a concentration of about 50 nM in a final volume of 800 μL. The substrates 
were added in 1 μL steps using a Harvard apparatus syringe pump equipped with a 500 μL 
gastight glass syringe (Hamilton). Using an excitation wavelength of 280 nm, emission 
was measured at 350 nm and 25 °C. After each addition of substrate, 10 s were allowed 
for equilibration and mixing, and the signals were averaged over 15 s. The data analysis 
was performed as described.9
Co-crystallization of ThiT with small-molecule binders and structure determination.
 The concentrated ThiT, purified in NG (0.35% (w/v)) and in the presence of 
compounds 2, 5–9 (see Table 2 for the concentrations used), was used to set up 24-
well hanging drop crystallization plates using a reservoir solution consisting of 0.15 M 
NH
4
NO3 and 20% (w/v) PEG 3350. Hanging drops of 2 μL were set up in a 1:1 ratio 
of concentrated-protein solution to reservoir solution. The plates were incubated at 5 
°C and after one to two weeks, crystals appeared. For cryoprotection, a cryoprotection 
solution (15 mM NH
4
NO3, 40% (w/v) PEG 3350 or 50% (w/v) PEG 3350) was used 
when the crystals were fished. Diffraction data were collected at the DESY, Hamburg 
(ThiT co-crystallized with compounds 6, 7 or 9) and the ESRF, Grenoble (ThiT co-
crystallized with compounds 2, 5 or 8). Data processing was carried out using XDS,19 
and molecular replacement was performed using Phaser MR of the CCP4 suite,20 using 
the structure of thiamin-bound ThiT (PDB 3RLB).11 Refinements were performed using 
both Phenix refinement and Refmac.21,22 Manual model building and the placement of 
substrate, detergent and PEG molecules was done using Coot.23 Refinement statistics are 
shown in Table S1 in the Supplemental Information. The crystal structures were deposited 
in the PDB with the following PDB codes: ThiT + compound 2: PDB 4MUU, ThiT + 
compound 5: PDB 4MHW, ThiT + compound 6: PDB 4MES, ThiT + compound 7: PDB 
4POV, ThiT + compound 8: PDB 4N4D, ThiT + compound 9: PDB 4POP.
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Figure S1: legend on page 55.
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Figure S2: legend on page 55.
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 of potent small-molecule binders to the S-component of the ECF transporter for thiamine
Figure S1: Binding modes of thiamine and the small-molecule binders. A-G) Schematic 
representation of thiamine and the top-ranked predicted binding modes of the small molecule 
binders 2 and 5–9 in the substrate-binding pocket of ThiT, obtained using the structure PDB 3RLB11 
and the program LeadIT.14 The figures were generated with PoseView24 as implemented in the 
LeadIT suite.
Figure S2: Co-crystal structures of ThiT with thiamine and small molecules. The residues 
involved in ligand binding are shown in the same format and color as in Figure 1D. A-G) The 
carbon atoms of thiamine and compounds 2, 5–9 are shown in dark green (PDB 3RLB), magenta 
(PDB 4MUU), cyan (PDB 4MHW), violet purple (PDB 4MES), lime (PDB 4POV), orange (PDB 
4N4D) and deep salmon (PDB 4POP), respectively. The detergent molecule in Panel D is shown in 
stick representation, with its carbon atoms colored brown. The figure was created using only chain 
B of the corresponding PDB file. 
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vitamin transport in bacteria
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Energy-coupling factor (ECF) transporters mediate the uptake of vitamins in 
bacteria. Given that these ECF transporters are not present in eukaryotic cells, they 
represent an interesting target for the development of novel antibiotics. Here, we 
present the design and synthesis of a second generation of compounds that bind to 
ThiT, the substrate-binding domain of the ECF transporter for thiamine from L. 
lactis. We modified the methyl substituent of the pyrimidine ring of thiamine, in 
order to evaluate its contribution to the binding affinity. Our results indicate that as 
long as a hydrophobic substituent is maintained, the high binding affinity is almost 




 As mentioned in Chapter 2, ECF transporters are predominantly found in Gram-
positive bacteria, including many human pathogens.1,2 A significant fraction of these 
human pathogens lack enzymes for the de novo synthesis of many vitamins and cofactors 
transported by ECF transporters, which makes the presence of these transporters essential 
for those pathogens. Given that eukaryotic cells do not make use of ECF transporters, 
but instead use unrelated secondary transport systems,3 ECF transporters represent an 
attractive target for the development of novel antibiotics. Studies on ECF transporters 
started only recently and the mechanism of transport is poorly understood. Five crystal 
structures of substrate-bound S-components,4–8 as well as three crystal structures of full 
transporters have been reported over the past five years,9–11 and have provided first insights 
into the structural basis of transport. Among these crystal structures was the structure of 
thiamine-bound ThiT from L. lactis.
 In the previous chapter, the first series of thiamine derivatives that bind to 
ThiT were described.13 These small-molecule binders were designed by modifying the 
thiazolium ring and the hydroxyethyl side chain of thiamine (1), and they show binding 
affinities for ThiT ranging over three orders of magnitude (KD = 0.18–528 nM), allowing 
us to understand how different functional groups contribute to the high binding affinity. 
In this chapter, we report a new generation of thiamine derivatives, in which we modified 
the methyl substituent of the pyrimidine ring of deazathiamine (2, Figure 1). This 
methyl group occupies a small, hydrophobic cavity in the substrate-binding pocket with 
a diameter of 4.3–6.5 Å, and the residues lining this cavity are conserved in different 
ThiT homologues.4,12 Our aim is to shed light on the mechanism of substrate binding 
and transport of ECF transporters by using modified substrates, which may lead to the 
development of new antibiotics that could block vitamin transport in pathogenic bacteria 
that rely on these transporters to survive. 
Results
Design of small-molecule binders.
 We designed small-molecule binders for ThiT using the co-crystal structure 
of ThiT in complex with its natural substrate thiamine (1; PDB ID: 3RLB).4 Thiamine 
interacts with many residues lining the substrate-binding pocket (Figure 2A): the amino 
group forms two hydrogen bonds with E84 and H125, the two pyrimidine ring nitrogen 
atoms form hydrogen bonds with N151, and, via an ordered water molecule, with Y146. 
The pyrimidine ring is also involved in a π–π-stacking interaction with W133, and the 
thiazolium ring of thiamine forms a π sandwich with W34 and H125. The positively 
charged nitrogen atom in the thiazolium ring is involved in an electrostatic interaction 
with E84. Finally, the hydroxyl group interacts via a hydrogen bond with Y85.
 In this chapter, we probed the role of the methyl substituent of the pyrimidine 
ring, which occupies a small lipophilic pocket, interacting with residues G129, W133, 
Y146, S147 and V150 (Figure 2B). The first four residues are well-conserved in different 
ThiT homologues, and mutagenesis studies have shown that G129, W133 and Y146 
are necessary to maintain the high binding affinity for thiamine (1).4,12 As mentioned 
before, W133 and Y146 are involved in π–π-stacking and hydrogen-bonding interactions, 
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1,
2,
Figure 1: Thiamine and one of its derivatives. The chemical structure of thiamine (1), 
















Figure 2: Thiamine-binding pocket of ThiT. A) The binding mode of thiamine in the binding 
pocket of ThiT (PDB ID: 3RLB).4 The substrate-binding residues of ThiT and thiamine are shown 
in stick representation, with the carbon atoms of ThiT and thiamine in gray and green, respectively. 
The black dashed lines indicate hydrogen bonds below 3.6 Å, and the gray sphere represents an 
ordered water molecule. B) Stereo view with surface representation of the residues lining the small, 
hydrophobic cavity occupied by the methyl group of thiamine, with the residues lining this pocket 
and thiamine shown as in Panel A. V150 is positioned behind the cavity.
respectively, with the pyrimidine ring of thiamine (1). In the case of G129, it only has 
hydrophobic and van der Waals interactions with the methyl substituent of thiamine 
(1). The G129A mutation shows a significant decrease in affinity (KD = 33.9 ± 3.9 nM), 
whereas the G129V mutation abolishes binding, most probably due to steric clashes with 
the ligand.12 Based on these findings, we wanted to probe possible extensions on the 




 We used the software MOLOC for molecular modeling,14 and the LeadIT suite 
to predict the binding mode (FlexX docking module)15 and to estimate the Gibbs free 
energy of binding (HYDE scoring function)16,17 of the designed molecules. Because the 
binding mode of deazathiamine (2) is almost the same as that of thiamine (1) (except for 
the electrostatic interaction of the positively charged nitrogen atom with E84, which is 
lost in the case of 2 given that it is a neutral molecule),13 we designed five new compounds 
with a thiophene ring instead of a thiazolium ring to make these compounds synthetically 
more accessible. We substituted the methyl group of the pyrimidine ring for groups with 
different properties (Figure 3): a hydrogen atom (3) or an amino (4), trifluoromethyl (5), 
ethyl (6) and isopropyl (7) group.
 Removal of the methyl group to afford the unsubstituted derivative 3, leads to a 
decrease in predicted binding affinity (Table 1, ΔGest = –44 kJ/mol) in comparison with 
our reference compound 2 (KD = 4.23 ± 1.69 nM, ΔGexp = –48 kJ/mol). The same trend is 
predicted when we introduce an amino group (4), in this case the loss of affinity would 
be even bigger (ΔGest = –38 kJ/mol). Compound 5, with a –CF3 group, which is more 
lipophilic than –CH3, would improve the binding affinity of deazathiamine (2), with a 
ΔGest = –56 kJ/mol. Alkyl groups such as an ethyl (6) and isopropyl (7) group would also 
bind with higher affinity compared to deazathiamine (2), with ΔGest = –57 and –50 kJ/
mol, respectively. According to these estimates, there is a clear trend: a polar group (NH2, 
compound 4) would have a weaker binding affinity than a hydrogen atom (compound 3), 
and alkyl groups would lead to stronger binding. When we tried to model groups bigger 
than isopropyl, the repulsions with residues G129, Y146 and V150 were too strong, and 
this would force the pyrimidine ring to adopt a different pose in the binding pocket, 
weakening the hydrogen bonds with E84, H125 and N151. Therefore, isopropyl appears 
to be the biggest substituent that ThiT can accommodate in this part of the substrate-
binding pocket.
Binding-affinity determination.
 We determined the binding affinities (KD values) of ThiT for the synthesized 
compounds by using an intrinsic protein fluorescence titration assay13 (compounds 3, 5–7) 
or isothermal titration calorimetry (ITC) (compound 4). In ITC, it is hard to determine 
accurate KD values in the low nanomolar range, since the transition between binding 
events and saturation of the protein with ligand is covered by only a few data points. In 
the intrinsic protein fluorescence assay, this transition is covered by far more data points, 
which allows the use of this assay to determine accurate KD values in the nanomolar range. 
However, for compound 4 we were unable to use the intrinsic protein fluorescence assay 
because no quenching of the intrinsic fluorescence upon ligand addition was observed.
 As predicted by modeling and docking, the binding affinities of compounds 3 (R 
= H) and 4 (R = NH2) are lower than the binding affinity determined for deazathiamine 
(2), with KD values in the micromolar range (Table 1). Compounds 5–7, which bear alkyl 
groups, have binding affinities in the same range as compound 2, with the KD of 6 (R = 
Et) being slightly, but not significant lower than that of 5 (R = CF3) and 7 (R = iPr), in 
agreement with the predictions of docking and scoring using the scoring function HYDE.
Docking of thiamine-derivatives in human thiamine-binding proteins.
As a preliminary evaluation of selectivity, we have docked the natural substrate
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3, R = H
4, R = NH2
5, R = CF3
6, R = Et
7, R = iPr
Figure 3: Second generation of small molecule binders. The chemical structure of the designed 
deazathiamine derivatives.
Table 1: Binding affinities of ThiT for thiamine and the small-molecule derivatives, with the errors 
indicating the standard deviations, together with the experimental and estimated Gibbs free energies 
of binding (ΔG). The latter is based on the scoring function HYDE.16,17
Compound KD ± S.D. (nm) ΔGexp (kJ/mol) ΔGest (kJ/mol)
1 0.122 ± 0.013 12 –57 –53
2 4.23 ± 1.69 13 –48 –52
3 (1.03 ± 0.187)*103 a –34 –44
4 (2.92 ± 0.420)*103 a –32 –38
5 8.48 ± 5.15a –46 –56
6 5.04 ± 0.92b –47 –57
7 13.6 ± 6.87c –45 –50
a The error represents the standard deviation, obtained from three experiments.
b The error represents the standard deviation, obtained from five experiments.
c The error represents the standard deviation, obtained from four experiments.
or cofactor and the new thiamine derivatives into the available crystal structures of 
human thiamine-binding proteins (Table 2). Although these proteins are not involved 
in the transport of thiamine across cell membranes, the docking studies provided an 
indication of the structural variation among thiamine-binding proteins. For thiamine 
pyrophosphokinase 1 (PDB ID: 3S4Y), the new thiamine derivatives 2–7 would bind to 
this enzyme, given that their ΔGest values are comparable to those of the natural substrate 
TDP. However, compound 4 featuring an amino group, would be considered as a weak 
binder. In case of transketolase (PDB ID: 3OOY), compounds 2 and 6 would bind as 
strongly as the natural substrate. Compound 7 is predicted not to bind to transketolase 
and should therefore be selective for ThiT. For thiamine triphosphatase (PDB ID: 
3TVL),18 only compound 5 with a trifluoromethyl substituent is predicted to bind with a 
predicted affinity comparable to that of the natural substrate/cofactor. And for branched-
chain α-ketoacid dehydrogenase (PDB ID: 1U5B),19 compounds 2–7 are predicted to be 
much weaker binders than the natural substrate. Upon subjecting the crystal structure of 
pyruvate dehydrogenase (PDB ID: 3EXE)20 to the same analysis, no reasonable docking 
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run could be performed using the LeadIT suite due to substantial intermolecular clashes. 
In summary, our docking study predicted compound 7 to be selective, since it is a strong 
binder for ThiT, whilst being predicted to be a weak binder for all other proteins, except 
for thiamine pyrophosphokinase 1.
Table 2: Estimated Gibbs free energy of binding (ΔGest) of thiamine derivatives for various human 
thiamine-binding proteins based on the scoring function HYDE.16,17




a -27a -31b -38a
2 -32 -27 -19 -30
3 -30 -19 -17 -24
4 -24 -13 -13 -20
5 -34 -23 -28 -30
6 -39 -31 -15 -28
7 -37 -3 -18 -27
PDB IDs = 3S4Y: human thiamine pyrophosphokinase 1, 3OOY: human transketolase, 3TVL: 
human thiamine triphosphatase,18 1U5B: human branched-chain α-ketoacid dehydrogenase.19
a thiamine diphosphate (TDP)
b thiamine triphosphate (TTP)
Discussion
We have shown that the methyl group of the pyrimidine ring of thiamine can 
be modified, maintaining the high binding affinity. The binding affinity of lipophilic 
groups (CF3, Et, iPr) is higher than that of more polar groups (NH2) or just a hydrogen 
atom. Steric effects are less pronounced than expected, with minor differences in binding 
affinity for the derivatives featuring -CF3, -Et, or -iPr groups. Apparently, the hydrophobic 
cavity that accommodates these groups is more flexible than expected.
Although the KD values of the new molecules are not significantly better than 
that of our reference compound deazathiamine (2), we have shown that the methyl 
group can be substituted for different groups (CF3, Et, iPr) without a substantial loss in 
affinity, which can be useful in future design of thiamine derivatives. This will allow us to 
design compounds with improved selectivity for ECF transporters over human thiamine 
transporters or thiamine-dependent enzymes, and with metabolic stability, as CF3 is 
metabolically more stable than CH3.
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Experimental section
Modeling and docking.
 The co-crystal structure of ThiT in complex with thiamine (PDB ID: 3RLB) was 
used.4 The program MOLOC,14 which has the MAB force field implemented, was used 
for modeling, keeping the coordinates of the protein and the water molecule HOH196 
fixed. Subsequently, the designed molecules were docked into the binding pocket of ThiT 
using the FlexX docking module of the LeadIT suite.15 For docking, the binding site of 
ThiT was restricted to 8.0 Å around the co-crystallized thiamine molecule, and the 30 top-
scored solutions were retained and subsequently post-scored with the scoring function 
HYDE.16,17 Poses with significant inter- or intramolecular clash terms or unfavorable 
conformations were excluded after careful visualization, and the remaining solutions 
were ranked according to their Gibbs free energy of binding.
 For docking of human thiamine-binding proteins, we selected the PDB files of 
wild-type proteins with the best resolution, with the exception of transketolase, given 
that the PDB ID: 3MOS,21 although having better resolution than EOOY, gave high 
intermolecular clashes using the LeadIT suite. Docking was performed following the 
same procedure as that for ThiT, and the binding pockets were prepared as follows: 
3S4Y: chains A and B, binding pocket restricted to 10 Å around the co-crystallized 
TDP, Ca2+ included; 3OOY: chains A and B, binding pocket restricted to 10 Å around 
the co-crystallized TDP, Ca2+ included; 3TVL18: chain A, binding pocket restricted to a 
10 Å sphere centered on the phosphorus atom of the alpha-phosphate group of the co-
crystallized triphosphate, Mn2+ included; 1U5B19: chain A, binding pocket restricted to 10 
Å around the co-crystallized TDP, Mn2+ included.
Expression and purification of ThiT.
 The expression and purification of wild type, substrate-free ThiT was performed 
as described previously in Chapter 2.13
Ligand-binding experiments.
For compounds 3 and 5–7, the binding affinity was determined using the 
intrinsic fluorescence titration assay described in Chapter 2,13 with 50 nM of ThiT in a 
final volume of 1000 µL of buffer A (50 mM KPi, pH 7.0, 150 mM KCl, 0.15 % (w/v) 
of DM (Anatrace)). For compound 4, the binding affinity was determined by isothermal 
titration calorimetry (ITC) using a MicroCal iTC200 apparatus (GE Healthcare) with a 
cell volume of 200 µL. The measurements were performed at 25 °C with 12.9 and 21.3 
µM of ThiT. A twenty-fold higher concentration of compound 4 was added in steps of 1 
µL. The data were analyzed using the MicroCal LLC iTC200 software.
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Many pathogenic bacteria lack biosynthetic pathways for the production of 
vitamins and rely on the ECF transporters for the uptake of these micronutrients. 
Since ECF transporters have been identified in prokaryotes only, they form an 
interesting target for the development of novel antibiotics. In this chapter, two sets 
of new thiamine derivatives for the S-component ThiT from L. lactis are presented. 
The first set was used to study substrate binding in combination with biochemical 
mutations, and identified the electrostatic interaction facilitated by residue E84 of 
ThiT as the main contributor to the sub-nanomolar binding affinity. The second 
set was used to probe a sub-pocket of the thiamine-binding pocket, which might be 
crucial for substrate transport. It contained one compound that bound to ThiT with 
lower affinity compared to the other compounds of this set, but which showed to 
inhibit cell growth in a manner unspecific to the full ECF ThiT transporter from L. 
lactis. Despite the fact that this compound would not be a suitable starting point for 
the development of antibiotics against ECF transporters, the results in this chapter 




 ECF transporters have only been identified in prokaryotes, where they mediate 
the import of essential micronutrients such as vitamins and their precursors, amino acids 
and the transition metal ions Co2+ and Ni2+. Given that these transporters are essential to 
many pathogenic bacteria that lack biosynthetic routes to obtain these micronutrients, they 
form a new target for the development of antibiotics. In order to create lead compounds 
that could be used in the early stage of antibiotics development, information is needed on 
the structural features and transport mechanism of these proteins. Over the past decade, 
ECF transporters have been studied extensively, and although some crystal structures 
of individual substrate-bound S-components and full-length ECF transporters have been 
reported,1–12 the knowledge about the mechanism of substrate-binding and transport is 
still limited.
 In this chapter, the study on substrate-binding to ThiT described in Chapters 2 
and 3,13,14 is continued. The crystal structure of ThiT in complex with thiamine (PDB ID: 
3RLB)2 shows that thiamine interacts with numerous residues lining the substrate-binding 
pocket (Figure 1A): the aminopyrimidine moiety forms hydrogen bonds with E84, H125, 
Y146 (via an ordered molecule of water) and N151, as well as a π–π-stacking interaction 
with W133; the thiazolium ring is involved in π–π-stacking and cation–π interactions 
with W34 and H125; the positively charged nitrogen atom of the same ring is forming 
an electrostatic interaction with E84; and the hydroxyl group is involved in a hydrogen 
bond with Y85. In Chapters 2 and 3, we described the binding of thiamine analogues 
with modifications in the thiazolium ring, hydroxyethyl side chain and methyl group 
of the pyrimidine ring, and we showed that ThiT still binds these designed compounds 
with high affinity (Figure 1B).13,14 In this chapter, we present a novel approach in which 
we rationalize ligand binding to ThiT by chemical and biochemical mutations in the 
ligand and in ThiT, respectively. In particular, we focus on the π–π-stacking interaction 
of the thiazolium ring of thiamine with residues W34 and H125, as well as the cation-π 
interaction with Glu84. These mutations will enhance our understanding of substrate 
binding by ThiT and be helpful for the structure-based design of small-molecule binders.
 In order to study the interactions with a new part of the substrate-binding pocket 
of ThiT that has never been explored and that may be crucial for substrate transport, we 
also present new molecules in which we extended the scaffold of compounds 2 and 3 at the 
hydroxyl group. These new compounds could provide us with valuable information about 
the mechanism of substrate binding and transport. In addition, they hold the potential 
to block thiamine transport and could therefore be developed into antibiotics with an 
unprecedented mode of action. We adopted a two-pronged approach in order to obtain the 
new compounds: we performed de novo design and used the KRIPO (Key Representation 
of Interactions in POckets) software,15 which creates a pharmacophore fingerprint of the 
binding site to identify similar pockets in unrelated proteins, leading to the proposal of 
the co-crystallized ligands as potential binders. Molecular-dynamics simulations enabled 
us to predict whether binding of these new compounds would induce conformational 
changes within ThiT. Besides, we performed in vivo assays to study the actual effect of 
the new compounds on thiamine transport.
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Figure 1: Ligand binding to ThiT. A) Binding mode of thiamine in the binding pocket of ThiT 
(PDB ID: 3RLB).2 Thiamine and the residues involved in binding are shown in stick representation, 
the gray spheres represent water molecules and the dashed lines indicate hydrogen bonds and an 
electrostatic interaction. B) Structure of thiamine (1) and five of the previously reported thiamine 
analogues (2–6), with their binding affinities.13 
Results
Variations in the ligand.
 When the thiazolium ring of thiamine is modified, the binding affinity of the 
thiamine derivatives changes: in the case of a thiophenyl ring (compounds 2 and 3), 
the KD increases about 30-fold, and in the case of a phenyl ring (compounds 5 and 6), a 
2000-fold increase in comparison to thiamine was observed (Figure 1B).13 In previously 
reported crystal structures,13 we observed that the π–π-stacking interactions of these 
aromatic rings with W34 were slightly different. In order to understand these changes in 
affinity, we wanted to investigate if the electronic properties of the aromatic ring could be 
responsible for the differences observed in affinity. To do so, we designed two derivatives 
of compound 5 with modifications in the phenyl ring based on the crystal structure of 
ThiT in complex with this thiamine analogue (5). When analyzing the binding mode 
of 5 in the pocket of ThiT (PDB ID: 4N4D),13 most of the interactions observed in the 
binding of thiamine are maintained (Figure 2A vs Figure 1A). The only difference is that 
in compound 5, the phenyl ring has flipped over such that the hydroxymethyl substituent 
is pointing towards N151 and is now forming a hydrogen bond with this residue instead 
of with Y85. In this way, there is space to extend the molecule in the direction of Y85 

















Figure 2: Design of small-molecules to test the electronic properties of the thiazolium 
substituent. A) Binding mode of compound 5 in the binding pocket of ThiT (PDB ID: 4N4D),13 
shown as in Figure 1A, with the carbon atoms of compound 5 colored orange. The black arrow 
indicates the potential point for extension. B) Chemical structure of compound 5 and its derivatives 
7 and 8. C) Chemical structure of the triazole derivative 9.
occupied by the hydroxyethyl group of thiamine (Figure 1A), thereby avoiding steric 
hindrance with the residues in the pocket. We introduced two substituents with opposite 
electronic effects: a methyl group as an electron-donating group and a trifluoromethyl 
functioning as an electron-withdrawing group (Figure 2B, compounds 7 and 8, 
respectively).
We determined the binding affinity of ThiT for compounds 7 and 8 by isothermal 
titration calorimetry (ITC). We expected one of the new compounds to be a stronger 
binder than compound 5, and the other one a weaker binder based on the differences in 
electronic properties of the new aromatic substituents. However, both compounds turned 
out to be weaker binders than compound 5, and display nearly identical KD values of 1.99 
± 0.636 μm and 2.30 ± 1.81 μm for 7 and 8, respectively (the errors represent the standard 
deviation from four experiments). Therefore, the reason why a thiamine analogue bearing 
a thiophenyl ring binds stronger to ThiT than a phenyl derivative cannot be explained by 
electronic effects. Apparently, the steric effects of the substituents play an important role, 
making it difficult to study one non-covalent interaction in isolation.
To further study this effect, we designed a new thiamine analogue bearing a 
triazole ring (9) in the position of the thiazolium ring (Figure 2C). We determined binding 
affinity of ThiT for this compound by ITC, yielding a KD value of 28.6 ± 10.1 μm (the error 
represents the standard deviation from three experiments). Taken together, we conclude 
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that the high binding affinity of the thiophene derivatives 2 and 3 are most likely ascribed 
to the sulfur atom, which engages in favorable S–π interactions with the aromatic residues 
W34 and H125.
Mutations in ThiT.
 Mutagenesis of four out of seven residues lining the binding site of ThiT, 
which were all involved in the interactions with the pyrimidine ring of thiamine, had 
been reported previously.16 In this chapter, we focus on the residues that interact with 
the thiazolium ring of thiamine (1): W34, E84 and H125 (Figure 1A). Previously, the 
W34A mutant proved to affect binding only to a minimal extent (Table 1).16 Here, we 
have studied the binding of thiamine to six new ThiT mutants, in which we have modified 
residues E84 and H125 (Table 1).
Table 1: Binding affinities of different ThiT mutants for thiamine, with the errors indicating the 
standard deviations or the range in the data.
Mutation KD ± S.D. (nm)
- (wild type) 0.122 ± 0.01316
W34A 0.35 ± 0.0516
E84D 2.21 ± 0.778a
E84Q (13.7 ± 3.62)*103 b
E84A (3.65 ± 1.71)*103 c
H125F no binding observed
H125N 13.6 ± 8.07c
H125A 14.9 ± 5.14a
a The error represents the standard deviation obtained from four experiments.
b The error represents the range in the data obtained from two experiments.
c The error represents the standard deviation obtained from five experiments.
 E84 forms an electrostatic interaction with the positively charged nitrogen atom 
of the thiazolium ring of thiamine, as well as hydrogen bonds with the amino group of the 
pyrimidine ring and with H125. Replacing E84 by an aspartate, shortens the amino acid 
side chain by one carbon atom, possibly increasing the distance to thiamine and thereby 
weakening the interaction, which could explain the 18-fold increase in KD value. However, 
when mutating into a glutamine or alanine residue, the interaction with thiamine becomes 
much weaker, leading to KD values in the micromolar range. These results highlight the 
importance of the negative charge on this residue and show that the resulting electrostatic 
interaction with thiamine appears to be the main contributor to the picomolar affinity.
 Within the thiamine-binding site, the side chain of H125 can form cation–π and 
π–π-stacking interactions with the thiazolium ring of thiamine as well as an hydrogen 
bond with the carbonyl side chain of E84 (Figure 1A). In case of the H125N mutant, the 
hydrogen bond with the carbonyl group in the side chain of E84 can still be conserved, 
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while this hydrogen bond is disrupted in the H125A mutant. The KD for thiamine in both 
mutants is similar (low-nanomolar range), but 100-fold higher compared to wild-type 
ThiT, which implies a low or no contribution of this hydrogen bond to substrate binding. 
Rather, the loss in affinity seems to be due to the disruption of the cation–π and π–π-
stacking interactions. When mutating H125 to a phenylalanine, no binding was observed. 
Compared to histidine, phenylalanine is unable to form hydrogen bonds. Besides, 
phenylalanine is bigger and possibly partially occupies the thiazolium-binding pocket, 
thereby preventing thiamine from binding.
 From these mutagenesis studies, we observed that E84 is very important for high-
affinity binding. Modification of the interaction with W34 or H125 has a smaller effect, 
most probably because these residues both form cation–π and π–π-stacking interactions 
with the thiazolium ring, enabling for one to compensate for loss of interaction by 
the other. These results support the fact that thiamine binds to ThiT with high affinity 
when the loop L1 is ‘open’.17 As a result, even if the π–π-stacking interaction with W34 
stabilizes the ligand in the substrate-binding pocket, that interaction is not crucial for 
sub-nanomolar affinity given that H125 can form cation–π and π–π-stacking interactions 
with the thiazolium ring as well. When thiamine is bound and the loop L1 closes over the 
substrate-binding pocket, W34 participates in this cation–π and π–π-stacking interaction 
network too, possibly helping to keep the S-component in the closed state until it has 
toppled over and substrate release on the other side of the membrane has been triggered.
Thiamine derivatives to explore an unoccupied sub-pocket.
When we analyzed the substrate-binding pocket of ThiT, we observed that the 
large pocket is only partially occupied by thiamine and extends in the direction of the 
hydroxyethyl substituent of thiamine (Figure 3). It would be informative to know if this 
empty sub-pocket plays an important role in substrate transport, given that molecules 
occupying this part of the substrate-binding pocket may block transport and become 
promising antibiotics. Considering that we do not rely on the thiamine-part of the pocket 
alone, these compounds would probably bypass or have fewer selectivity issues. 
 In order to design compounds that would form additional interactions with 
this sub-pocket, we used the software MOLOC18 for molecular modeling and the FlexX 
docking module and HYDE scoring function19,20 of the LeadIT suite to predict binding 
poses and to estimate the Gibbs free energy of binding of such compounds. In our design, 
we maintained the thiophenyl ring of our previously reported best binders (compounds 2 
and 3, Figure 1B). ThiT was shown to have high binding affinity for thiamine diphosphate 
(KD = 1.6 ± 0.00 nm),16 which carries two additional phosphate groups at the end of the 
original hydroxyethyl side chain of thiamine. When adding these two phosphate groups 
to our compound 3 to form deazathiamine diphosphate 10 (Figure 4), the binding affinity 
was decreased 50-fold compared to the affinity for compound 3, to a KD value of 209 ± 
98.0 nm (Table 2). This result suggests that extension of the thiophenyl ring into the large 
sub-pocket is possible, and even though we do not improve the affinity, the compounds 
might interfere with transport. The first approach to develop more extended molecules 
with nanomolar affinity was de novo design, by doing modeling and docking using the 
co-crystal structure of ThiT in complex with its natural substrate thiamine (1) (PDB 
ID: 3RLB).2 Given that the unexplored sub-pocket is rather big, we first tried if one 
aromatic ring would improve binding or interfere with the loop L1. This led to the design 
of compounds 11 and 12 (Figure 4), bearing a phenyl or an indolyl ring. These rings 
could form π–π-stacking interactions with W63 and Y85, or with W34, respectively, as
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Figure 3: The large substrate-binding pocket of ThiT. Structure of ThiT in complex with thiamine 
(PDB ID: 3RLB).2 The surface of ThiT is shown in gray, with the surface of the loop L1 (residues 






Figure 4: New generation of thiamine derivatives. Structure of deazathiamine diphosphate (10) 
and the compounds chosen to interact with the sub-pocket of ThiT obtained by de novo design 
(compounds 11-13) or by using KRIPO (compounds 14–16).
predicted by modeling and docking (Table 2, ΔGest = –55 and –56 kJ/mol, respectively). 
Careful visual inspection revealed several small cavities in the pocket. In order to interact 
with two of those small cavities at the same time within one molecule, we designed 
compound 13 (ΔGest = –61 kJ/mol).
 With the aim of improving our initial design, we used the software KRIPO15 
to identify fragments that can bind with high affinity in the unexplored sub-pocket. 
KRIPO creates a pharmacophore of the binding pocket, which is compared with 
pharmacophores of other proteins that are available in the PDB. Subsequently, the ligands 
(or fragments of the ligands) that bind to proteins displaying similar features as ThiT, 
are taken as potential binders of ThiT. We ran three individual searches with KRIPO 
and divided the unoccupied part of the pocket into three smaller sub-pockets (Figure 5). 
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Table 2: Binding affinities of ThiT for compounds 10–16, with the errors indicating the standard 
deviations, and the experimental and estimated (scoring function HYDE19,20) Gibbs free energies 
of binding (ΔG).
Compound KD ± S.D. (nm) ΔGexp (kJ/mol) ΔGest (kJ/mol)
10 209 ± 98.0a
11 40.3 ± 15.7b –42 –55
12 20.1 ± 3.30b –44 –56
13 168 ± 113c –39 –61
14 (49.8 ± 27.3)*103 b –25 –57
15 96.7 ± 23.7c –40 –48
16 183 ± 16.8c –38 –59
a The error represents the standard deviation obtained from five experiments.
b The error represents the standard deviation obtained from three experiments.
c The error represents the standard deviation obtained from four experiments.
Pocket A Pocket B Pocket C
Hydrophobe Positive charge Negative charge H-bond acceptor H-bond donor Aromatic
Figure 5: Results of the KRIPO search. Pharmacophore features of the three small sub-pockets 
A, B and C within ThiT.
For sub-pocket A, mainly hydrophobic fragments were found, and we selected 
an adamantyl moiety as the best fitting fragment. In case of sub-pocket B, we observed 
that a lot of hits were heterocycles containing nitrogen atoms and sugar moieties. As 
a result, we selected a pyridyl and a glucose moiety as representative fragments. The 
search with sub-pocket C led to a large variety of compounds, but when we modeled 
and docked these compounds into ThiT, we observed numerous repulsions with several 
residues. Therefore, we decided to continue only with the results for sub-pockets A and B. 
Taking into account the distance between our deazathiamine scaffold (compounds 2 and 
3) and the fragments identified with KRIPO, we designed synthetically accessible linkers, 
resulting in compound 14 (for pocket A, ΔGest = –57 kJ/mol), as well as compounds 15 
and 16 (both for pocket B, with ΔGest = –48 and –59 kJ/mol, respectively) (Figure 4).
The binding affinity of ThiT for the new compounds was determined by using 
the intrinsic fluorescence assay (compounds 10-13, 15 and 16) or by ITC (compound 
14) (Table 2). For compound 14, we were unable to use the intrinsic fluorescence assay, 
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since no clear quenching pattern of the intrinsic protein fluorescence was observed upon 
addition of this ligand. We observed that most of the new compounds bind to ThiT with 
high affinity, featuring KD values in the nanomolar range, despite the large modifications 
introduced with respect to the structure of thiamine. The binding affinities observed 
experimentally, however, do not match with our prediction as well as in our previous 
work. Upon ligand binding, the studied sub-pocket might display greater flexibility 
compared with the rather rigid thiamine-binding pocket, possibly explaining the observed 
discrepancy.
Evaluation of the effect of small-molecule binders in vivo. 
 In order to study the effect of the thiamine derivatives on the full ECF ThiT 
transporter in vivo, we performed growth assays in which the medium was supplemented 
with varying concentrations of compounds 11–16. In the first growth assay, the effect of 
these compounds on the growth of E. coli MC1061, carrying the sequence for ECF ThiT 
from L. lactis on the p2BAD plasmid,21,22 was studied (Figure 6). E. coli has a biosynthetic 
pathway for thiamine,23 so in case the compounds inhibit thiamine transport, cell growth 
should still be observed. However, if the compounds are taken up by the E. coli cells 
and appear to have a toxic effect, inhibition of growth should be observed. The control 
experiments in the absence or presence of 2% (v/v) of DMSO only, led to a minor delay in 
initial growth in the presence of DMSO, showing that the DMSO in which the compounds 
are solubilized, would not interfere with the effects of the compounds themselves (Figure 
6A). The presence of arabinose as an inducer of the ECF ThiT expression slows down cell 
growth after 4.5–5 hours when reaching an OD600 of 0.43–0.45, as a result of decreasing 
concentrations of nutrients. In the absence of arabinose, the growth slowed down in a 
less pronounced way from that point (after 4.5–5 hours) and the cells kept on growing 
slowly over the time frame of the complete experiment of 26 hours. An explanation for 
this difference could be that in the absence of induction, less nutrients are consumed 
to perform protein expression, and therefore enough nutrients are available to slowly 
continue growing over the time frame of the experiment.
 For the concentrations tested, the compounds 11, 12, 15 and 16 do not seem to 
affect growth as the OD600 signal increased about 0.3 a.u. within the first 5 hours with a 
growth rate similar to the control experiment with DMSO and arabinose only (Figure 
6B–C and 6F–G). In case of 11 and 12, the OD600 signal at the start of the experiments 
showed dose-dependence with higher values than for the control experiments and 
compounds 15 and 16. We ascribe this behavior to solubility problems of these compounds 
in the growth medium, with the precipitate causing light scattering. Compound 13 also 
showed solubility problems at 0.50 mm and 1 mm concentrations (Figure 6D). The OD600 
signal at these concentrations, however, did decrease over the whole time range of the 
experiment, implying that the compound slowly dissolves due to changes in the growth 
medium, and maybe also inhibits cell growth to some extent. Inhibition of cell growth by 
14 was clearer: at a concentration of 0.50 mm, the final OD600 was decreased by roughly 
50%, and no growth was observed in the presence of 1.0 mm of 14 (Figure 6E). Given 
that this compound is still soluble in 2% (v/v) of DMSO in growth medium at 1.0 mm 
concentration, this is the most promising candidate to inhibit cell growth.
 In order to see if compound 14 was taken up specifically by the ECF ThiT 
transporter for L. lactis and not via a different pathway in E. coli, the growth assay was 
repeated with E. coli MC1061 cells carrying the sequence of the ECF FolT2 transporter 










Figure legend on the next page
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Figure 6: Growth curves of E. coli MC1061 p2BAD ECF ThiT (from L. lactis) in the absence 
and presence of small-molecule binders. A) Growth curve in the absence or presence of 2% (v/v) 
of DMSO or 1*10-3 % (w/v) of l-arabinose, as indicated by the legend in the figure. B–G) Growth 
curves in the presence of various concentrations of 11 (B), 12 (C), 13 (D), 14 (E), 15 (F) and 16 (G), 





+ DMSO, ECF ThiT
- DMSO, ECF ThiT
+ DMSO, ECF FolT2
- DMSO, ECF FolT2
+ DMSO, -
- DMSO, -
Figure 7: Growth curves of E. coli MC1061 p2BAD ECF ThiT (from L. lactis), E. coli MC1061 
p2BAD ECF FolT2 (from L. delbrueckii) and L. lactis NZ9000 in the absence and presence of 
small-molecule binders. A) Growth curves of the different organisms (ECF ThiT: E. coli MC1061 
p2BAD ECF ThiT, ECF FolT2: E. coli MC1061 p2BAD ECF FolT2, -: L. lactis NZ9000) in the 
absence or presence of 2% (v/v) of DMSO as indicated by the legend in the figure. B –D) Growth 
curves of the different organisms at equal concentration of 14 (B), 15 (C) and 16 (D), as indicated 
by the legends in the figures.
same time, cells of the L. lactis NZ9000 strain were taken along,24 which would be able to 
express the endogenous ECF ThiT transporter. In the control experiments in the absence 
and presence of 2% (v/v) of DMSO, again only a minor delay in initial growth in the 
presence of DMSO was observed (Figure 7A). In the presence of 1.0 mm of 14, the 
growth of all three organisms was drastically affected (Figure 7B). In case of the E. coli 
cells with the ECF ThiT plasmid, growth was delayed by about 15 hours. An explanation 
why at least some growth was seen this time compared to the previous experiment, can 
be that the cells at some point managed to cope with the presence of 14. For the E. coli 
cells with the ECF FolT2 plasmid, growth was clearly affected as well, implying that 14 
was not taken up specifically by the ECF ThiT transporter. E. coli has an endogenous 
ABC transporter for thiamine,25 which could take up the compound. Alternatively, growth 
might be affected in a different manner, without requiring uptake. Control experiments 
with 15 and 16 for all three organisms only showed a somewhat slower start of growth 
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for the L. lactis cells (Figure 7C–D), but this was in no comparison to the effect of 14.
Molecular-dynamics simulations.
 We have performed molecular-dynamics (MD) simulations of thiamine (1) and 
compounds 13 and 14 in the substrate-binding pocket of ThiT to gain further insight 
into the substrate-protein interactions. We observed that during the simulation time the 
protein structure remains stable when thiamine or 13 are bound. However, 14 generated 
changes in the protein conformation with respect to the original ThiT + thiamine crystal 
structure (Figure 8A). The same trend is observed when we look at the RMSD variations 
of the ligands (Figure 8A). Thiamine and 13 show on average a relative low dynamic 
behavior compared to 14. These results indicate that in the case of compound 14, both the 
protein and the ligand need to sample multiple conformations to find the best fit. In fact, 
when we look at the dynamics of loops L1, L3 and L5 of ThiT (Figure 8B), we see some 
movement of loop L3 for simulation of 14-bound ThiT. This observation can be explained 
by the fact that the adamantyl fragment of compound 14 mainly interacts with residues 
in helix 3 (W63, S67), helix 4 (E84, Y85) and the L3 loop (H72, A73, Y74) (Figure 
8D). Evaluation of the MD simulation suggests that the main difference after 40 ns is 
a conformational change of the side chain of Y74 moving away from 14. Interestingly, 
conformational changes of this loop L3 play a role during the transport cycle of the ECF 
FolT2 transporter for folate form L. delbrueckii (Chapter 5).10 The fact that 14 is less well 
accommodated in the substrate-binding pocket of ThiT might explain the weaker affinity 
of this compound for ThiT (KD in the upper micromolar range).
 In agreement with our predicted binding poses from modeling and docking, we 
observe that compounds 13 and 14 display a similar binding mode in the simulations, 
maintaining the thiamine scaffold in the same conformation as in the case of the MD 
simulation and the crystal structure of thiamine bound to ThiT, with the new fragments 
(two phenyl rings and one adamantyl moiety for 13 and 14, respectively) occupying the 
new sub-pocket (Figure 8C).
Discussion
In this chapter, the contribution of the interactions between ThiT residues and 
the thiazolium ring of thiamine was further investigated using both chemical mutations 
in the sense of new thiamine derivatives, as well as biochemical mutations in ThiT. The 
chemical mutations indicated that the electronic properties of the aromatic ring occupying 
the thiazolium-binding pocket are not the only crucial factor for high binding affinity, 
given that analogues bearing groups with opposite electronic properties (compounds 7 
and 8) display nearly the same binding affinity for ThiT. The fact that these compounds 
are bulkier than our reference compound 5, cannot be the only reason why their binding 
affinities dropped, given that an analogue of thiamine bearing a triazole ring (compound 
9), also showed a binding affinity in the micromolar range. Therefore, the sulfur atom 
of the thiophenyl ring (compounds 2 and 3) must be crucial for high-affinity binding, 
probably due to S–π interactions that it undergoes with W34 and H125.
The biochemical mutations indicate that E84 is the main contributor in the 
high affinity substrate binding. We observed that when the electrostatic interaction with 
the positively charged nitrogen atom of thiamine is weakened or disrupted, the binding
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Figure 8: Molecular dynamics simulations of ThiT binding thiamine, compound 13 and 
compound 14. A) Dynamics of ThiT and the bound ligands (thiamine: black, 13: blue, 14: red), 
with RMSD variations of the back bone carbon atoms of ThiT and the ligand atoms plotted as a 
function of the simulation time of 50 ns. B) Dynamics of the residues in loops L1 (black), L3 (blue) 
and L5 (red), with the RMSD variations plotted as in A. C) Superimposition of the most abundant 
poses of thiamine-, 13- and 14-bound ThiT observed during the simulations, shown in cartoon 
representation and colored pale green, teal and gray, respectively. Thiamine, 13 and 14 are shown 
in sticks and their carbon atoms are colored green, light blue and dark gray, respectively. The loops 
L1, L3 and L5 are indicated. D) Close-up of 14 binding to ThiT, with the residues predicted to be 
involved in hydrogen bonding with 14 shown in sticks. The residues involved in interactions with 
the characteristic tail of 14 are indicated.
affinity decreases by at least one order of magnitude. This result matches with our previous 
observations when we replaced the thiazolium ring of thiamine with a thiophenyl ring 
(compound 3).13 In addition, the hydrogen bond of this residue with the aminopyrimidine 
moiety can be necessary for nanomolar affinity too. H125 can, however, be replaced by 
small residues without any aromatic properties, although the binding affinities increase 
about 18-fold when the cation–π and π–π-stacking interactions are abolished. To study 
if any aromatic residue in this position would maintain the sub-nanomolar affinity, 
we mutated H125 to a phenylalanine, but no binding was observed, probably because 
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phenylalanine is bigger and does not allow thiamine to fit into the pocket.
In addition, we have shown that both de novo design and the use of KRIPO are 
efficient methods for the design of ligands for ThiT. The new compounds were predicted 
to bind in the thiamine-binding pocket, and at the same time, the substituents were 
appended onto our deazathiamine scaffold to occupy a sub-pocket of ThiT that had not 
been studied before. Most of the novel compounds bound to ThiT in the nanomolar range, 
except for compound 14 that has an adamantyl group occupying the new sub-pocket 
and binds in the upper micromolar range. It is remarkable that these ‘big compounds’ in 
comparison with thiamine, are still able to bind with such a high affinity. Even though 
none of the compounds has a better affinity than thiamine, we need to consider that the 
concentration of thiamine in the natural environment of prokaryotes is rather low. Hence, 
the S-component could easily be saturated with one of the thiamine analogues, which 
could be provided in higher concentration to compensate for the lower affinity.
In order to see if binding of these big thiamine derivatives to ThiT in the full 
ECF ThiT transporter would lead to transport and a subsequent effect, growth assays 
were performed. In these assays we observed that only compound 14 clearly affected 
growth of both E. coli and L. lactis strains, although the mechanism of action remains 
unknown. For the other compounds, no clear effect was observed. This does not mean that 
these compounds could not be transported into the cells, but rather that upon transport, 
these compounds would not be toxic to the cells. The MD simulations provided insight 
into the binding of 14 to ThiT, showing that ThiT has to be more flexible in order to 
accommodate this compound in the binding pocket compared to the simulations with 
thiamine and 13, which is in line with the lower affinity that this compound displayed. 
However, comparing the superimposition of the most abundant poses in the simulations 
of all three ligands revealed no significant differences, implying that the complete ECF 
ThiT transporter should be able to transport 14 into the cell. 
The fact that the toxic effect was not restricted to cells containing the ECF 
ThiT transporter, does not make 14 a suitable starting point for the development of 
antibiotics against ECF transporters. In order to see if one of the other compounds would 
be inhibiting thiamine transport in a specific way, a different growth assay should be 
set up with a thiamine-depending bacterial strain. However, this chapter has shown 
that with the information on substrate binding and our workflow of design, synthesis, 
biological evaluation and MD simulations of our thiamine derivatives, we have obtained 
tools to successfully extend thiamine derivatives in such a way that substrate binding and 
probably transport are still possible. 
Experimental section
Modeling and docking.
 The crystal structure of ThiT in complex with thiamine (PDB ID: 3RLB)2 
was used for modeling and docking, keeping the coordinates of the protein and the 
crystallographically localized water molecule HOH196. The software MOLOC18 was 
used for molecular modeling, the MAB force field of this program was used to minimize 
the energy of the system, and the hydrogen bonds and hydrophobic interactions were 
measured. Then, the designed molecules were docked into the binding pocket of ThiT 
considering 12.5 Å around the co-crystallized thiamine, by using the FlexX docking 
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module of the LeadIT suite. Subsequently, the 30 top-scored solutions were post-scored 
with the scoring function HYDE.19,20 After visual inspection, poses with significant inter- 
or intramolecular clash terms or unfavorable conformations were excluded, and the 
resulting solutions were ranked according to their Gibbs free energy of binding.
KRIPO search.
For the KRIPO search, we used the December 2013 version of the KRIPO 
database of target–ligand complexes, which contained all protein–ligand complexes 
deposited in the PDB at that time. The pocket of ThiT was divided in three sub-pockets, 
and the pharmacophore used by KRIPO in the three queries consisted of the following 
features:
- Subpocket A: hydrophobic contacts from F22 and L26; negative charge from E38; 
hydrogen bond acceptors from S25 (OH side chain and CO backbone), E38, S67, H72 (N 
imidazole side chain and CO backbone), Y74 and Y85; and hydrogen bond donors from 
Trp63.
- Subpocket B: hydrophobic contacts from W63, A88 and P89; positive charge from 
K121; negative charge from E38; hydrogen bond acceptors from E38, S67 and E85 (CO 
backbone); and aromatic interactions from W63, Y85 and H125.
- Subpocket C: hydrophobic contacts from W34, I36, I39, A40, W63 and Y74; negative 
charge from E38; hydrogen bond acceptors from S25 (CO backbone) and Y85; hydrogen 
bond donors from N29 and A47 (NH backbone).
Mutagenesis of ThiT.
 For cloning and mutagenesis purposes, the gene encoding ThiT was placed in 
the pREnHis plasmid containing a N-terminal His8-tag.16 In order to introduce the desired 
mutations, site-directed mutagenesis was performed using quick change PCR with the 
primers given in Table 3. After verification by DNA sequencing (Seqlab and GATC, 
Germany), the mutated pREnHis ThiT plasmids were converted to mutated pNZnHis 
ThiT plasmids using the vector backbone exchange protocol in order to be used as 
expression vectors in L. lactis.26
Expression and purification of wild-type ThiT and ThiT mutants.
 The expression and purification of substrate-free wild-type ThiT and the ThiT 
mutants was performed as described in Chapter 2, with the cultivation and expression 
of the ThiT mutants being performed semi-anaerobically in 2 L of chemically defined 
medium27 without thiamine and supplemented with 2.0 % (w/v) of glucose and 5 µg/mL 
of chloramphenicol in a 3 L fermenter (Applikon) instead of a 10 L fermentor.
Ligand-binding experiments.
 For compounds 10-13, 15 and 16, the binding affinity was determined using the 
intrinsic  fluorescence titration assay described in Chapter 2,13 with 50 nm of ThiT in a 
final volume of 1000 µL of Buffer A (50 mm KPi, pH 7.0, 150 mm KCl, 0.15% (w/v) 
of DM (Anatrace)). For compounds 7, 8, 9 and 14, as well as for the ThiT mutants, the 
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Table 3. Primers for mutagenesis of wild type ThiT, with the mutated bases underlined.













binding affinity was determined by isothermal titration calorimetry (ITC) using a MicroCal 
iTC200 apparatus (GE Healthcare) with a cell volume of 200 µL. The measurements 
were performed at 25 °C with 4.80–26.0 µm of ThiT. Various concentrations of the 
compounds, or thiamine in case of the ThiT mutants, were added in steps of 1 µL (Table 
4), while maintaining equal volume percentages of DMSO in both the protein and the 
substrate solution when determining the binding affinities for the compounds. The data 
were analyzed using the MicroCal LLC iTC200 software.
Growth assay.
 Cells from glycerol stocks of the E. coli MC1061 strain with the p2BAD ECF 
ThiT (from L. lactis)21 or p2BAD ECF FolT2 (from Lactobacillus delbrueckii) plasmid 
(see Chapter 5),10 were grown overnight in 5 mL of Luria Broth medium (10 g/L of 
BactoTM trypton, 5 g/L of BactoTM yeast extract, 10 g/L of NaCl), supplemented with 100 
µg/L of ampicillin, at 37 °C and 200 rpm. Cells from the glycerol stock of the L. lactis 
NZ9000 strain24 were grown overnight in 5 mL of M17 medium (Difco), supplemented 
with 2 % (w/v) of glucose, at 30 °C. The next morning, the E. coli and L. lactis cells were 
diluted in 5 mL of fresh medium to an OD600 of ~0.05 and allowed to grow to an OD600 of 
0.5. Subsequently, the cells were harvested by centrifugation (4.712 x g, 10 min, 4 °C), 
washed twice with 30 mL of ice-cold 50 mm KPi, pH 7.5, and resuspended in ice-cold 50 
mm KPi, pH 7.5, to a final OD600 of 0.5.
For the growth assay, 30 µL of these precultures were taken to inoculate a total 
volume of 300 µL of Luria Broth medium supplemented with 100 µg/mL of ampicillin or 
300 µL of M17 medium supplemented with 2 % (w/v) of glucose. Additionally, the media 
were supplemented with 2 % of DMSO or various concentrations of compounds dissolved 
in DMSO, and with 10-3 % (w/v) of l-arabinose in case of the E. coli cells. Controls 
without DMSO and without arabinose were taken along as well. The cultures were 
pipetted together in a transparent and sterile 96-well microtiter plate (Greiner BioOne,  flat 
bottom) and the growth at 30 °C was monitored for 26 hours in a Biotek plate reader at 600 
nm, with 15 minute intervals between the OD600 measurement and continuous shaking.
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Table 4. Conditions under which ITC measurements were performed.
Compound/mutation [protein] (µm) [substrate] (µm) [substrate]:[protein] ratio
7 9.02-14.7 250-375 20-30
8 10.2-16.8 204-322 20
9 3.54-9.42 354-952 100-101
22 16.1 1.67*103 103
E84D 4.80-9.04 9.6-120 2-13.3
E84Q 8.06-13.8 806-1.38*103 100
E84A 6.19-10.7 200-350 20-35
H125F 9.48-16.2 162-974 10-100
H125N 12.1-26.0 121-260 10
H125A 9.28-9.52 95.2-140 10-15.1
Molecular-dynamics simulations.
 Atomistic MD simulations were performed with ThiT and the three ligands 
thiamine, compound 13 and compound 14. In all cases, the binding pose structures that 
were embedded in a lipid membrane with explicit solvent were used. To this purpose, 
the CHARMM Membrane Builder28 was used and converted to AMBER format. The 
ligands were parameterized using the GAFF force field and the antechamber module 
in the AmberTools package (version 15).29,30 Each ThiT-ligand complex was embedded 
in a lipid bilayer composed by 150 1-palmitoyl-2-oleoylphosphatidylcholine (POPC) 
lipids, hydrated with TIP3P31 water molecules and 0.15 m of NaCl ion concentration. 
The prepared systems were minimized and equilibrated as explain elsewhere,32 from the 
fixed initial coordinates of the complex (10 kcal/mol/Å) to a relaxed system. Both the 
equilibration and production phases were run with AMBER1433 using the NPT ensemble 
(1 atm, 303 K) with periodic boundary conditions and the Langevin thermostat.
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Chapter 5
Structural insight in the toppling mechanism of an 
energy-coupling factor transporter
This chapter is based on: Lotteke J. Y. M. Swier, Albert Guskov and Dirk J. Slotboom 
(2016) Nat. Commun. 7:11072
Energy-coupling factor (ECF) transporters mediate uptake of micronutrients in 
prokaryotes. The transporters consist of an S-component that binds the transported 
substrate and an ECF module (EcfAA’T) that binds and hydrolyzes ATP.  The 
mechanism of transport is poorly understood but presumably involves an unusual 
step in which the membrane-embedded S-component topples over to carry the 
substrate across the membrane.  In many ECF transporters, the S-component 
dissociates from the ECF module after transport. Subsequently, substrate-bound 
S-components out-compete the empty proteins for re-binding to the ECF module 
in a new round of transport. Here, we present crystal structures of the folate-
specific transporter ECF FolT2 from Lactobacillus delbrueckii. Interaction of the 
ECF module with FolT2 stabilizes the toppled state, and simultaneously destroys 
the high-affinity folate binding site, allowing substrate release into the cytosol. We 
hypothesize that differences in the kinetics of toppling can explain how substrate-




 Energy-coupling factor (ECF) transporters are a recently discovered class of 
ATP-binding cassette (ABC) transporters.1–4 The transporters are exclusively present in 
prokaryotes, where they catalyze the uptake of a wide variety of micronutrients, typically 
water-soluble vitamins and transition metals such as Ni2+ and Co2+.3 ECF transporters 
consist of two identical or highly similar cytoplasmic ATPases, EcfA and EcfA’, and 
two transmembrane subunits, EcfT and the S-component.1,2,4 In contrast to classical ABC 
importers, ECF transporters do not make use of additional substrate-binding domains or 
proteins. The membrane-embedded S-component serves as both the substrate-binding 
and the substrate-translocation domain. The other three subunits (EcfA, EcfA’ and EcfT) 
together form the ECF module that energizes substrate transport by the S-component.4–6 
 Based on the genomic location of the genes encoding the transporter subunits, 
ECF transporters have been categorized into two groups. Group I consists of dedicated 
transporters, in which the ECF module interacts with a single S-component, whereas 
group II ECF transporters share their ECF module with multiple S-components of 
different substrate specificities.2 S-components from group II transporters can be released 
from the ECF module, and compete with each other for binding to the module.7–9
 Several crystal structures of solitary S-components from a variety of organisms 
have been solved.10–14 Despite low sequence identity (~15%), the S-components 
for different substrates share a similar fold with a core of six membrane-embedded 
α-helices. In addition, three crystal structures of complete group II ECF transporters 
from Lactobacillus brevis have been solved, all containing the same ECF module and 
a different S-component: ECF FolT, ECF HmpT and ECF PanT.5,6,15 The structures have 
provided the first glimpse of the mechanism of transport and the shared utilization of the 
ECF module by group II transporters.
 Based on the structures, as well as mutational, accessibility and cross-linking 
studies on EcfT and S-components from different organisms,4,14–16 a toppling mechanism 
of transport has been proposed, in which the S-component rotates in the lipid bilayer to 
expose its binding site alternately to the exterior (helices oriented as membrane-spanning) 
or the interior (toppled orientation with helices parallel to the membrane). The latter state 
was captured in the structures of the full complexes and is referred to as post-translocation 
state,15 in which the substrate has been released into the cytosol. ATP binding in the 
ATPase subunits is thought to cause a conformational change in EcfT, which allows the 
S-component to topple back to the outward facing state. In group II ECF transporters, ATP 
binding and hydrolysis also leads to release of the substrate-free S-component from the 
ECF module and allows for competition among different substrate-bound S-components 
for the same ECF module.7–9
 In this chapter, we report crystal structures of the group II ECF transporter for 
folate from L. delbrueckii in the apo-state and in complex with the slowly hydrolysable 
ATP analogue AMP-PNP. In addition, we present a structure of the solitary S-component 
(FolT1) from the same organism in the folate-bound state. Comparison of the structures of 
the S-component in the complex and in isolation reveals how it captures its substrate from 
the extracellular side, and how association with the ECF module is coupled to substrate 
release in the cytosol. We re-evaluate existing data in the light of the new structures 
and provide a working model for the transport mechanism that can explain a crucial 
observation that led to the discovery of ECF transporters: the more effective competition 
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of S-components in the substrate-bound state for the ECF module than proteins in the 
substrate-free state.
Results
S-components for folate in L. delbrueckii.
 The genome of L. delbrueckii encodes two FolT homologues, which we named 
FolT1 and FolT2. They share 93 % sequence identity and have likely arisen from a recent 
gene duplication. FolT1 and FolT2 share only between 30 and 33 % identity with the 
characterized FolT proteins from L. brevis, E. faecalis and Lactobacillus casei (Figure 
S1 in the Supplemental Information).5,14,17 Purified FolT1 and FolT2 in detergent solution 
bound folate with high affinity, with dissociation constants of 1.0 ± 0.24 nM and 3.1 ± 1.4 
nM, respectively (Figure S2 in the Supplemental Information). The affinities of FolT1 and 
FolT2 for folate are higher than the affinities determined previously for the FolT proteins 
from E. faecalis (29.8 nM)14 and L. casei (9 nM).17 FolT1 and FolT2 differ in only twelve 
residues, none of which interact with folate, with the only possible exception of residue 
122, which is a tyrosine in FolT1 and an asparagine in FolT2. The FolT1 mutant Y122N 
binds folate with a dissociation constant of 2.5 ± 1.2 nM (Figure S3 in the Supplemental 
Information), indicating that the tyrosine contributes to a slightly higher affinity, although 
the differences are small.
Crystal structure of folate-bound FolT1.
 We determined the crystal structure of folate-bound FolT1 at 3.0 Å resolution 
(Table S1 in the Supplemental Information). FolT1 consists of six membrane-embedded 
α-helices (Figure 1A-B), which have a similar structure as in other solitary S-components 
with specificities for various substrates (RibU10, ThiT11, BioY12, NikM213, FolT14). 
Structurally, FolT1 is most closely related to FolT from E. faecalis with which it shares 
30 % sequence identity. Based on the hydrophobicity of the helical segments and the 
positive-inside rule,18 solitary FolT1 is predicted to be oriented in the membrane with 
the N- and C-terminal ends and loops L2 and L4 located in the cytoplasm, and loops L1, 
L3 and L5 facing the extracellular environment (Figure 1B). However, deduction of the 
membrane orientation from the structure is difficult in this case because we know that the 
S-component can topple over in the context of the complete ECF transporter. Nonetheless 
it is plausible that the solitary S-component can adopt the orientation shown in Figure 
1A as it is in agreement with molecular dynamics simulations that revealed a similar 
orientation for the solitary S-component ThiT from L. lactis in a lipid bilayer.19
Well-defined non-protein electron density inside the α-helical core was assigned 
to the folate molecule (Figure 2). The occluded folate-binding site is lined by all six 
membrane α-helices and is located close to the extracellular side of the membrane 
(orientation as in Figure 1A), where it is shielded from the exterior by the L1 loop 
connecting helices 1 and 2, and the L3 loop between helices 3 and 4. The substrate-
binding pocket has a volume of about 1400 Å3, which leaves a vast amount of space 
for extensions on the folate molecule such as a polyglutamate tail. The N1 atom from 
the pterin ring forms a hydrogen bond with the backbone amine group of the conserved 
F82 (in some species replaced with Y) in the L3 loop, while the N2H2 group can form 




















Figure 1: Crystal structure of folate-bound FolT1. A) Cartoon representation of FolT1 colored 
from blue (N-terminus) to red (C-terminus), with folate shown in stick representation. H1-6 indicate 
α-helices 1-6. The carbon atoms of folate are shown in deep salmon. The membrane orientation was 
derived from the hydrophobicity of the surface, the positive inside rule and the location of aromatic 
residues shown in panel B, in which the transparent surface is colored according to the surface 
electrostatic potential (negative potential in red and positive potential in blue), and tryptophan 
residues are shown in sticks with their carbon atoms colored yellow. The bottom of the protein faces 
the cytoplasm, while the top faces the extracellular side of the membrane. 
residues D68 and T86 in H3 and H4, respectively (Figure 2C). The side chain of D68 also 
forms a hydrogen bond with the N3H group. The side chain of N77 from the L3 loop forms 
hydrogen bonds with the N3H and the O atom of the pterin ring, while being coordinated 
via backbone interactions by G80 in the same loop. Simultaneously, the pterin ring has 
π-π interactions with the side chain of the conserved F85 (in some species replaced with 
Y) in H4. The backbone O atom of A37 in the L1 loop forms a hydrogen bond with the 
amine group of the aminobenzoate moiety, while the benzoate is stacked by Q40 (often 
replaced with K or R in other species) from the L1 loop (Figure 2C). Q40 is coordinated 
in this position by a hydrogen bond formed between its side chain and the backbone O 
atom of D36. At the same time, the backbone amine of Q40 and the side chain of the 
conserved R145 in H6 form hydrogen bonds with the carbonyl O atom of the benzoate 
moiety. The backbone carboxyl group of the glutamate moiety can form four hydrogen 
bonds with the side chains of N126 in H5, and R145, a conserved K148 (in some species 
replaced with Q) and E149 (in some species replaced with Q or N) in H6; additionally, 
the side chain carboxyl group forms two hydrogen bonds with the side chain of K148 
and the backbone O atom of G42 in the L1 loop. Furthermore, there are interactions 
between the side chains of K148 and E149, and the backbone of R145 and K148. All of 
the coordinating residues located in the helices interact with folate via their side chains, 
whereas the residues located in the L1 and L3 loops interact via their backbones.
 Although the interactions between the invariant residues D68, F85, T86, R145 
and K148 and folate were also found in the recent structure of FolT from E. faecalis,14 
there are also conspicuous differences. Four residues involved in folate binding in the 
enterococcal protein (R26, K36, N117 and T121) are not conserved in FolT1, where the 
corresponding residues Q31, Q40, Y122 and N126 are either not involved in folate binding 
(Q31 and Y122), or interact with folate in a different way (Q40 and N126). Conversely, 
N77 interacts tightly with the pterin ring in FolT1, but this residue is not conserved in the 
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Figure 2: Crystal structure of folate-bound FolT1. A) Chemical structure of folate. B) 2Fo-Fc 
electron density at 2σ in blue contouring folate as bound in the substrate-binding pocket. C) Close-
up of the residues involved in binding the pterin ring of folate. The backbone is shown in ribbon 
representation and the hydrogen bonds are depicted by black dashed lines. D) FolT1 residues 
involved in binding of the aminobenzoate and glutamate moieties of folate.
 
enterococcal protein. These differences highlight that caution must be taken when inferring 
mechanistic details from comparisons of structures from different proteins with low 
sequence identity and originating from different organisms. In this light, it is noteworthy 
that FolT1 and FolT2 from L. delbrueckii differ only in twelve residues, none of which 
affect the interactions with folate or the association with EcfT (see below), with the only 
possible exception of position 122, which is a tyrosine in FolT1 and an asparagine in 
FolT2. The latter could provide an additional hydrogen bond with the carboxyl side chain 
group of the glutamate moiety of folate.
Transport activity of ECF FolT1 and ECF FolT2.
FolT1 and FolT2 interact with the same ECF module to assemble into full ECF 
transporters. We purified the ECF FolT1 and ECF FolT2 complexes, reconstituted them 
into proteoliposomes and performed transport assays with radiolabeled folate (Figure 
3A-B). Both ECF transporters mediated association of radiolabeled folate with the 








Figure 3: Transport and ATPase activity of ECF FolT2. A) Transport activity of ECF FolT2 in 
proteoliposomes loaded with 5 mm of MgATP (circles), 5 mm of MgADP (inverted triangles), 5 mm 
of MgAMP-PNP (triangles) or 5 mm of Na2ATP plus 5 mm of EDTA (squares). B) Transport activity of ECF FolT1 in proteoliposomes loaded with 5 mm of MgATP (circles), 5 mm of MgADP (inverted 
triangles) or 5 mm of Na2ATP plus 5 mm of EDTA (squares). C) Efflux activity of ECF FolT2 from proteoliposomes loaded with 5 mm of MgATP, after accumulation of radiolabeled folate for 16 min. 
At t = 16 min, 5 mm of MgATP (circles), 5 mm of MgADP (inverted triangles), 5 mm of Na2ATP plus 5 mm of EDTA (squares) or 100 µM of non-radiolabeled folate (diamonds) was added to the 
reactions. D) ATPase activity of ECF FolT2 reconstituted in proteoliposomes (black bars) and back-
ground ATPase activity by empty liposomes (white bars). When indicted, folate was present both 
in the lumen of the liposomes and in the environment. The error bars show the standard deviations 
from three independent measurements. 
Although these experiments suggest that the ECF transporters translocate folate across 
the membrane into the lumen, they are not conclusive. The reason for the ambiguity is 
that there are apparently more protein molecules present in the liposomes than folate 
molecules associating with them. Therefore it cannot be excluded that MgATP-dependent 
binding of folate to the proteins might have occurred, without translocation. In the case 
of ECF FolT2, there was an almost seven fold excess of protein complexes (8.7 pmol, 
assuming a reconstitution efficiency of 100%) over folate molecules associated with 
the liposomes (1.3 pmol). Transport assays reported previously using other purified and 
reconstituted ECF complexes from L. lactis and L. brevis, showed similar ambiguities, 
although they were not discussed. In these cases, we calculated protein to substrate 
excesses of 12.7 fold (ECF NiaX20), 29.0 fold (ECF RibU20), and 627 fold (ECF FolT5).
To unambiguously show that ECF FolT2 could transport folate across the 
membrane, we made use of the observation that the orientation of membrane proteins 
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in liposomes is often scrambled during the reconstitution procedure: liposomes contain 
both right-side-out and inside-out oriented protein complexes. If the ECF complexes can 
catalyze transport rather than just binding, the inside-out oriented complexes should allow 
export of luminal folate from the proteoliposomes in the presence of external MgATP. To 
test this prediction, we performed a folate uptake experiment as described above until a 
steady-state level of folate association was reached (after 16 minutes, Figure 3C), and 
then added external MgATP or MgADP to the liposomes. Efflux of the radiolabeled folate 
occurred upon addition of MgATP, but not upon addition of MgADP, which shows that 
ECF transporters indeed translocate their substrates across the membrane and use an ATP-
dependent mechanism. As a further control, we added a thousand-fold excess of non-
radiolabeled folate to the proteoliposomes after the steady-state level of folate association 
had been reached. The excess folate did not chase off the accumulated radiolabel, which 
again is consistent with transport rather than binding.
 To test whether ATP binding is sufficient for transport or ATP hydrolysis is 
required we filled the proteoliposomes with ATP and EDTA (in the absence of Mg2+) or 
with the slowly hydrolysable ATP analogue AMP-PNP (in the presence of Mg2+) (Figure 
3A-B). In neither condition folate transport occurred, indicating that ECF FolT2 mediates 
folate translocation only under ATP hydrolyzing conditions.
 Beside folate transport, we also measured the ATPase activity of ECF FolT2 
in the proteoliposomes, both in the presence and absence of 100 nm of folate (Figure 
3D).  The presence of folate did not significantly affect the ATPase activity, indicating 
poor coupling between transport and nucleotide hydrolysis. High futile ATPase activity 
has also been observed for the group I transporter BioMNY.16 Comparison of the rate of 
ATP hydrolysis with the rate of folate transport corroborates that there is poor coupling, 
as the ATPase rate is more than four orders of magnitude higher than the transport rate. 
Apparently, futile ATP hydrolysis is an inherent characteristic of the ECF transporters.
Crystal structures of full ECF FolT2 complexes.
 We determined crystal structures of the ECF FolT2 complex from L. delbrueckii 
in the apo state (no nucleotides or folate) and in an AMP-PNP bound state at 3.0 Å and 
3.3 Å resolution, respectively (Table S1 in the Supplemental Information). The overall 
structures of the two complexes are shown in Figure 4. Although both structures globally 
resemble the structures of the ECF transporters from L. brevis,5,6,15 the corresponding 
subunits share only between 30% and 50% sequence identity. Importantly, the comparison 
of the structures of solitary FolT1 and the full ECF FolT2 from a single organism now 
allows insight into the conformational transitions that take place during transport which 
cannot be obtained from the comparison of proteins with low sequence similarity from 
different organisms.
 In both structures of ECF FolT2, the ATPases EcfA and EcfA’ are in an open 
conformation with the subunits separated, thus leaving the two ATP hydrolysis sites 
incomplete (Figure 7A-B). In the AMP-PNP bound structure, EcfA and EcfA’ each bind a 
molecule of the nucleotide, but binding does not lead to closure of the ATPase dimer (see 
below). EcfT can be divided into two domains: the transmembrane domain formed by five 
transmembrane helices (TMH1-5), and the coupling domain formed by the three coupling 
helices (CH1-3). The cytosolic side (“bottom”) of the coupling domain interacts with 
the ATPase subunits, whereas the membrane side (“top”) binds only the S-component. 























































Figure 4: Crystal structures of apo ECF FolT2 and AMP-PNP bound ECF FolT2. A) Cartoon 
representation of apo ECF FolT2 viewed from the plane of the membrane, with EcfA and EcfA’ 
colored in two shades of red, EcfT in cyan and FolT2 in yellow. The transmembrane helices of 
EcfT are indicated by TMH1-5 and the three coupling helices by CH1-3. B) Surface representation 
using the subunit colors from panel A. Loop L1 of FolT2 and proline 71 (P71) in TMH3 of EcfT are 
colored orange. The pathway leading from the open folate binding cavity to the cytosol is indicated 
by the dashed arrow. C) View along an axis perpendicular to the membrane. D-F) Same as in panels 
A-C for AMP-PNP bound ECF FolT2, with the AMP-PNP molecules shown in stick representation 
and their carbon and phosphor atoms colored gray and orange, respectively. 
below). Compared to the putative membrane orientation of the solitary FolT1 (Figure 
1A), FolT2 has toppled over and the helices lie roughly parallel to the membrane plane 
(Figure 4A, C-D and F). Because the AMP-PNP bound and the apo complexes have 
similar structures, we will focus our further discussion on the AMP-PNP bound structure, 
and consider the apo complex only when it differs from the AMP-PNP bound structure. 
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Figure 5: Comparison of folate-bound FolT1 and substrate-free FolT2. A) Structural alignment 
of folate-bound FolT1 (pale yellow) and substrate-free FolT2 (bright yellow). The viewpoint is from 
the extracytoplasmic side of the membrane. The carbon atoms of folate are shown in pale yellow 
and loops L1 and L3 are colored in pale and bright orange for FolT1 and FolT2, respectively. The 
arrow shows the movement of loop L1 between FolT2 and substrate-bound FolT1 B) Repositioning 
of loop L3 of FolT2 (bright yellow) compared to FolT1 (pale yellow) disrupts the interactions with 
folate, of which the carbon atoms are colored yellow. C) Surface representation showing how loop 
L1 (pale yellow) of substrate-bound FolT1 would clash with P71 (orange) of EcfT when forming a 
complex with the ECF module, with respect to the position of loop L1 in FolT2 (orange). The arrow 
shows the movement of loop L1 between FolT2 and substrate-bound FolT1. D) Slice-through 
representation of ECF FolT2 at the level of the dashed line in panel C. FolT2 is shown in surface 
representation with loops L1 and L3 in orange, and P71 of EcfT in orange surface representation. 
E) The same slice as shown in panel D but with substrate-bound FolT1 replacing FolT2, with the 
carbon atoms of folate shown in gray. Loops L1 and L3 would clash with P71.
Comparison of solitary FolT1 with FolT2 in the complexes.
The FolT2 proteins in the AMP-PNP bound and apo complexes do not have folate 
bound. Nonetheless the structure of substrate-free FolT2 is very similar to the structure of 
solitary, folate-bound FolT1 with RMSD values of 1.35 Å (FolT1 compared with FolT2 
from the AMP-PNP bound structure) and 1.25 Å (FolT1 compared with FolT2 from 
the apo structure). All α-helical segments and cytoplasmic loops are in almost identical 
conformations. The only differences are the conformations of the L1, L3 and L5 loops 
(Figure 5A). In FolT1, L1 and L3 cover the folate-binding pocket and provide multiple 
interactions with the substrate, whereas they have moved away in the substrate-free state, 
creating a wide opening.  Upon the movements of the L1 and L3 loops, the interactions 
with folate are lost and the high-affinity binding site is destroyed (Figure 5B, discussed 
below).  Loop L5 also adopts a slightly different conformation but this displacement does 
not affect the folate-binding site directly (Figure 5A). The loss of the high-affinity binding 
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site for folate in the complex explains why no electron density for folate was found in 
the structure of the AMP-PNP bound complex even though a high concentration of the 
substrate was added during crystallization. Consistently, biochemical characterization of 
ECF RibU has shown that riboflavin could bind only to solitary RibU, but not to the full 
complex.8 The structures also explain how folate is released into the cytoplasm, because 
the L1 and L3 loops that occluded the binding site in the solitary S-component are now 
moved and allow passage of the substrate towards the cytoplasm (Figure 5C-E).
 The structural resemblance of FolT1 and FolT2 indicates that only small 
conformational changes take place in S-component upon substrate binding or release. 
This notion is consistent with EPR and pre-steady state fluorescence experiments on 
thiamin binding to the S-component ThiT that showed minor conformational changes 
upon binding and very rapid association kinetics, close to the diffusion limit.19 From 
the outward-occluded state of solitary FolT1 (orientation shown in Figure 1), small 
movements of loops L1 and L3 would be sufficient to open access from the substrate-
binding site to the extracellular side of the membrane. High-affinity folate-binding from 
the outside has indeed been demonstrated in whole cell assays.17 The small conformational 
changes combined with high affinity substrate binding make solitary S-component 
efficient scavengers for scarce and precious substrates in the environment of the bacteria.
Interaction of FolT with EcfT triggers substrate release.
 The high-affinity folate-binding site is destroyed in the structures of the ECF 
FolT2 complex, which allows for accumulation of substrate in the cytoplasm, and likely 
results in higher off-rates than in the solitary S-components, leading to physiologically 
relevant transport rates. The free energy required to destroy the binding site must be 
provided by the interaction energy liberated upon docking of the S-component to the 
ECF module. The coupling domain of EcfT provides the main surface for interaction 
with FolT2, with the three coupling helices forming a hydrophobic platform that binds 
an equally hydrophobic surface on helices 1 and 3 of FolT2 (Figure 6A-B). Two alanines 
of the well-conserved AxxxA motif in helix 1 of FolT2, which have been shown to be 
crucial for the interaction of other S-components with the ECF module,11,15 are part of the 
interaction surface. The shapes of the two surfaces are highly complementary creating a 
tight fit.
 The structure of the surface interacting with EcfT is identical in substrate-free 
FolT2 and folate-bound FolT1, which raises the question how the folate binding site is 
disrupted in the complex. The structures show that the association of the S-component 
to EcfT via the hydrophobic interface allosterically disrupts the folate-binding site. The 
conformations of loops L1 and L3 in folate-bound FolT1 are incompatible with binding 
to the ECF module, because they would clash with TMH3 of the membrane domain of 
EcfT at the position of the conserved P71 (Figure 5C-E). This proline also introduces a 
kink in TMH3, which directs the N-terminal end of the helix away from the S-component, 
allowing a wide passageway from the folate-binding pocket to the cytoplasm (compare 
Figure 4B and 4E with 5C-E). The steric clash with TMH3 shows that toppling of the 
S-component can occur only if simultaneous displacement of loops L1 and L3 takes 
place, which results in loss of the folate-binding site. Thus, high-affinity binding of folate 
to the S-component and interaction of EcfT with the S-component are mutually exclusive.
 The displacement of loops L1 and L3 in the toppled state is stabilized by 
interactions with EcfT. As will be discussed below, these interactions are probably much 
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Figure 6: Sites of interaction between EcfT and FolT2. A) Slice-through of the ECF module in 
surface representation viewed from the extracellular side of the membrane. FolT2 has been deleted 
to show the hydrophobic platform on top of the coupling domain of EcfT, indicated by the oval. 
Coloring according to hydrophobicity, from red (hydrophobic) to gray (hydrophilic). B) Surface of 
FolT2 interacting with the surface shown in panel A, using the same color-coding. C) Structural 
flexibility in the EcfT subunit. The apo and AMP-PNP-bound structures were superimposed by 
structural alignment of the ATPase subunits (dark gray surface representation). The resulting 
positions of the EcfT subunits are shown in cartoon representation with a viewpoint from the 
membrane plane. The coupling domains with coupling helices CH1-3 are in almost identical 
positions in the two complexes, but the membrane domains differ. The membrane domain in the 
apo-structure (gray) has hinged away compared to the AMP-PNP bound structure (cyan). Proline 
71 on TMH3 of EcfT as well as loops L1 and L3 in FolT2 (gray surface representation) are shown 
in orange. D) Interactions between the serine- and threonine-rich stretch of EcfT and loop L3 of 
FolT2. E) Interaction of R115 in EcfT with the C-terminus of H5 in FolT2.
weaker than the interaction between the hydrophobic surfaces of FolT2 and the coupling 
domain of EcfT. The position of the L1 loop in the complexes is stabilized by a hydrogen 
bond between the backbone carbonyl group of G35 and the highly conserved R196 (in the 
AMP-PNP bound structure) or N189 (in the apo structure) in the coupling domain of EcfT. 
The L3 loop interacts with a conserved serine- and threonine-rich stretch (STφφTφTT, 
in which φ is a hydrophobic residue) in TMH4 of EcfT. The hydroxyl groups of the side 
chains of S123 and T127 from this motif form hydrogen bonds with the backbones of G76 
and G80 in the L3 loop (Figure 6D), leading to a conformation of the L3 loop that cannot 
form the backbone interactions with the folate molecule found in FolT1, and forcing the 
side chain of N77 into the position of the pterin ring (Figure 5B).
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Besides loops L1 and L3, the C-terminal end of H5 from FolT2 also interacts 
with EcfT. The partial negative charge from the helix dipole binds to the positive charge 
of the conserved R115 in TMH4 in the membrane domain of EcfT (Figure 6E). The 
interactions between EcfT and loops L1, L3 and H5 are not dependent on the amino acid 
sequence of the S-component because either backbone groups (loops L1 and L3) or the 
negative charge from a helix dipole (H5) are involved. The sequence-independence of 
the interactions explains how S-components for different substrates can topple along and 
bind to the same ECF module. 
AMP-PNP binding does not lead to a closed conformation.
 Two patches of well-defined electron density were observed in EcfA and 
EcfA’ of the complex crystallized in the presence of MgAMP-PNP and were assigned 
to the nucleotide molecules (Figure 7). The two AMP-PNP molecules interact with 
the conserved motifs that are essential for ATP binding and hydrolysis in other ABC 
transporters.21 All the important motifs are present in both subunits, which share 35 % 
sequence identity (Figure 7C). Within the binding site, an aromatic residue in the A-loop 
(F13 in EcfA, Y’12 in EcfA’) forms a π-π interaction with the adenosine ring of the AMP-
PNP molecule. K46/K’46, the backbones of two glycines and N42/T’42 in the Walker 
A motif interact with the phosphate groups. E169/E’171 of the Walker B motif interacts 
with the conserved H203/H’204 in the H-loop, which in turn interacts with the D’177/
D175 of the D-loop in EcfA/EcfA’ site. The Q-loop is followed by the Q-helix formed 
by Q96/Q’97 and D94/E’95, which is a conserved feature in ECF transporters.22 This 
Q-helix has been proposed to form the link between the ATP hydrolysis site and the 
coupling helices of EcfT.22 In our AMP-PNP bound structure, the conserved residues 
R184 and R225 at the C-terminal ends of coupling helices 2 and 3, are inserted into 
the EcfA’ and EcfA subunits, respectively, where they interact with D106’ and D105, 
respectively (Figure 7B-C). The two arginines were first predicted to be important for 
coupling based on mutagenesis studies.23 In EcfA’, R184 also interacts via Q’181 with 
Q’97 of the Q-helix, while this network is not observed in EcfA. In the ECF FolT and 
ECF HmpT structures of L. brevis, the same arrangement was shown.5,6 However, in our 
structure we also observe how E’95 on the opposite side of the Q-helix interacts via R’152 
with the backbone of Q’92 (Figure 7C). This provides a connection from the ATP binding 
site to the coupling helices, making it possible to move the coupling helices according 
to events taking place in the ATP binding site. Even though AMP-PNP molecules are 
bound to both subunits, binding does not lead to the closed conformation of the ATPases. 
The AMP-PNP molecules interact only with motifs from a single ATPase subunit, and 
are separated from the LSGGQ signature motifs on the other subunit. Therefore the ATP 
hydrolysis sites are still incomplete. 
Structural flexibility in the membrane domain of EcfT.
Although the structures of the apo and AMP-PNP bound complexes are very 
similar overall, the relative orientation of the transmembrane and coupling domain of 
EcfT is different (Figure 6C). The coupling domains of the two complexes are in identical 
positions relative to the two ATPases and FolT2. Consequently, the hydrophobic interface 
that interacts with FolT2 (Figure 6A) and the interface interacting with the ATPase subunits 
(Figure 7B) are both intact in the two structures. In contrast, the transmembrane domains 
are in different orientations. In the AMP-PNP structure, it is packed tightly against the 
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Figure 7: AMP-PNP binding to the EcfAA’ heterodimer. A) Surface representation of the 
AMP-PNP bound EcfAA’ heterodimer colored as in Figure 3 with the AMP-PNP molecules in 
stick representation. The viewpoint is from the extracytoplasmic side. B) Cartoon representation 
of the AMP-PNP bound EcfAA’ heterodimer and the coupling helices CH2 and CH3 of EcfT. The 
conserved arginines at the C-terminal end of the coupling helices, as well as the aspartates in the 
EcfAA’ heterodimer with which they interact, are shown in sticks. The interactions are indicated by 
the dashed lines. C) AMP-PNP binding site on EcfA’ (colored light red) and the interaction via the 
Q-helix with the conserved R184 at the C-terminus of CH2. The conserved motifs found in ABC 
transporter ATPases are indicated. D) 2Fo-Fc electron density at 2σ in blue contouring the AMP-
PNP molecule in Panel C. 
FolT2 subunit and interacts with the L3 loop and the C-terminus of H5, but in the 
apo structure, it has hinged away and the two membrane proteins interact less tightly 
(Figure 6C). It is likely that the structural flexibility of the membrane domain serves two 
functions. First, it allows toppling, which may require structurally different parts of the 
S-component (loops L1, L3 and L5) to slide along the membrane part of EcfT. Second, 
EcfT has to be sufficiently flexible to allow the binding of different S-components with 
different sequences and structures in group II ECF transporters, which use the same ECF 
module.15 The structural flexibility of the membrane domain of EcfT also suggests that 
the interactions with loop L3 and the C-terminus of H5 from FolT2 are relatively weak, 
in contrast to the strong hydrophobic and Van der Waals interactions between the rigid 




 Based on the work presented here and a wealth of data on various ECF 
transporters dating back to the 1970s, we tentatively provide a scheme for the transport 
cycle consistent with the available experimental data (Figure 8). There are important 
differences compared to previously published models, which we will discuss below.
 In all structures of complete ECF transporter complexes,5,6,15 the S-components 
are trapped in an inward-facing post-translocation state, in which they interact tightly 
with the coupling domain of EcfT via complementary hydrophobic surfaces. To escape 
from this state, the interaction interface must be disrupted, which requires input of energy. 
Presumably the formation of a closed EcfA-EcfA’ dimer by the binding of ATP, deforms 
the coupling helices from the EcfT subunit, thus destroying the hydrophobic interaction 
surface (Step (1) in Figure 8). ATP binding to the group II ECF RibU transporter from 
Listeria monocytogenes has indeed been shown to drive the release of the S-component 
from the ECF module.8 The solitary S-component in the absence of substrate reorients to 
expose the empty binding site to the outside of the cell, ready to bind a new substrate (Step 
(2) in Figure 8). The high affinity of the S-components for their substrates subsequently 
allows for efficient scavenging from the environment (Step (3) in Figure 8). For group 
I ECF transporters, it has been suggested that the reorientation step does not lead to 
complete dissociation of the S-component from the ECF module.16 Although it is possible 
that group I transporters indeed use a different mechanism, it is noteworthy that the 
experiments indicating the lack of dissociation were conducted in a nanodisc environment, 
which may prevent the detection of dissociation because of physical confinement.
 Our structural work shows that the binding of AMP-PNP to ECF FolT2 is not 
sufficient to form the closed EcfA-EcfA’ dimer. The lack of closure contrasts with the 
observed full closure when AMP-PNP binds to a partial complex of the ATPase subunits 
without the membrane subunits.8 Apparently, closure is more difficult in the context of the 
complete complex. In other ABC transporters, the binding of AMP-PNP sometimes led 
to closed ATPase subunits (e.g. in the maltose transporter24,25), but in other cases left the 
ATPases in an open conformation.26
ATP is hydrolyzed when the transport cycle proceeds. The requirement of full 
ATP hydrolysis for transport in lipid bilayers is obvious from the transport experiments 
presented in Figure 3. The high basal ATPase activity of the ECF FolT2 transporter when 
reconstituted in liposomes suggests that continuous ATP turnover may take place in the 
ECF module (Step (4) in Figure 8). Futile ATP consumption may be an acceptable trade-
off to ensure capturing as much as possible of scarcely available nutrients. The high basal 
ATPase activity probably can only be sustained in the cell if low amounts of the ECF 
module are present. Indeed, the levels of the ECF module are usually much lower than 
the levels of S-components.2
 In previously published models, it has been postulated that toppling of the 
S-component from the outward to the inward facing orientation requires strict coupling to 
ATP hydrolysis.8,16 In contrast, we hypothesize that solitary substrate-loaded S-components 
have an intrinsic ability to topple over in the lipid bilayer (Step (5) in Figure 8). Such 
toppling may be possible because the substrate-bound S-components form compact 
structures without exposed charged or hydrophilic residues on the extracellular face. The 
toppled proteins will be trapped by the hydrophobic binding platform of EcfT, which 
consequently destroys the high-affinity binding site and leads to substrate release in the 
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Figure 8: Working model for the transport mechanism of group II ECF transporters. Colors 
of the subunits as in Figure 3. Starting with the complex trapped in the post-translocation state, 
binding of ATP is needed to release the empty S-component by disruption of the hydrophobic 
interface (red) (step (1)). The S-component will reorient to the outward-facing state (2), and can 
bind its substrate on the extracellular side of the membrane (3). ATP hydrolysis in the ECF module 
regenerates the binding platform for the S-component (4). Possibly futile ATP hydrolysis takes 
place in this stage. The substrate-bound S-component can topple over in the membrane possibly 
aided by the vicinity of the ECF module (5). The toppled S-component binds to the ECF module 
via the complementary hydrophobic surfaces, colored in red (6). Binding of the S-component to 
the ECF module forces the disruption of the substrate-binding site and release of the substrate into 
the cytoplasm.
cytoplasm (Step (6) in Figure 8). A strong indication that spontaneous toppling can indeed 
take place comes from the observation that some S-components can mediate substrate 
transport in the absence of an ECF module.27–30
 Transport by solitary S-components is incompatible with strict coupling between 
ATP hydrolysis in the ECF module and toppling of the substrate loaded S-component. 
Moreover, there is no conclusive experimental evidence for such coupling. For the group 
I transporter BioMNY, it has been shown that ATP hydrolysis is required for substrate 
release, but the data did not reveal the sequence of events.16 ATP hydrolysis may take 
place in the absence of the S-component, only to reset the ECF module to the state that 
can interact tightly with the S-component again (Steps (4) and (6) in Figure 8). Even 
though strict coupling between ATP hydrolysis and toppling may not be necessary, it 
is possible that continuous ATP hydrolysis by the ECF module (step (4) in Figure 8) 
facilitates toppling by distorting the lipid bilayer in the vicinity of the S-component.
 In the 1970s, shared use of the ECF module by different S-components in group 
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II transporters had already been proposed based on in vivo uptake experiments.7 These 
experiments showed that substrate-loaded S-components compete more efficiently for 
the limited number of ECF modules than the substrate-free proteins. Recently, these 
experiments have been reproduced using recombinant proteins produced in E. coli.9 
In the light of the structures presented here, it is very unlikely that tighter binding of 
substrate-loaded than substrate-free S-components to the ECF module would cause the 
competitive advantage. In fact, substrate-bound FolT1 seems to be unable to interact with 
the ECF module because of steric clashes between loops L1 and L3 and the membrane 
domain of EcfT. To explain the competition experiments, we hypothesize that substrate-
loaded S-components do not bind more tightly to the ECF module than the substrate-
free proteins, but they can reach the binding platform more efficiently. The observed 
competition is then caused by differences in the kinetics of toppling. Substrate-free 
S-components cannot topple over as easily because their hydrophilic loops L1 and L3 are 
fully exposed. Therefore, they are unable to reach the hydrophobic interaction platform 
of EcfT, even though they would bind to it very tightly if they could.
 Importantly, the mechanism of competition described above does not require 
the existence of a stable state in which the ECF module is in complex with a substrate-
loaded S-component. The existence of such a state was postulated when structures of the 
same S-component in the substrate-bound and apo-conformation were not yet known.8,16 
In the work on the group I transporter BioMNY, the authors detected biotin binding to 
the solitary BioY, but not to the full complex. The authors postulate that an inaccessible 
(occluded) binding site exists in the complex.16 Based on the structural data presented 
here and published previously, we explain the lack of binding by the disruption of the 
binding site, and consequent extrusion of biotin on the cytoplasmic side. The scheme 
presented here does not require the postulation of an occluded state, yet can explain the 
ensemble of experimental data, and therefore is more parsimonious than previous models.
 For the group II transporter ECF RibU, the existence of a stable riboflavin-
bound full complex has also been proposed. A mutant that could bind, but not hydrolyze 
ATP, readily exchanged its S-component RibU with a fluorescently labeled solitary RibU 
molecule in the presence of ATP in detergent solution.8 Although this experiment elegantly 
supports the “catch-and-release” mechanism of S-components, it does not require that the 
substrate riboflavin is bound to RibU in the complex. Even if riboflavin would bind to the 
full complex, the affinity might be much lower than for solitary RibU, consistent with the 
model proposed here.
 The working model for the mechanism of transport presented in Figure 8 accounts 
for the observed high basal ATPase activity, the competition of different S-components 
for the same ECF module, the release of the S-component from the ECF module during 
turnover and substrate release from the S-component during toppling. This model will be 
used as handle for further experiments to study the toppling mechanism. 
Experimental section
Cloning.
 The genes encoding EcfA, EcfA’ and EcfT of Lactobacillus delbrueckii subsp. 
bulgaricus are annotated as cbiO (both for LDB_RS01805, ecfA and LDB_RS01810 
ecfA’) and cbiQ (LDB_RS01815, ecfT). The ECF module operon was cloned downstream 
105
Chapter 5
Structural insight in the toppling mechanism of an energy-coupling factor transporter
of the first arabinose inducible promoter of the p2BAD vector31 between the BspE1 
and BglII sites, in-frame with a sequence coding for a N-terminal His10-tag and TEV 
cleavage site before EcfA. folT1 (LDB_RS07025) or folT2 (LDB_RS07030) was cloned 
downstream of the second promoter, between the XbaI and XhoI sites in-frame with a 
sequence coding for a C-terminal STREPII tag (WSHPQFEK). The p2BAD His10-ECF 
FolT1/2-STREPII plasmid was transformed into Ca2+-competent cells of the E. coli strain 
MC1061.
 Solitary folT1 and folT2 were cloned in the pREnHis vector, which contains the 
sequence encoding a N-terminal His8-tag. Subsequently, the vectors were converted into 
L. lactis  expression vectors using the vector backbone exchange protocol.32 The resulting 
pNZnHisFolT1/2 vectors were transformed into electrocompetent cells of the L. lactis 
strain NZ9000.33 The mutation in the FolT1 sequence was introduced using the primers 
given in Table 1.








Expression and membrane vesicle preparation.
Expression of ECF FolT(1/2) was performed in a 5 L flask containing 2 L of 
Yeast Trypton medium (8 g/L BactoTM trypton, 5 g/L BactoTM yeast extract, 2.5 g/L NaCl), 
supplemented with 2.5 mM KPi, pH 7.0, 0.5 % glycerol and 100 µg/mL ampicillin. The 
E. coli MC1061 cells with p2BAD His10-ECF FolT1/2-STREPII were grown at 37°C, 
200 rpm to an OD600 of 0.8, after which the temperature was reduced to 25°C. After 
allowing the cultures to cool down for 20 minutes, expression was induced by addition 
of 1.0*10-2 % of arabinose. After three hours of expression, the cells were harvested by 
centrifugation (15 min, 7,446 x g, 4°C), washed in buffer A (50 mM KPi, pH 7.5) and 
resuspended in the buffer B (50 mM KPi, pH 7.5, 10 % glycerol). Membrane vesicles 
were either prepared immediately, or the resuspended cells were stored at -80°C after 
flash freezing in liquid nitrogen.
 For folate binding assays, substrate-free FolT1 and FolT2 were produced in L. 
lactis cells grown semi-anaerobically in chemically defined medium34 without folate, and 
supplemented with 2.0 % (w/v) glucose, 5 µg/mL chloramphenicol, in a 2 L fermenter 
at 30°C and pH 6.5. The cell culture was induced at an OD600 of ~1.5 by addition of 0.1 
% (v/v) culture supernatant of a nisin A-producing strain.33 For crystallization, FolT1 
and FolT2 were produced in L. lactis cells grown in M17 broth (Difco), supplemented 
with 2.0 % (w/v) glucose, 5 µg/mL chloramphenicol, in a 1 L bottle. In this case the cell 
culture was induced at OD600 ~ 0.8 by addition of 0.2 % (v/v) culture supernatant of the 
nisin A-producing strain. After three hours of expression, the cell cultures were harvested 
and washed as described above for the expression of ECF FolT(1/2), but resuspended in 
buffer B at pH 7.0.
 Before membrane vesicle preparation, 1 mM MgSO
4
 and ~50-100 µg/mL DNase 
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were added to the cells. The cells were lysed by high-pressure disruption (Constant Cell 
Disruption System Ltd, UK, two passages at 25 kPsi for E. coli cells or at 39 kPsi for L. 
lactis cells, 5°C) and cell debris was removed by low-speed centrifugation (30 minutes, 
12074 x g, 4°C). Membrane vesicles were collected by ultracentrifugation  (120 min, 
193,727 x g, 4°C), and resuspended in buffer B to a final volume of 5 mL per 1 L of 
cell culture. Subsequently, the membrane vesicles were aliquoted, flash frozen in liquid 
nitrogen and stored at -80°C. The total protein concentration in the membrane vesicles 
was determined by Bradford Protein Assay (Bio-Rad). 
Protein purification.
For the purification of ECF FolT(1/2), membrane vesicles were thawed rapidly 
and solubilized in buffer C (50 mM KPi, pH 7.5, 300 mM NaCl, 15 mM imidazole, 1 
% (w/v) n-dodecyl-β-d-maltopyranoside (DDM, Anatrace)) for one hour at 4°C, while 
gently rocking. Unsolubilized material was removed by centrifugation (20 min, 442,907 
x g, 4°C). The supernatant was incubated for one hour at 4°C under gently rocking with 
Ni2+-Sepharose resin (column volume of 0.5 mL), which had been equilibrated with 
buffer D (50 mM KPi, pH 7.5, 300 mM NaCl, 50 mM imidazole, 0.05 % (w/v) DDM). 
Subsequently, the suspension was poured into a 10 mL disposable column (BioRad) and 
the flow through was collected. The column material was washed with 15 mL of buffer 
D. The ECF FolT2 complex was eluted in three fractions of buffer E (50 mM KPi, pH 
7.5, 300 mM NaCl, 500 mM imidazole, 0.05 % (w/v) DDM) of 400 µL, 750 µL and 500 
µL, respectively. To the second elution fraction, 1 mM of EDTA was added to remove co-
eluted Ni2+ ions. Subsequently, the second elution fraction was purified by size-exclusion 
chromatography using a Superdex 200 10/300 gel filtration column (GE Healthcare), 
equilibrated with buffer F (50 mM KPi, pH 7.5, 150 mM NaCl, 0.05 % (w/v) DDM) in 
case of purification for reconstitution or equilibrated with buffer G (20 mM Tris, pH 8.0, 
150 mM NaCl, 0.05 % (w/v) DDM) in case of purification for crystallization. After size-
exclusion chromatography, the fractions containing the ECF FolT(1/2) complex were 
combined and used directly for reconstitution, or concentrated by the use of a Vivaspin 
500 concentrating device with a molecular weight cut-off of 100 kDa (Sartorius stedim) 
to a final concentration of 5-8 mg/mL when used for crystallization.
FolT1 and FolT2 were purified using the same protocol, but with different 
buffers. Solubilization of the membrane vesicles was performed in buffer H (50 mM KPi, 
pH 7.0, 200 mM KCl, 1% (w/v) DDM), the Ni2+-Sepharose resin was equilibrated and 
washed with buffer I (50 mM KPi, pH 7.0, 200 mM KCl, 50 mM imidazole, 0.35 % (w/v) 
n-nonyl-β-d-glucopyranoside (NG, Anatrace)), the proteins were eluted from the Ni2+-
Sepharose column using buffer J (50 mM KPi, pH 7.0, 200 mM KCl, 500 mM imidazole, 
0.35 % (w/v) NG) and the Superdex 200 10/300 gel filtration column was equilibrated 
with buffer K (50 mM KPi, pH 7.0, 150 mM KCl, 0.35 % (w/v) NG). After size-exclusion 
chromatography, the fractions containing FolT1 or FolT2 were combined and directly 
used for substrate binding assays. When FolT1 was used for crystallization, the protein 
was incubated in the presence of 100 µM of folate overnight at 4°C under gently rocking 
and subsequently concentrated by the use of a Vivaspin 500 concentrating device with a 
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Crystallization and structure determination.
 Initial crystals of the apo ECF FolT2 complex were found in the G8 condition (50 
mM Tris, pH 7.5, 17 % (v/v) PEG350 MME) of the MemGold2 HT-96 screen (Molecular 
Dimensions) and diffracted up to 8 Å resolution. Optimizations using the AdditiveTM 
(HR2-428) and DetergentTM (HR2-408) screens of Hampton Research led to an optimized 
condition of 50 mM Tris, pH 7.5, 17 % (v/v) PEG350 MME, 10 mM spermidine, 2 
% (w/v) NG, which yielded crystals diffracting up to 3.7 Å resolution. Multiple rounds 
of seeding in 24-well hanging drop crystallization plates resulted in diamond-shaped 
crystals, which grew in clumps and diffracted up to 2.7 Å resolution. Using the apo ECF 
FolT2 crystals for seeding, ECF FolT2 in the presence of 10 mM MgCl2, 10 mM AMP-
PNP and 1 µM folate crystallized in single diamond-shaped crystals diffracting up to 
3.0 Å resolution. Diffraction data were collected at the European Synchrotron Radiation 
Facility (ESRF), Grenoble (λ = 0.97 Å, T = 100 K, ID23). The crystals of apo ECF FolT2 
belong to space group P1 (unit cell parameters: a = 88.82 Å, b = 95.32 Å, c = 107.57 Å, 
α= 83.45°, β = 65.75° and γ = 61.99°). The crystals of ECF FolT2 grown in the presence 
of 10 mM MgCl2, 10 mM AMP-PNP and 1 µM folate belong to space group P1 (unit 
cell parameters: a = 90.07 Å, b = 97.26 Å, c = 105.45 Å,  α= 84.67°, β = 64.78° and 
γ = 62.59°). Crystals of FolT1 were obtained using the hanging drop vapor diffusion 
technique using a reservoir solution of 100 mM Tris, pH 7.5, 24 % (v/v) PEG350 MME. 
These crystals had a rectangular shape and diffracted up to 2.8 Å resolution. Diffraction 
data were collected at the Swiss Light Source (SLS), Villigen (λ = 0.92 Å, T = 100 K, 
X06SA). The FolT1 crystals belong to space group C121 (unit cell parameters: a = 108.91 
Å, b = 77.54 Å, c = 89.45 Å, α= 90.00°, β = 116.36° and γ = 90.00°). All datasets suffered 
from severe anisotropy and were treated with the diffraction anisotropy server.35  Data 
were processed with XDS and molecular replacement was carried out with Phaser MR.36 
For the apo structure, molecular replacement with the EcfA-EcfA’ heterodimer structure 
of Thermotoga maritima (PDB ID: 4HLU) yielded a solution for the EcfA and EcfA’ 
subunit, in which the structures of EcfT and FolT2 were built in by hand with Coot,37 
guided by the structure of ECF FolT of Lactobacillus brevis (PDB ID: 4HUQ), and 
with the help of Phenix autobuild,38 using the AMP-PNP bound structure. To override 
bias problems, Rosetta-based MR39 was also used and refinement was performed with 
Phenix refinement.40 The Ramachandran statistics are 91.9 %, 90.3 % and 96.1 % for 
favored regions for apo ECF FolT2, AMP-PNP bound ECF FolT2 and folate-bound FolT, 
respectively, and 7.4 %, 8.8 % and 3.9 % for allowed regions. The statistics for data 
collection and refinement are summarized in Table S1 in the Supplemental Information, 
and the atomic coordinates and structure factors for the crystal structures of folate-bound 
FolT1, AMP-PNP bound ECF FolT2 and apo ECF FolT2 have been deposited in the 
Protein Data Bank under the accession codes 5D0Y, 5D3M and 5JSZ, respectively.
Substrate binding assay by intrinsic fluorescence titration.
 The affinity of FolT1, FolT2 and their mutants for folate was determined by 
performing an intrinsic fluorescence titration assay at 25°C,41,42 using a Spec Fluorlog 322 
fluorescence spectrophotomer. The protein was diluted in buffer K to a final concentration 
of 50 nM (final volume of 800 µL) and added to a 1000 µL quartz cuvette. After incubation 
for 5 min, folate was added in 1 µL steps using a Harvard apparatus syringe pump equipped 
with a 100 µL gastight glass syringe (Hamilton). Using an excitation wavelength of 280 
nm, the emission was recorded at 350 nm. After each substrate addition step, 10 s were 
allowed for mixing and the fluorescence signals were averaged over a time range of 15 s. 
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Data analysis was performed as described previously.41
Reconstitution into proteoliposomes.
Purified ECF FolT(1/2) was reconstituted in proteoliposomes as described 
previously,43 using a protein to lipid (w/w) ratio of 1:250 and using liposomes composed 
of E. coli polar lipids and egg phosphatidylcholine (3:1 (w/w) ratio). 
Radiolabeled folate transport assay.
In order to use in the transport assay or the ATPase activity assay, proteoliposomes 
were thawed and 5 mM of MgATP, 5 mM of MgADP, 5 mM of Na2-ATP plus 5 mM 
of EDTA or 5 mM of MgAMP-PNP were added. To include these compounds in the 
proteoliposomes, three cycles of flash-freezing in liquid nitrogen and quick thawing of 
the proteoliposomes were performed. Subsequently, the proteoliposomes were extruded 
through a 400 nm pore size polycarbonate filter (Avestin, eleven passages). To wash away 
the external nucleotides, the proteoliposomes were diluted 32 times to a final volume 
of 8 mL. After centrifugation (45 min, 285,775 x g, 4°C), the proteoliposomes were 
resuspended in buffer A to a final concentration of 0.5-1 µg ECF FolT(1/2)/µL. For each 
time point in the transport assays, a reaction volume of 200 µL of buffer A supplemented 
with 5 nM of [3, 5, 7, 9-3H] radiolabeled folate and 95 nM of non-radiolabeled folate 
was incubated at 25°C while being stirred. Transport was started by adding 1 µg of ECF 
FolT(1/2), reconstituted in proteoliposomes. At the indicated time point, 2 mL of stop 
buffer (ice-cold buffer A) was added and the reaction was rapidly filtered over a BA-85 
nitrocellulose filter. After washing the filter with another 2 mL of stop buffer, the filter 
was dried for 1 h at 80°C. Subsequently, the filter was dissolved in 5 mL of Filter Count 
scintillation liquid (PerkinElmer) and the levels of radioactivity were determined using 
a PerkinElmer Tri-Carb 2800 TR isotope counter. For the efflux experiments, uptake of 
radiolabeled folate by MgATP loaded proteoliposomes was allowed for 16 min, after 
which 5 mM of MgATP, 5 mM MgADP, 5 mM ATP plus 5 mM EDTA or 100 µM non-
radiolabeled folate was added and efflux was followed for an additional 8 min.
ATPase activity assay.
 The ATPase activity of ECF FolT2 reconstituted in proteoliposomes (loaded with 
0 nM or 100 nM of folate as described above) was measured by using a coupled enzyme 
assay, in which the amount of ADP produced (and thus the amount of ATP hydrolyzed) 
is coupled stoichiometric with the oxidation of NADH.44 The assay was performed at 
30°C in a 96-well plate and the absorbance at 340 nm was measured by a Synergy MX-
96 well plate reader (BioTek Instruments, Inc.). 200 µL of reaction solution per well 
contained 50 mM KPi, pH 7.5, 200 mM NaCl, 5.2 nM (1.2 µg) of ECF FolT2, 4 mM of 
sodium phosphoenolpyruvate, 0.3 mM of NADH and 3.5 µL of pyruvate kinase/lactic 
dehydrogenase enzyme mixture from rabbit muscle (Sigma-Aldrich) in 50% glycerol. 
The reaction solutions were supplemented with 0 nM or 100 nM folate as indicated 
(folate was thus present both on the inside and the outside of the proteoliposomes in the 
100 nM folate condition). After incubation of the reaction solutions for 3 min at 30°C, 1 
mM of MgATP, pH 7.5, was added to each of the reactions and the absorbance of NADH 
at 340 nm was followed for 7 min. The ATPase activity was expressed in µmol of ATP 
hydrolyzed/(min*mg of ECF FolT2).
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Figure S1: Sequence alignment of FolT proteins. A) Sequence alignment of FolT1 from 
L. delbrueckii with FolT2 of L. delbrueckii and FolT of Lactobacillus brevis (WP_01166775), 
Enterococcus faecalis (WP_002385065) and Lactobacillus casei (WP_003567081). Invariant 
residues are highlighted in red. The FolT1 residues involved in the interaction with folate are 
indicated by black triangles. At the end of the sequences, the sequence identity of the others protein 
with FolT1 is given. B) Schematic representation of the location of folT1 and folT2 on the genome 
of L. delbrueckii. The genes overlap but make use of different reading frames.
Figure S2 on page 111.
Figure S2: Folate binding to FolT1 and FolT2. A) Fluorescence emission spectrum (excitation 
wavelength of 280 nm) of FolT1 (50 nM) in the absence of folate (black trace) and in the presence 
of various concentrations of folate up to 60 nM (purple trace). B) Same as in panel A with FolT2, 
with the concentrations of folate ranging from 0 nM (black trace) to 70 nM (gray trace). (C, E and G) 
Fluorescence titration (excitation wavelength of 280 nm, emission wavelength of 350 nm) showing 
the quenching of the intrinsic fluorescence of FolT1 (50 nM) as function of the concentration of 
folate. The data was fitted to a single site binding model and the determined KD value is indicated 
together with the error of the fit. (D, F and H) Same as in panels C, E and G for 50 nM of FolT2.
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KD = 0.86 ± 0.15 nM
KD = 0.95 ± 0.33 nM
KD = 1.32 ± 0.30 nM
KD = 1.52 ± 0.98 nM
KD = 4.03 ± 3.51 nM




KD = 1.78 ± 0.31 nM
C D
KD = 2.22 ± 0.24 nMKD = 3.40 ± 0.40 nM
Figure S3: Folate binding to FolT1 Y122N. A) Fluorescence emission spectrum (excitation 
wavelength of 280 nm) of FolT1Y122N (50 nM) in the absence of folate (black trace) and in the 
presence of various concentrations of folate up to 70 nM (purple trace). B-D) Fluorescence titration 
(excitation wavelength of 280 nm, emission wavelength of 350 nm) showing the quenching of the 
intrinsic fluorescence of FolT1 Y122N (50 nM) as function of the concentration of folate. The data 
was fitted to a single site binding model and the determined KD value is indicated together with the 
error of the fit.
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Table S1: Data collection, phasing and refinement statistics. 
FolT1 AMP-PNP bound ECF FolT2 apo ECF FolT2
Data collection
Space group C121 P1 P1
Cell dimensions
a, b, c (Å) 108.91, 77.54, 89.45 90.07, 97.26, 105.45 88.82, 95.32, 107.57






Rmerge 0.12 (0.38)* 0.026 (0.86)* 0.04 (0.92)*
I / σI 5.3 (2.18)* 12 (1.10)* 10.5 (1.65)*
Completeness (%) 82.3 (44)* 94.4(78.8)* 92.6 (86.6)*
Redundancy 2 (1.8)* 1.8 (1.7)* 1.8 (1.72)*
Refinement
Resolution (Å) 3.01 3.30 3.00
No. reflections 10960 33723 41549
Rwork / Rfree 0.235/0.286 0.252/0.294 0.232/0.279
No. atoms 2456 15554 15398
Protein 2392 15430 15398
Ligand/ion 64 124 -
Water - - -
B-factors
Protein 36 159 98
Ligand/ion 17 158 -
Water - - -
R.m.s deviations 
Bond lengths (Å) 0.011 0.006 0.005
Bond angles (°) 1.429 1.404 1.263
*Values in parentheses are for the highest-resolution shell.
For each structure, one crystal was used for data collection. 
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Reconstitution of ECF transporters in phospholipid 
bilayer nanodiscs
Lotteke J. Y. M. Swier and Dirk J. Slotboom
Studying membrane proteins purified from their native membrane can be quite 
problematic, since detergents or model membrane systems do not always provide the 
required characteristics for the stability and functionality of these proteins. In this 
chapter, we describe the optimization of reconstitution in a non-compartmentalized 
model membrane system, the phospholipid nanodisc, for two ECF transporters 
from different organisms; the ECF NiaX transporter for niacin from L.lactis and 
ECF FolT2 from L. delbrueckii. With these transporters reconstituted in nanodiscs, 
the ATPase activity was studied in the presence and absence of their substrates. 
The ATPase activity turned out to be four orders of magnitude higher than the 
transport activity measured in proteoliposomes, and independent of the presence 
of the substrate. This suggests that cells can afford to hydrolyze extra ATP to make 
sure that the ECF module is available for interaction with a S-component as soon as 




 The part of a membrane protein that is inserted in the membrane, has a hydrophobic 
surface and interacts with the hydrophobic tails of the lipids forming the lipid bilayer. 
When working with purified membrane proteins in vitro, they need to be extracted from 
their native membrane. Hereby, care must be taken to shield the hydrophobic surface 
from the aqueous solution in which the proteins are put, otherwise they will aggregate. A 
classical method is to solubilize the membrane protein in detergent, which will form a belt 
of detergent molecules around the hydrophobic part of the protein and makes it soluble 
in an aqueous solution. Many different kinds of detergents are available, having ionic 
(charged), non-ionic (non-charged) or zwitterionic (having both positively and negatively 
charged groups, with a net charge of zero) head groups and tails with a length ranging 
from one to sixteen carbon atoms, which can be branched or not, saturated or unsaturated 
and can contain functional groups.1 However, detergents are a non-natural environment 
and often give stability issues. Finding the right detergent that keeps your membrane 
protein stable, can be tedious, and even then, your protein might not be functional because 
of the absence of a native-like lipid bilayer. There is the possibility to solubilize your 
membrane protein in mixed lipid-detergents micelles, but this does not always do the 
trick.
 To solve the stability and functionality issue, membrane proteins are commonly 
reconstituted in liposomes for functional studies. The resulting proteoliposomes have the 
membrane protein inserted in a lipid bilayer, of which the composition is controllable, 
and the size of the proteoliposomes can be more or less controlled by extrusion through 
polycarbonate membranes with a certain pore size. Besides, the enclosure of the lumen 
makes it possible to build gradients and to study transport activity. However, upon 
reconstitution, a mixture of proteins reconstituted right-side out and inside-out is obtained, 
and none of the proteins is accessible from both sides. Proteoliposomes also have the 
disadvantage that they are rather big (diameters in the high nanometer to micrometer 
range), which makes them unsuitable for some types of experiments. Besides, they are 
sensitive to osmotic changes and compounds that make them leaky, and it is difficult to 
prepare them with a precise controlled size and protein-to-lipid stoichiometry. In the last 
thirty years, three new model membrane systems have been developed, being bicelles,2,3 
phospholipid bilayer nanodiscs4,5 and native nanodiscs.6 In this chapter, we will focus on 
the use of the phospholipid bilayer nanodiscs.
 The phospholipid bilayer nanodisc consists of a small disc of phospholipid 
bilayer, which is encircled by two amphipathic membrane scaffold proteins (MSPs) in 
a head-to-tail belt-like conformation (Figure 1).4,5,7 These MSPs are modelled after the 
human serum apolipoprotein A-1, which bundles phospholipids and cholesterol molecules 
together in disc-like high density lipoproteins (HDLs) that play a role in cholesterol 
transport.8,9 Reconstitution of membrane proteins in nanodiscs has many advantages. 
There has been a range of membrane scaffold proteins engineered, making it possible 
to form nanodiscs with diameters ranging from 95 to 170 Å.10–13 The thickness of the 
bilayer depends on the lipid composition, which is easy to control. Upon reconstitution, 
the membrane proteins experience a native-like environment which provides stability 
and functionality requirements, while they are soluble in aqueous solution at the same 
time.14,15 The size-restriction by the MSP provides control of the oligomeric state of the 
protein and ensures to a close-to-homogenous sample preparation, which is reproducible 
over different batches. The small size of the nanodiscs makes them suitable for many
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Figure 1: Reconstitution in phospholipid bilayer nanodiscs. Top view (left) and side view (right) 
of a schematic, not scaled representation of a nanodisc, with the membrane scaffold proteins shown 
as two dark blue bands that encircle the patch of phospholipid bilayer, of which the phospholipid 
head groups are represented by white balls and the phospholipid tails by black lines. The bar above 
the side view indicates the range of diameters that can be obtained using different MSPs.
techniques only applicable to small, soluble particles, and since only one membrane 
protein is reconstituted per nanodisc under the appropriate condition, this model 
membrane system is even suitable for single-molecules studies. By modifying the MSPs, 
the nanodiscs can be immobilized on surfaces as well.
 When reconstituting your membrane protein of interest in nanodiscs, time needs 
to be invested in finding the optimal membrane protein to MSP to lipid ratio for the 
preparation of the nanodiscs. Based on the diameter of the lipidic discs calculated for the 
different MSPs, an estimate for the number of lipids needed can be made. However, it 
is unknown how many of these lipids are replaced upon reconstitution of the membrane 
protein into the nanodisc. Using high MSP to protein ratios will increase the change of 
incorporating only one membrane protein per nanodiscs, but lower ratios will decrease 
the number of empty nanodiscs.10 If the lipid to MSP ratio is taken too low, lipid-poor 
particles will be formed in which the membrane protein cannot be reconstituted with high 
stability.4,11,15 On the other hand, if the lipid to MSP ratio is too high, larger particles in the 
form of small vesicles will be formed. Besides an optimal membrane protein to MSP to 
lipid ratio, the size of the nanodisc can be of importance in case conformational changes 
of the membrane protein are required for functionality, and the right choice of lipid needs 
to be made if specific lipids are essential.
 In this chapter, we describe the optimization of the reconstitution of the ECF 
NiaX transporter for niacin from L. lactis and of ECF FolT2 from L. delbrueckii. The 
biotin transporter BioMNY from Rhodobacter capsulatus, belonging to the group I ECF 
transporters, has been reconstituted in nanodiscs previously,16 but this is the first report 
on the reconstitution of members from the group II ECF transporters in nanodiscs. Since 
S-components need to be exchanged during the transport cycle in case of the group II 
ECF transporters, our transporters might need more space within the nanodiscs to enable 
transport. The nanodisc formation is analyzed by size-exclusion chromatography and 
SDS-PAGE analysis, and the protein activity is checked using the ATPase activity assay 
described in Chapter 5.17 The research started off with ECF NiaX, but since a higher 




Reconstitution of ECF NiaX in nanodiscs.
 For the reconstitution of purified ECF NiaX from L. lactis, we started off with 
the membrane scaffold protein MSP1D1, which should yield nanodiscs with a diameter 
of about 97 Å.11 The diameter of the transmembrane part of ECF FolT2 transporter from 
L. delbrueckii is roughly 50 to 60 Å over the longest axis.17 Taking into account that 
conformational changes of the S-component and EcfT within the membrane might be 
required upon substrate translocation, nanodiscs with this diameter should be suitable to 
accommodate functional ECF NiaX.
 For the lipid composition of the nanodiscs, two available ratios of synthetic 
lipids 1,2-dioleoyl-sn-glycero-3-phosphatidylcholine (DOPE) : 1,2-dioleoyl-sn-glycero-
3-phosphatidylethanolamine (DOPC) : 1,2-dioleoyl-sn-glycero-3-phosphatidylglycerol 
(DOPG) of 60:20:20 and 50:12:38 have been used. With the first lipid composition, 
an optimal ECF NiaX:MSP1D1:lipid ratio of 1:5:500 was found. The size-exclusion 
chromatography (SEC) profile of the nanodiscs from this ratio shows two main peaks 
of nanodiscs with slightly different sizes (retention volumes of 10.2 mL and 11.4 mL, 
respectively, see the two arrows in Figure 2A, blue curve), accompanied by a peak at 
the void volume of the column (retention volume of 8.5 mL) and a shoulder (retention 
volume of 13 mL). According to SDS-PAGE analysis of the SEC fractions (Figure 2C), 
both peaks contain nanodiscs with the ECF NiaX transporter, although the band of NiaX 
in the second peak (retention volume of 11.4 mL) seems to be a bit less intense compared 
to the first peak. This can imply that the second main peak also contains nanodiscs with 
not complete ECF NiaX complexes. A previous study on the reconstitution of the ABC 
transporter OpuA in nanodiscs with the same membrane scaffold protein has shown that 
the SEC fractions at the void volume contain non-symmetric, donut-shaped structures 
with a diameter of about 20 nm.18 These particles are most probably formed by the excess 
of lipids, which will form some kind of vesicles with the proteins that are not included 
in nanodiscs. The shoulder has about the same retention volume as the empty nanodiscs 
formed from the ECF NiaX:MSP1D1:lipid ratio of 0:5:500 (Figure 2B, blue curve) and 
will probably contain empty nanodiscs without ECF NiaX.
 In case of lowering the amount of lipids to a ratio of 1:5:400 (Figure 2A, black 
curve, which has shifted compared to the blue curve due to technical problems), the second 
main peak (retention volume of 12 mL) with the nanodiscs of smaller size becomes a bit 
more abundant, while the opposite is true for the 1:5:600 ratio (Figure 2A, red curve). 
This shift in size is also seen in the SEC profile of the corresponding empty nanodiscs 
(indicated by the arrows in Figure 2B), suggesting the partition of a higher number of 
lipids in the nanodiscs when starting off with a higher fraction of lipids.
 When changing to the lipid composition DOPE:DOPC:DOPG of 50:12:38 and 
the ECF NiaX:MSP1D1:lipid ratio to 1:10:1000, the peak at the void volume increased 
enormously (indicated by the arrow in Figure 2D, black curve, ). Compared to 1:5:500 
ratio, the peak of the empty nanodiscs (retention volume of 13 to 14 mL) increased too 
with respect to the peak with ECF NiaX nanodiscs (retention volume of 10.5 to 12 mL), 
indicating that the amount of MSPs and lipids is way too high in the 1:10:1000 ratio 
and results in the formation of other lipid-rich particles. Under the same conditions, the 
ATPase inactive mutant ECF NiaX EcfA E166Q EcfA’ E’170Q has been reconstituted in 
nanodiscs. Also for this reconstitution, as well as in the preparation of empty nanodiscs 
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Figure 2: Reconstitution of ECF NiaX into nanodiscs. A) Size-exclusion chromatography (SEC) 
profile of the purification of the ECF NiaX nanodiscs from the reconstitution mixtures of ECF 
NiaX:MSP1D1:lipid of 1:5:400 (black), 1:5:500 (blue) and 1:5:600 (red). B) Same as in panel A 
for the empty nanodiscs from the reconstitution mixtures of ECF NiaX:MSP1D1:lipid of 0:5:400 
(black), 0:5:500 (blue) and 0:5:600 (red). C) SDS-PAGE gels of the reconstitution mixtures and 
fractions from the SEC purification of the nanodiscs. The MSP1D1 and the EcfA, EcfA’, EcfT and 
NiaX subunits of ECF NiaX are indicated by MSP, A, A’, T and S, respectively. D) SEC profiles of 
the purification of nanodiscs with wild type ECF NiaX (black), the ECF NiaX EcfA E166Q EcfA’ 
E170Q mutant (blue) and the empty nanodiscs (red), formed from reconstitution mixtures of ECF 
NiaX(wild type or mutant):MSP1D1:lipid of 1:10:1000 or 0:10:1000. E) ATPase activity of the 
nanodiscs from different reconstitution mixtures, measured in the presence (black bars) and in the 
absence (white bars) of 100 µM niacin. For the 1:10:1000 ECF NiaX:MSP1D1:lipid ratio, WT and 
122
Chapter 6
mutant indicate the activity of wild type ECF NiaX and the ECF NiaX EcfA E166Q EcfA’ E’170Q 
mutant. The error bars represent the standard deviation from three measurements. The arrows in 
panels A, B and D indicate peaks to which is referred in the text.
from the 0:10:1000 ratio, the formation of other lipid-rich particles was observed (Figure 
2D, blue and red curves).
ATPase activity of ECF NiaX reconstituted in nanodiscs.
 ECF NiaX reconstituted in nanodiscs formed under the 1:5:500 reconstitution 
ratio, showed ATPase activity in the coupled-enzyme ATPase activity assay both in the 
absence and in the presence of 100 µM of its substrate niacin, with the activity being 
lowered by 25 % in the absence of niacin (Figure 2E). Although the preparation of 
nanodiscs under the 1:10:1000 ratio was not optimal, the ATPase activity of ECF NiaX in 
nanodiscs from this ratio was comparable with the one of the 1:5:500 ratio, and the same 
decrease in the absence of niacin was observed. This indicated that the ATPase activity 
of ECF NiaX is not dependent on one of the two lipid composition that we tested. When 
reconstituting the ATPase inactive mutant ECF NiaX EcfA E166Q EcfA’ E170Q under 
the same conditions (lipid composition DOPE:DOPC:DOPG of 50:12:38 and the ECF 
NiaX:MSP1D1:lipid ratio to 1:10:1000), the activity was lowered to background values 
measured in the presence of empty nanodiscs, confirming that this mutant is not able to 
hydrolyze ATP.
Reconstitution of ECF FolT2 in nanodiscs.
 For the reconstitution of ECF FolT2 from L. delbrueckii in nanodiscs, initially 
the same ECF FolT2:MSP1D1:lipid ratio of 1:5:500 as for ECF NiaX was used, with 
synthetic lipid composition DOPE:DOPC:DOPG of 60:20:20. This resulted in low 
ATPase activity (0.1 µmol ATP hydrolyzed per minute per mg of ECF FolT2) and no clear 
bands of the ECF FolT2 subunits were seen on the SDS-PAGE gel when analyzing the 
SEC fractions. Taking into account that the S-component needs to topple over and also 
might need to dissociate from the ECF module during the transport cycle, we switched to 
the larger membrane scaffold protein MSP2N2. This MSP would form nanodiscs with a 
diameter of 170 Å, in which the diameter of the lipid bilayer would be 145 Å.13 Since these 
nanodiscs would need to contain more lipids, we tried different ECF FolT2:MSP2N2:lipid 
ratios (Table 1). For the ratios of 1:5:1800, 1:5:2000 and 1:5:2200, the SEC profiles 
showed a big peak at the void volume of the column (Figure 3A), while the SEC fractions 
with retention volumes of 9-10 mL and 11-11.5 mL (indicated by arrows in Figure 3A) 
showed to contain the MSP2N2, EcfA, EcfA’, EcfT and FolT2 proteins in a ratio of about 
2:1:1:1:1 (Figure 3B), implying one ECF FolT2 transporter incorporated per nanodisc 
surrounded by two MSP2N2 proteins.
 In order to get rid of the big peak at the void volume, the number of lipids 
was lowered. At the same time, the lipid composition was changed to E. coli lipids:egg 
PC of 3:1, since this lipid composition was successfully used in the reconstitution of 
ECF FolT2 in proteoliposomes (see Chapter 5).17 Analysis of the nanodisc formation 
from reconstitution mixtures with ECF FolT2:MSP2N2:lipid ratios of 1:4:750, 1:4:1000, 
1:4:1250 and 1:4:1500 showed differences in abundance of the two peaks with retention 
volumes between 9 and 12 mL (indicated by the arrows in Figure 3C). For the 1:4:750 
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Figure 3: Reconstitution of ECF FolT2 in nanodiscs. A) SEC profile of the purification of the ECF 
FolT2 nanodiscs and empty nanodiscs from the reconstitution mixtures of ECF FolT2:MSP2N2:lipid 
of 1:5:1800 (black), 1:5:2000 (blue), 1:5:2200 (red) and 0:5:2000 (gray). B) SDS-PAGE gel of 
fractions from the SEC purifications of nanodiscs from panel A. C) Same as in panel A for the 
reconstitution mixtures of ECF FolT2:MSP2N2:lipid of 1:4:750 (black), 1:4:1000 (blue), 1:4:1250 
(red) and 1:4:1500 (green). D-E) SDS-PAGE gel of fractions from the SEC purifications of nanodiscs 
from panel C and from the SEC purification of the ECF FolT2:MSP2N2:lipid ratio of 1:5:1500 in 
Panel F. F) Same as in panel A for the reconstitution mixtures of ECF FolT2:MSP2N2:lipid of 
1:2:1500 (black), 1:3:1500 (blue), 1:4:1500 (red) and 1:5:1500 (green). The arrows in panels A, C 
and F indicate peaks to which is referred in the text.
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Table 1: Different protein:MSP:lipid mixtures tested for the reconstitution of ECF FolT2 in 
nanodiscs.
Membrane scaffold protein Lipid composition ECF FolT2:MSP:lipid ratio
MSP1D1 DOPE:DOPC:DOPG of 60:20:20 1:5:1500












ratio with the lowest amount of lipids, the later peak is more abundant, while higher 
amounts of lipids in the other ratios cause higher abundance of the first peak, which 
would contain bigger nanodiscs. Analysis of the SEC fractions on gel showed poorer 
staining of EcfT and FolT2 compared to EcfA and EcfA’ (Figure 3D and 3E), but this 
phenomena has been seen more often and has to do with the fact that these membrane 
protein stain less well compared to the soluble nucleotide binding domains. However, 
the bands of EcfT and FolT2 from the 1:4:1500 ratio fractions seem to be a bit more 
pronounced, and therefore optimization was continued from this protein to lipid ratio by 
changing the number of MSP2N2 proteins in the reconstitution ratio.
 When lowering the number of MSP2N2 proteins to ratios of 1:3:1500 and 
1:2:1500, the peak at the void volume appears again and the peak with nanodiscs between 
9 and 11.5 mL decreases, implying a lower amount of stable nanodiscs being formed 
(Figure 3F, black and blue curve). Analysis of the SEC fractions from these 1:3:1500 and 
1:2:1500 ratios by SDS-PAGE gel did not show clear bands for the ECF FolT2 subunits, 
and no band for the MSP2N2 protein at all, which raises the question if nanodiscs were 
formed at all. The SEC profile of nanodiscs from the ECF FolT2:MSP2N2:lipid ratio 
of 1:5:1500 is similar to the one from the 1:4:1500 ratio, with a new peak at a retention 
volume of about 9.5 mL appearing (indicated by the arrow in Figure 3F, green curve). The 
ratio of MSP2N2, EcfA, EcfA’, EcfT and FolT2 on SDS-PAGE is roughly 2:1:1:1:1, only 
the staining of FolT2 is not as pronounced as for the other three (Figure 3E).  Considering 
the height peak of ECF FolT2 nanodiscs with an expected MSP:protein ratio of 2:1 as 
shown by SDS-PAGE, as well as the absence of a peak at the void volume, the 1:5:1500 
reconstitution ratio was chosen to be the most optimal one.
ATPase activity of ECF FolT2 reconstituted in nanodiscs.
 Taking the main fraction of the peaks with ECF FolT2 nanodiscs from all 
different reconstitution ratios, the ATPase activity was measured in the presence and in 
the absence of 100 µM of folate (Figure 4A). After the 1:3:1500 ratio, the nanodiscs from 
the 1:5:1500 and 1:4:1500 ratio show the highest activity. For the 1:3:1500 and 1:2:1500 
ratio, the activity in the absence of folate is 52 % and 61 % higher than in the presence of 
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Figure 4: ATPase activity of ECF FolT2. A) ATPase activity of ECF FolT2 reconstituted in 
nanodiscs from different reconstitution mixtures, measured in the presence (black bars) and 
in the absence (white bars) of 100 µM of folate. Empty nanodiscs of five different ratios were 
taken along as well. The error bars represent the standard deviation from three measurements. B) 
ATPase activity assay of ECF FolT2 in detergent solution and reconstituted in proteoliposomes 
or nanodiscs, measured in the presence (black bars) and in the absence (white bars) of 100 µM of 
folate. The activity measured in the presence of empty liposomes and empty nanodiscs was taken 
along as well. The error bars represent the standard deviation from three measurements.
folate, while this difference is only 25 % and 26 % for the ratios 1:5:1500 and 1:4:1500, 
respectively. A similar difference of 31 % is seen in the ATPase activity of ECF FolT2 in 
detergent solution, while the ATPase activity of ECF FolT2 in proteoliposomes is similar 
in the presence and in the absence of folate (Figure 4B). In case of empty nanodiscs from 
different ratios and empty liposomes, the background ATPase levels are similar.
Discussion and conclusion
 Although ECF NiaX from L. lactis and ECF FolT2 from L. delbrueckii both 
belong to the group II transporters for which the S-component is predicted to dissociate 
from the ECF module during the transport cycle, different MSPs needed to be used to get 
the transporters reconstituted in a functional way. For ECF NiaX, the smaller MSP1D1, 
which forms nanodiscs with a diameter of 95 Å, was used. However, ECF FolT2 turned 
out to be inactive when the same MSP1D1 and protein to MSP to lipid ratio was used as 
for ECF NiaX, implying that there is no “one size fits all” solution when reconstitution 
membrane proteins in nanodiscs, even not when working with similar proteins. This 
raised the question why ECF NiaX was satisfied with MSP1D1, while ECF FolT2 needed 
the larger MSP2N2.
 When superimposing the crystal structure of folate-bound FolT1 from L. 
delbrueckii (PBD ID 5D0Y) with the structures of thiamine-bound ThiT (PDB ID 
3RLB) and biotin-bound BioY from L. lactis (PDB ID 4DVE),17,19,20 the dimensions were 
identical. This suggests that NiaX and FolT2 would not differ structurally that much 
from each other either. No crystal structure of a whole ECF transporter from L. lactis 
is available, so it is unknown if EcfT from L. lactis is structurally different from the 
one from L. delbrueckii. If it has a more compact structure compared to EcfT from L. 
delbrueckii, it is possible that the smaller nanodisc provides just enough space for the 
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conformational changes that need to occur to accommodate transport, while the same 
nanodisc is too small for the transporter from L. delbrueckii.
 On the other hand, an explanation with regard to the biochemical properties of 
NiaX might be more plausible. Competition studies performed with NiaX and ThiT from 
L. lactis competing for interaction with the same ECF module for substrate transport, 
have shown that NiaX competes more efficiently for the ECF module than ThiT.21 It 
is possible that NiaX has higher affinity for the ECF module in order to make niacin 
transport more efficient, because the uptake of niacin is preferred over the uptake of other 
substrates. In the absence of another S-component within the nanodisc, NiaX therefore 
does not dissociate from the ECF module. In case of FolT2, the affinity can be lower in 
comparison to the one for NiaX, with the consequence that FolT2 does dissociate during 
the transport cycle and therefore, ECF FolT2 requires more space within the nanodisc to 
complete the transport cycle.
 When determining the ATPase activity of both transporters in the optimized 
nanodiscs, a drop in the ATPase activity of about 25 % was seen for ECF NiaX in the 
absence of its substrate niacin, while the ATPase activity was increased by about 25 % for 
ECF FolT2 in the absence of its substrate folate. This implies that there is no clear substrate 
dependence on the ATPase activity among these ECF transporters. When looking at the 
ATPase activity of ECF FolT2 in detergent solubilized state, the activity in the absence 
of folate is 31 % higher compared to the activity in the presence of folate, and in the non-
optimized ECF FolT2 nanodiscs from the protein to MSP to lipid ratios of 1:2:1500 and 
1:3:1500, the activity in the absence of folate is even 52 % and 61 % higher than in the 
presence of folate. However, when ECF FolT2 was reconstituted in proteoliposomes, the 
activity was similar regardless of the presence of folate. In the detergent solubilized state, 
the detergent micelle does not provide the same stability and properties as a lipid bilayer 
would provide, and maybe the nanodiscs in this optimized state do not provide the same 
properties as a lipid bilayer in a proteoliposome or in a cell in order for the substrates to 
have no influence on the ATPase activity at all.
 Besides the different effects of niacin and folate, the ATPase activities 
measured were four orders of magnitude higher compared to the transport activities 
previously measured for ECF NiaX and ECF FolT2 (Chapter 5) when reconstituted 
in proteoliposomes.17,22 High futile ATPase activity has been observed for the biotin 
transporter BioMNY from Rhodobacter capsulatus as well, which belongs to the group 
I ECF transporters.16 As mentioned in Chapter 5 already, the high turnover of ATP by 
the ECF module might be accepted to make sure that the ECF module is in the right 
conformation to interact with a substrate-bound S-component as soon as it has captured 
its substrate, thereby making substrate transport efficient and giving the cell the ability 
to scavenge as much of the scarcely available nutrients as needed. However, it is still 
unknown if these high levels of futile ATP hydrolysis occur in vivo too. 
 To conclude, the research in this chapter has shown how to optimize the 
reconstitution of ECF transporters in nanodiscs while maintaining their activity, resulting 
a new model membrane system to study the ATPase activity of ECF transporters.
Experimental section
Expression and purification of ECF NiaX complexes.
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Reconstitution of  ECF transporters in phospholipid bilayer nanodiscs
 ECF NiaX and the ECF NiaX EcfA E166Q EcfA’ E170Q mutant have been 
cloned in the p2BAD vector previously and the vectors were transformed to E. coli 
MC1061 cells.22,23 Cultivation was performed aerobically in 10 L of Yeast Trypton 
medium (8 g/L BactoTM trypton, 5 g/L BactoTM yeast extract, 2.5 g/L NaCl) supplemented 
with 100 µg/mL ampicillin in a 15 L fermenter at 37°C, 500 rpm, 30 % air. At OD600 of 
~1.6, the temperature was lowered to 25°C and after allowing the cell culture to cool down 
for 20 minutes, expression was induced by addition of 1.5*10-3 % (v/v) of l-arabinose. 
One hour after induction, 0.2 % of glycerol was added to the cell culture. After 2.5-3 
hours of expression, the cells were harvested by centrifugation (15 min, 7,446 x g, 4°C), 
washed and resuspended in buffer A (50 mM KPi, pH 7.5), and stored at -80°C after 
flash-freezing in liquid nitrogen. Before cell disruption, the cells were thawed and ~50 
µg/mL of DNase, 1 mM of MgCl2 and 1 mM of PMSF were added. The cells were lyzed 
by high-pressure disruption (Constant Cell Disruption System Ltd, UK, one passage at 
25 kPsi, 5°C) and the cell debris was removed by low-speed centrifugation (30 min, 
27,167 x g, 4°C). Membrane vesicles were pelleted by high-speed centrifugation (90 min, 
185,677 x g, 4°C), and resuspended in buffer A to a total protein concentration of 15 mg/
mL, as determined by Bradford Protein Assay (Bio-Rad). After aliquoting the membrane 
vesicles, they were flash-frozen in liquid nitrogen and stored at -80°C.
 For the purification of the ECF NiaX proteins, membrane vesicles were thawed 
rapidly and solubilized in buffer C (50 mM KPi, pH 7.5, 300 mM NaCl, 10 % glycerol, 
1 % (w/v) n-dodecyl-β-d-maltopyranoside (DDM, Anatrace)) for one hour at 4°C, while 
gently rocking. Unsolubilized material was removed by centrifugation (30 min, 285,775 
x g, 4°C). The supernatant was incubated for one hour at 4°C under gently rocking with 
Talon resin (column volume of 1.1 mL), which had been equilibrated with buffer D (50 
mM KPi, pH 7.5, 300 mM NaCl, 10 % glycerol, 10 mM imidazole, 0.05 % (w/v) DDM). 
Subsequently, the suspension was poured into a 10 mL disposable column (BioRad) and 
the flow through was collected. The column material was washed with 22 mL of buffer D. 
The ECF NiaX complexes were eluted in three fractions of 750 µL of buffer E (50 mM 
KPi, pH 7.5, 300 mM NaCl, 300 mM imidazole, 0.05 % (w/v) DDM). 1 mM of EDTA 
was added to the second elution fraction to remove co-eluted Ni2+ ions. Subsequently, the 
second elution fraction was purified by size-exclusion chromatography, using a Superdex 
200 10/300 gel filtration column (GE Healthcare), equilibrated with buffer F (50 mM 
ammonium bicarbonate, pH 7.5, 150 mM NaCl, 0.05 % (w/v) DDM).
Expression, purification and reconstitution of ECF FolT2 complexes in proteoliposomes.
 The expression, purification and reconstitution of the ECF FolT2 complexes in 
proteoliposomes has been performed as described in Chapter 5 using buffer G (50 mM 
KPi, pH 7.5, 150 mM NaCl, 0.05 % (w/v) DDM) for size-exclusion chromatography.17
Expression and purification of MSP1D1 and MSP2N2.
 The pMSP1D1 and pMSP2N2 plasmids (Addgene plasmids 20061 and 
26282, respectively) were purchased from Addgene and freshly transformed into Ca2+ 
competent cells of the E. coli BL21(DE3) strain before cultivation. For expression, the 
E. coli BL21(DE3) cells carrying the pMSP1D1 or pMSP2N2 plasmids were cultivated 
aerobically in 2 L of Terrific Broth medium (12 g/L BactoTM trypton, 6 g/L BactoTM yeast 
extract, 0.5 % glycerol) supplemented with 10 µg/mL of kanamycin, 17 mM KH2PO4 
and 72 mM K2HPO4 in a 3 L fermenter (Applikon) at 37°C, 400-650 rpm, 50 % air. 
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Expression of MSP1D1 or MSP2N2 was induced at an OD600 of ~2 by addition of 1 mM 
of IPTG, and after three hours, the cells were harvested by centrifugation (15 min, 7,446 
x g, 4°C). Subsequently, the cells were washed and resuspended in 200 mL of buffer H 
(50 mM KPi, pH 7.8) and stored at -80°C after flash-freezing in liquid nitrogen. Before 
cell disruption, 100 µg/mL of DNase and 1 mM of MgSO
4
 were added to the thawed 
cells and after the cells were lysed by high-pressure disruption (Constant Cell Disruption 
System Ltd, UK, one passage at 25 kPsi, 5°C), 1 mM of PMSF and 1 % (v/v) of Triton 
X-100 (Sigma) was added. Cell debris was removed by low-speed centrifugation (30 min, 
30,000 x g, 4°C) and 20 mM of imidazole was added to the supernatant.
 For purification of MSP1D1 or MSP2N2, the supernatant was incubated for 
one hour at 4°C with Ni2+-Sepharose column material (column volume = 7.5 mL for 
supernatant from 1 L of cell culture), which had been equilibrated with buffer H. The 
column material was then washed with 40 mL of each of the three following buffers: 
buffer I (40 mM Tris/HCl, pH 8.0, 0.3 M NaCl, 1 % (v/v) Triton X-100), buffer J (40 mM 
Tris/HCl, pH 8.0, 0.3 M NaCl, 50 mM Na-cholate, 20 mM imidazole) and buffer K (40 
mM Tris/HCl, pH 8.0, 0.3 M NaCl, 50 mM imidazole). MSP1D1 or MSP2N2 was eluted 
in twelve elution fractions of 2 mL of buffer L (40 mM Tris/HCl, pH 8.0, 0.3 M NaCl, 
500 mM imidazole), and the fractions that contained protein were combined and dialyzed 
overnight against 1 L of  buffer M (20 mM Tris/HCl, pH 7.4, 0.1 M NaCl, 0.5 mM EDTA) 
to remove the imidazole. After filtering of the protein sample using a 0.22 µm syringe 
filter, it was diluted to a final protein concentration of 8 mg/mL and 0.01 % of NaN3 was 
added. Subsequently, 500 µL aliquots of the purified protein were stored at -80°C.
Reconstitution into nanodiscs.
 The reconstitution of the ECF transporters in phospholipid nanodiscs was 
performed as described previously with some modifications.18 Briefly, liposomes with 
a synthetic lipid composition of DOPE:DOPC:DOPG of 50:12:38 were used for the 
reconstitution of the ECF NiaX complexes, while the liposomes with synthetic lipid 
composition of DOPE:DOPC:DOPG of 60:20:20 were used for both proteins, and 
liposomes with a lipid composition of E. coli polar lipid extract:egg PC of 3:1 were 
used only for the reconstitution of the ECF FolT2 complexes. The thawed liposomes 
were extruded through a 400 nm pore size polycarbonate filter (Avestin, eleven passages) 
and after addition of 1 % (w/v) of DDM, the mixture was vortexed until an optically 
clear solution was obtained. Purified ECF NiaX complexes, purified MSP1D1 and the 
destabilized liposomes were mixed in buffer N (50 mM KPi, pH 7.5, 12 mM DDM) 
to obtain different molar ratios as stated in the Results section, with the concentration 
of ECF NiaX varying from 1.4 µM to 4.3 μM and a concentration of 7.3 μM for the 
ATPase inactive ECF NiaX mutant (EcfA E166Q EcfA’ E170Q). The purified ECF 
FolT2 complexes were mixed with purified MSP1D1 or MSP2N2 and the destabilized 
liposomes in buffer N to obtain the different molar ratios stated in the Results section 
with the concentration of ECF FolT2 varying from 1.4 µM to 5.0 µM. Subsequently, 
these reconstitution mixtures were incubated for 60 min at 4°C while gently rocking, 
after which 300 mg of Amberlite XAD-2 polymeric absorbent beads (Supelco, Sigma-
Aldrich) were added. After incubation overnight at 4°C while gently rocking, the beads 
were removed by centrifugation (17,949 x g, 4°C) and the nanodiscs were purified from 
the supernatant by size-exclusion chromatography using a Superdex 200 10/300 gel 
filtration column (GE Healthcare), equilibrated with buffer O (50 mM KPi, pH 7.5, 150 
mM NaCl). The fractions containing the nanodiscs were used directly or combined and 
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Reconstitution of  ECF transporters in phospholipid bilayer nanodiscs
concentrated using a Vivaspin 500 concentrating device with a molecular weight cut-off 
of 100 kDa (Sartorius stedim) if no accurate protein concentration could be determined 
by Nanodrop. Subsequently, the nanodiscs were kept on ice until used, or frozen in liquid 
nitrogen and stored at -80°C.
ATPase activity assay.
 The ATPase activity of the ECF transporters reconstituted in nanodiscs was 
measured by using a coupled enzyme assay described previously.18 The assay was 
performed at 30°C in a 96-well plate, and the absorbance at 340 nm was measured by a 
Synergy MX-96 well plate reader (BioTek Instruments, Inc.). A standard experiment of 
200 µL of reaction solution per well contained 50 mM KPi, pH 7.5, ~50 nM (1.2 µg) of 
ECF transporter, 4 mM of sodium phosphoenolpyruvate, 0.3 mM of NADH and 3.5 µL 
of pyruvate kinase/lactic dehydrogenase enzyme mixture from rabbit muscle (Sigma-
Aldrich) in 50 % glycerol. After incubation of the reaction solutions for 3 min at 30°C, 1 
mM of MgATP, pH 7.5, was added to each of the reactions and the absorbance of NADH 
at 340 nm was followed for 7-10 min. The ATPase activity was expressed in µmol of ATP 
hydrolyzed/(min * mg of ECF transporter) and bar charts were prepared using SigmaPlot 
version 11 software.
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Chapter 7
Attempts to trap ECF FolT2 in a nucleotide-bound 
state
Lotteke J. Y. M. Swier and Dirk J. Slotboom
ABC transporters hydrolyze ATP to fuel transport of their substrates across the 
membrane. In case of the ECF transporters, the steps of ATP binding and hydrolysis 
are proposed to reset the transporter after the substrate has been released into the 
cytosol. In this chapter, the order of events in ECF FolT2 following substrate release 
was studied. Analysis by size-exclusion chromatography revealed dissociation of the 
S-component from the ECF module only in the presence of both folate and MgATP, 
with the requirement that ATP can be hydrolyzed. Together with the information 
obtained from biochemical characterization and mutations, this knowledge was 
used to update the proposed working model for the transport mechanism of ECF 
transporters. To validate this model with structural data, attempts were made 
to trap ECF FolT2 in a nucleotide-bound state to see what closure of the EcfAA’ 
heterodimer does to the conformation of the coupling helices of EcfT and the 




 In Chapter 5, the crystal structures of apo and AMP-PNP bound ECF FolT2 in a 
conformational state after substrate release into the cytosol, were revealed. By comparing 
the conformation of FolT2 in these structures with the conformation of folate-bound 
FolT1 described in the same chapter, and re-evaluating previously published data on ECF 
transporters in the light of these new crystal structures, a new working model for the 
transport mechanism of ECF transporters was proposed. In this model, the binding and 
hydrolysis of ATP was proposed to reset the transporter after substrate release. The next 
step in validating the model, is to study what actually happens during the events of ATP 
binding and subsequent hydrolysis.
 In classical ABC transporters, the binding and hydrolysis of ATP in the 
nucleotide binding domains (NBDs) causes these domains to convert from an open to a 
close conformation and vice versa. These conformational changes are transferred via the 
coupling helices to the transmembrane domains (TMDs) and give access to the substrate 
binding site within these TMDs from either the extracytoplasmic or the cytoplasmic side, 
thereby allowing substrate transport. In order to obtain this knowledge, the transporters 
have been crystallized under different conditions in the presence or absence of substrate, 
nucleotides or other additives, and upon the introduction of mutations or formation of 
disulfide bonds by cross-linking (see Chapter 1). Besides, validation of proposed transport 
mechanisms were performed by biochemical experiments, mutagenesis, cross-linking 
studies, EPR and single-molecule spectroscopy.
 Focusing on the classical ABC importers, there are two transporters that have 
been crystallized in a nucleotide-bound, pre-hydrolysis state with the NBDs in a closed 
conformation; the maltose transporter MalFGK2 and the vitamin B12 transporter BtuCDF 
from E. coli. MalFGK2 has been crystallized in an ATP-bound state, stabilized by an 
ATPase inactivating mutation in each of the two NBDs.1 In this mutation, the conserved 
glutamate of the Walker B motif within the NBD is mutated into a glutamine. This 
glutamate serves as the general base in ATP hydrolysis by polarizing the attacking water 
molecule, and the mutation to a glutamine had shown to abolish the ATPase activity in the 
maltose transporter, the ABC exporters BmrA from Bacillus subtilus and HlyB from E. 
coli, and in the NBDs MJ0796 and MJ1267 from Methanococcus jannaschii.1–5 Besides, 
this mutation increased the affinity of the MJ0796 NBDs for eachother by four orders of 
magnitude and enable crystallization of an ATP-bound dimer in closed conformation.2,6 
The same glutamate to glutamine mutation was introduced in BtuCDF, where it abolished 
the ATPase activity.7 
 Another strategy to fix the NBDs in a closed, nucleotide-bound conformation, is 
to introduce a cross-link that holds the two subunits together. For BtuCDF, the glutamate 
to glutamine mutation was not enough to crystallize the transporter in an AMP-PNP bound 
state, but upon introduction of a cysteine residue in each of the two D-loops of the NBDs 
and subsequent cross-linking, a crystal structure with the desired closed conformation 
of the AMP-PNP bound NBDs was obtained.7,8 The Cα atoms of mutated residues were 
separated over a distance of 6.5 Å, and equivalent residues in MalFGK2 in the nucleotide-
bound state were 6 Å apart, compared to 9.2 and 12.2 Å in the open conformation of the 
NBDs, respectively. Upon cross-linking of the D-loops in BtuCDF, both the ATPase and 
the transport activity were decreased, but not completely abolished. Therefore, to make 
sure that corresponding conformational changes did not interfere with crystallization of 
the transporter, the glutamate to glutamine mutation was introduced as well.8
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 Using the working model and the methods described in Chapter 5 and 6, the 
dissociation of the S-component from the ECF module is studied in this chapter using 
size-exclusion chromatography. Next, ECF FolT2 is characterized biochemically and the 
knowledge obtained is used to update the model of the transport mechanism proposed 
in Chapter 5. Next, attempts were made to trap the transporter in a nucleotide-bound 
state by introducing ATPase inactivating mutations, as well as cysteine mutations in the 
D-loops of the EcfA and EcfA’ subunits in order to cross-link these domains. In the apo 
and AMP-PNP bound structures of ECF FolT2, the distances between the Cα atoms in 
the D-loops are 5.8-7.3 Å, which is similar to the distances of the corresponding residues 
in the D-loops of BtuCDF after cross-linking. Therefore, it is well possible that the cross-
linking itself does not force the ECFAA’ heterodimer to obtain a closed conformation, but 
rather prevents the dimer to convert to an open state after ATP hydrolysis has taken place.
Results
Dissociation of the S-component from the ECF module.
 ECF FolT2 belongs to the group II ECF transporters, for which the S-component 
is predicted to dissociate from the ECF module after releasing the substrate into the 
cytosol, in order to capture the next substrate molecule to be transported. In the absence 
of MgATP and folate, the S-component stayed attached to the ECF module in a toppled 
conformation as shown by the crystal structures in Chapter 5. This resulted in one peak 
in the size-exclusion chromatography (SEC) profile with a retention volume of about 
11.5 mL, as shown in Figure 1A (black curve). Beside this main peak, there is a small 
peak visible with a retention volume of about 13 mL. In order to see what is required to 
dissociate the S-component from the ECF module, the purified ECF FolT2 transporter 
after Ni2+-Sepharose affinity chromatography was incubated with 5 mM of MgATP, 100 
µM of folate or 5 mM of MgATP plus 100 µM of folate for one hour, and subsequently 
purified by SEC. In the presence of MgATP or folate (Figure 1A, blue and red curves, 
respectively), the main peak eluted at the same retention volume as without MgATP or 
folate. The small peak at the retention volume of about 13 mL has increased compared 
to the condition without MgATP or folate, but so has the main peak, and this is due 
to a higher protein concentration. However, when the transporter was incubated with 
both MgATP and folate, the main peak still eluted at the same retention volume but had 
decreased in height, while the peak at the retention volume of about 13 mL had increased 
in size (Figure 1A, green curve). 
When analyzing the elution fractions containing these SEC peaks on SDS-PAGE 
gels, all four subunits of the transporter seemed to be present in all fractions (Figure 1C). 
In case of the peak at 13 mL in the presence of both MgATP and folate, the intensity of 
the bands was somewhat lower compared to the main peak at 11.5 mL, but there was 
no clear difference in the ratio of the four bands. When purifying the lone ECF module 
in the absence of FolT2 in the same detergent as used for purification of the complete 
transporter, it appeared to elute at the same retention volume of 13 mL (Figure 1B, purple 
curve), although the purification protocol was not optimized and additional peaks yielding 
the EcfAEcfA’ dimer and lone EcfT protein appeared in the SEC profile as well (Figure 
1C). However, when purifying FolT2 in the same detergent as used for the purification 
of ECF FolT2, it also eluted at the same retention volume of 13 mL (Figure 1B, orange 
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Figure 1: Dissociation of the S-component from the ECF module analyzed by size-exclusion 
chromatography. A) Size-exclusion chromatography (SEC) profiles of ECF FolT2 without 
incubation (black) or after incubation with 5 mM of MgATP (blue), 100 µM of folate (red) or 5 mM 
of MgATP plus 100 µM of folate (green). B) Overlay of the SEC profiles of ECF FolT2 without 
incubation (black) and after incubation with 5 mM of MgATP plus 100 µM of folate (green), with 
the SEC profiles of the lone ECF module (purple) and lone FolT2 (orange). C) SDS-PAGE gels 
of the SEC fractions from the SEC profiles in panels A and B. The sizes of the bands of the low 
molecular weight markers (in kDa), as well as the bands of EcfA (A), EcfA’ (A’), EcfT (T) and 
FolT2 (S), are indicated. D) SEC profiles of the ATPase inactive mutant E169Q E’171Q without 
incubation or after incubation with 5 mM of MgATP (blue), 100 µM of folate (red) or 5 mM of 
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the presence of MgATP and folate, but since the detergent micelle with FolT2 or the ECF 
module has about the same size, they elute at the same retention volume and therefore, no 
difference can be seen on SDS-PAGE gel.
 In order to see if ATP hydrolysis is required to dissociate the S-component, or if 
only binding of ATP is enough, the same experiment has been performed with an ATPase 
inactive mutant ECF FolT2 EcfA E169Q EcfA’E171Q (E169Q E’171Q), in which the 
conserved glutamates of the Walker B motifs had been mutated to glutamines. When 
comparing the SEC profiles of this mutant without incubation, or after incubation with 
5 mM of MgATP, 100 µM of folate or 5 mM of MgATP plus 100 µM of folate, both 
peaks with the retention volumes around 11.5 and 13 mL appeared, with the first being 
the highest under all conditions (Figure 1D). The reason why the height of the peaks 
differed between the different samples, had to do with differences in incubation time 
before the protein was loaded on the SEC column (longer incubation times resulted in the 
formation of more aggregates in the sample, which were removed before the sample was 
applied to the SEC column, resulting in a lower protein concentration). In the presence of 
MgATP and folate, the ratio between the two peaks around 11.5 and 13 mL did not change 
significantly as it did in case of wild type ECF FolT2. When analyzing the peak fractions 
of both peaks obtained under the different conditions on SDS-PAGE gels, FolT2 did not 
stain well, and also the amounts of EcfT and EcfA’ were lower compared to EcfA in the 
main peak eluting around 11.5 mL (Figure 1E). The second peak eluting around 13 mL 
was enriched in EcfA compared to the first peak, while the amounts of EcfA’ and EcfT 
were lower and FolT2 was not visible. This suggested that this protein preparation did not 
contain equal amounts of all four subunits, making it impossible to draw conclusions from 
the SDS-PAGE gel. However, the SEC profiles of the mutant implied no change in the 
composition of the protein sample under the different conditions tested, suggesting that 
ATP hydrolysis is required for dissociation of the S-component from the ECF module.
Biochemical characterization of ECF FolT2. 
 To get more insight in the transport mechanism of ECF transporters, biochemical 
characterization of ECF FolT2 was performed using the radiolabeled folate uptake assay 
with ECF FolT2 reconstituted in proteoliposomes (described in Chapter 5). Folate uptake 
via ECF FolT2 was determined in the presence of different concentrations of folate and 
the data were fitted with the Michaelis-Menten equation, which resulted in a KM for 
folate of 59.8 nM and a Vmax of 0.771 pmol of folate taken up per minute per µg of ECF 
FolT2 (Figure 2A). Using this Vmax, a kcat of 0.00148 s-1 was calculated, meaning that 
one molecule of folate is transported every 11.2 minutes. When performing the same 
experiment at a folate concentration of 100 nM of folate, while varying the concentration 
of MgATP enclosed in the proteoliposomes, the data was fitted to the Hill equation and 
gave a KM for MgATP of 5.54 mM, a Vmax of 0.493 pmol of folate taken up per minute 
per µg of ECF FolT2 and a Hill coefficient (nH) of 1.75 (Figure 2B). This Hill coefficient 
implies more than one molecule of ATP being cooperatively involved in folate transport. 
With two ATP-binding and -hydrolysis sites present per ECF transporter, we assume 
cooperative binding and hydrolysis of two molecules of ATP per molecule of folate 
transported across the membrane.
 In Chapter 5, ECF FolT2 was crystallized in complex with AMP-PNP, which 
showed to bind at the ATP-binding and -hydrolysis site. AMP-PNP is a competitive 
inhibitor of ATP hydrolysis in classical ABC transporters, in which it also bound at the 








KM   = 59.8 ± 11.9 nM
Vmax = 0.771 ± 0.0498 pmol/   
           min*µg ECF FolT2
KM   = 5.54 ± 1.68 mM
Vmax = 0.493 ± 0.110 pmol/
           min*µg ECF FolT2
apparent Ki   = 0.498 ± 0.0398 mM
nH    = 1.75 ± 0.378
Figure 2: Kinetics of ECF FolT2 determined by radiolabeled uptake activity assays. A) KM and Vmax determination for folate by plotting the initial uptake rate of folate transport against the 
concentration of folate. B) KM, Vmax and Hill coefficient (nH) determination for MgATP by plotting the initial uptake rate of folate transport against the concentration of MgATP. C) Inhibition of folate 
uptake by the presence of MgAMP-PNP, shown by plotting the initial uptake rate of folate transport 
against the concentration of MgAMP-PNP. D) Determination of the apparent Ki of MgAMP-PNP for folate transport by plotting the percentage of inhibition against the concentration of MgAMP-
PNP, setting the percentage of inhibition in the presence of 40 mM of MgAMP-PNP to 100 %. E) 
Folate uptake over time in the presence of 5 mM of MgATP (black circles) or 5 mM of MgATP plus 
10 mM of vanadate (white circles). F) Folate uptake over time in the presence of 5 mM of MgATP 
(black circles) or 5 mM of MgATP plus 25 mM of vanadate (white circles). The errors in all graphs 
indicate the standard deviation of three measurements, while the errors given for the KM, Vmax, nH 
and Ki values represent the error of the fit.
ATP-binding and hydrolysis sites.8–11 After determining the initial transport rates of ECF 
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the percentage of inhibition by MgAMP-PNP could be plotted against the MgAMP-PNP 
concentration and an apparent Ki value of 0.498 mM was determined (Figure 2C-D). 
This confirms AMP-PNP being an inhibitor to ECF transporters as well, and with the 
knowledge that AMP-PNP binds at the ATP-binding and –hydrolysis site in the crystal 
structure of ECF FolT2, it can be classified as a competitive inhibitor. Another inhibitor 
of ATPases is the γ-phosphate mimic ortho-vanadate (VO
4
3-). Upon ATP hydrolysis, 
vanadate substitutes for the leaving inorganic phosphate group before ADP leaves the 
ATP-binding and -hydrolysis site.12 Therefore, one turnover of ATP would be necessary 
to fix the EcfAA’ heterodimer in a post-hydrolysis state. We have performed radiolabeled 
folate uptake assays in the presence of a twofold and fivefold excess of vanadate over 
MgATP (Figure 2E-F). In the presence of a twofold excess of vanadate, the initial transport 
activity was inhibited by about 50 %, while this percentage was increased to about 90-95 
% in the presence of a fivefold excess, showing that vanadate is a potential tool to trap 
ECF FolT2 in a nucleotide-bound state. The big difference in the levels of folate uptake 
in the presence of MgATP only between Figures 2E and 2F, has to do with the life time 
of the stocks of radioactive folate used; the older the stock gets, the lower the amount of 
radioactivity it emits, and this results in lower numbers of folate uptake activity.
Transport activity of ECF FolT2 mutants.
 To further investigate ATP hydrolysis from the structural point of view, two 
important residues within the ATPases were mutated. The conserved glutamate in the 
Walker B motif was mutated to a glutamine to obtain the ATPase inactive mutant, and 
the conserved aspartate of the D-loop was mutated to an alanine. This aspartate of one 
ATPase subunit, interacts with the conserved histidine of the H-loop and the Walker A 
motif in the other ATPase and partitions in the ATP hydrolysis-site of the latter subunit by 
coordinating and activating the attacking water molecule, thereby playing an important 
role in ATP hydrolysis in this subunit, as well as in communication between the two 
ATPases.4,6,9 Due to problems at the level of mutagenesis (the quick change PCRs used 
to introduce the single mutations in EcfA of the wild type ECF FolT2 sequence, were not 
successful), no single mutants for EcfA were obtained, but single mutants in EcfA’ and 
double mutants in both ATPases have been studied using the radiolabeled uptake assay 
with proteoliposomes and the ATPase activity assay with nanodiscs described in Chapter 
6 (Figure 3). When comparing the folate uptake activity of the mutants to the activity of 
wild type ECF FolT2, the ATPase inactive mutant E169Q E’171Q showed no transport 
activity (Figure 3A, red curve versus dark green curve), while the single ECF FolT2 EcfA’ 
E171Q mutant (E’171Q) was still able to take up folate at a rate of only 3.9 % of the wild 
type rate (Figure 3A, light green curve). The aspartate to alanine mutation lowered the 
transporter activity too, with the double mutant being less active than the single mutant, 
but the effect was less pronounced as for the glutamate to glutamine mutations (Figure 
3A, light blue and dark blue curves). The transport rate of the single mutant was 23 % of 
the wild type rate, while this was 6.4 % for the double mutant.
 To distinguish between folate binding and transport, the subsequent efflux of 
radiolabeled folate from the proteoliposomes was followed upon the addition of MgATP 
or an excess of non-radiolabeled folate at t = 16 minutes (Figure 3A). In case of wild type 
ECF FolT2, radiolabeled folate was transported out of the proteoliposomes by the inside-
out oriented transporters in the presence of MgATP, while no release was observed upon 
the addition of non-radiolabeled folate, indicating real transport as discussed in Chapter 





Figure 3: Transport and ATPase activity of wild type ECF FolT2 and the ATPase mutants. 
A) Transport activity of wild type ECF FolT2 (red) and the mutants E’171Q (light green), E169Q 
E’171Q (dark green), D’177A (light blue) and D175A D’177A (dark blue), reconstituted in 
proteoliposomes loaded with 5 mM of MgATP. The color code for wild type and the mutants is 
maintained throughout the figure. At t = 16 min, 5 mM of MgATP (colored circles) or 100 µM 
of non-radiolabeled folate (white circles) was added to the reactions, and the efflux activity was 
followed for an additional 7 minutes. B) Efflux activity of the mutants E’171Q, D’177A and D175A 
D’177A from proteoliposomes loaded with 5 mM of MgATP, after accumulation of radiolabeled 
folate for 55 minutes to levels of 1.0, 1.7 and 0.84 pmol/µg of protein, respectively. At t = 55 
min, 5 mM of MgATP (colored circles) or 100 µM of non-radiolabeled folate (white circles) was 
added to the reactions. C) ATPase activity of wild type ECF FolT2 and the mutants reconstituted 
in nanodiscs, measured in the absence or presence of 100 nM of folate. The background activity 
measured in the presence of empty nanodiscs is shown in yellow. The errors in all graphs represent 
the standard deviation from three experiments.
of MgATP, as a result of not having reached a steady-state level of folate association 
after 16 minutes of uptake. When extending folate uptake for 55 minutes, still folate 
was taken up by this mutant upon addition of MgATP (Figure 3C). The addition of an 
excess of non-radiolabeled folate had no effect, indicating that this mutant is able to 
transport folate, although at a low rate. For the D’171A and D175A D’171A mutants, 
no clear effect was observed upon the addition of an excess of non-radiolabeled folate. 
After the short time scale of folate uptake of 16 minutes, it seems that about 10 % of 
folate leaves the proteoliposomes with the single mutant upon addition of an excess of 
non-radiolabeled folate, while this amount is increased to roughly 20 % in case of the 
double mutant (Figure 3A). However, when allowing folate uptake for 55 minutes and 
subsequent chasing off with unlabeled folate, the internalized folate is released by the 
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single mutant but not by the double mutant. It needs to be noted that the errors for these 
experiments are large. Upon the addition of MgATP, a small increase in the amount of 
associated folate is observed, implying that no equilibrium of the folate levels on the 
inside and outside of the proteoliposomes had been reached after 55 minutes of uptake, as 
was observed for the E’171Q mutant.
ATPase activity of ECF FolT2 mutants.
Besides the transport activity, the ATPase activity of the transporters reconstituted 
in nanodiscs was studied in the absence and presence of 100 nM of folate (Figure 3D). 
Both double mutants showed to be ATPase inactive, with ATPase activities at the level 
of the background activity measured in the presence of nanodiscs. Compared to the 
ATPase activity of wild type ECF FolT2 after subtraction of the background activity, 
the E’171Q mutation decreased the activity by about 71 and 76 % in the presence and 
absence of folate, respectively. For the D’177A mutation, these numbers were 38 and 53 
%, respectively. In case of both mutants, the ATPase activity is independent of the folate 
concentration, while the absence of folate leads to an increase in activity of about 25 % 
for wild type ECF FolT2.
Combining the results from the transport and ATPase activity assays, it is clear 
that the E169Q E’171Q mutation abolishes folate transport by inactivation of ATP 
hydrolysis. For the E’171Q mutant, ATP hydrolysis by only one of the ATPase subunits 
is possible, which seems to impair transport activity almost completely, implying that 
functionality of both ATPases is required for substrate transport. For the aspartate to 
alanine mutation, the single mutant was still able to hydrolyze ATP and showed clear 
transport activity, of which a fraction corresponded to folate binding only. The double 
mutant did not show any ATPase activity, but the transport assay implied association of 
folate to the proteoliposomes, of which a fraction could be binding only. Since values of 
the ATPase activities are around four orders of magnitude higher as the values observed 
for the transport activity, it is possible that the double mutant is still capable of ATP 
hydrolysis, but that the amount is just too low to be observed in our ATPase activity assay. 
A useful control experiment would be to perform the transport assay in the presence of 
MgADP instead of MgATP. If folate uptake by the double mutant would still be observed 
in this case, it would imply that this mutation turns transport into facilitated diffusion. 
The fact that this is combined with partial release of folate upon addition of an excess of 
non-radiolabeled folate, suggests that the efficiency of transport after substrate-binding is 
lowered by the aspartate to alanine mutation, while the substrate is released directly upon 
interaction of the S-component with the ECF module in case of the wild type transporter. 
Cross-linking of the EcfAA’ heterodimer.
 In order to trap ECF FolT2 in a nucleotide-bound state, the EcfAA’ heterodimer 
was cross-linked by mutating two residues in the D-loop of each of the ATPases to 
cysteines; S172 and M173 in EcfA and A’174 and G’175 in EcfA’ (Figure 4A). In the apo 
and AMP-PNP bound crystals structures, the Cα atoms of these residues are separated by 
5.8 and 7.3 Å, which is well in the range for cross-linking. Wild type ECF FolT2 already 
contains four cysteines, of which one is located in EcfA near the Walker B motif. To 
prevent undesired cross-linking reactions, the cysteine mutations were introduced in a 
cysteine-less version of ECF FolT2. In case of the triple mutant in which only the EcfA’ 
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Figure 4: Cross-linking of the S172C G’175C and M173C A’174C mutants, without and in 
combination with the E169Q E’171Q mutations. A) Stick representation of the four residues of 
the D-loops being mutated to cysteines, with their carbon atoms colored green. The other atoms 
and the EcfAA’ heterodimer are colored as in Chapter 5. B) SDS-PAGE gel of the cross-linking 
with 5 mM of Cu-phenthroline or 1 mM of HgCl2, in the absence or presence of 5 mM of MgATP 
as indicated. The lanes containing the S172C G’175C and M173C A’174C mutants are indicated 
as well. C) SDS-PAGE gels of the cross-linking with 1 or 5 mM of Cu-phenanthroline, performed 
on ice or at room temperature (RT) and for different time frames, as indicated. The left gel contains 
samples of the S172C G’175C mutant, while the right gel contains samples of the M173C A’174C 
mutant. D) SDS-PAGE gels of the cross-linking with 5 or 7.5 mM of Cu-phenanthroline, the 
absence or presence of 10 mM of MgATP and performed for different time frames, as indicated. 
The left gel contains samples of the E169Q S172C E’171Q G’175C mutant, while the right gel 
contains samples of the E169Q M173C E’171Q A’174C mutant. The lanes just right to the markers 
contain the proteins before cross-linking.
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phenanthroline or HgCl2 was obsered (data not shown). Therefore, it was decided to 
continue with two double mutants, instead of trying to obtain the quadruple mutant.
For the ECF FolT2 EcfA S172C EcfA’ G175C (S172C G’175C) and ECF 
FolT2 EcfA M173C EcfA’ A174C (M173C A’174C) mutants, cross-linking with 5 mM 
of Cu-phenanthroline lowered the intensity of all four bands of the transporter subunits 
significantly and caused two new bands to appear, one with a molecular weight of more 
than 97 kDa and another that was unable to enter the gel (Figure 4B). The appearance 
of this first band was also observed upon cross-linking with 1 mM of HgCl2, but was 
not as intense as for the cross-linking with Cu-phenanthroline. Besides, the intensity 
of the four subunit bands did not decrease as see with Cu-phenanthroline, making Cu-
phenanthroline a better cross-linker. The absence or presence of 5 mM of MgATP did 
not influence the cross-linking, and when performing the cross-linking with 1 or 5 mM 
of Cu-phenanthroline, at different temperatures and for different time scales, both the 
temperature and time did not seem to be of influence, but the higher concentration of 
Cu-phenanthroline led to a higher percentage of cross-linking (Figure 4C). In both 
experiments, the S172C G’175C mutant seemed to cross-link better than the M173C 
A’174C mutant, in terms that the bands of EcfA and EcfA’ from this first mutant became 
less intense upon crosslinking (Figure 4B-C).
 When combining the cysteine mutations with the ATPase inactivating mutations 
EcfA E169Q and EcfA’ E171Q, cross-linking with Cu-phenanthroline was still successful 
under different conditions in the sense that the intensity of the EcfA and EcfA’ bands was 
lowered, while higher bands with a molecular weight of more than 97 kDa appeared, 
as well as a band that could not enter the gel (Figure 4D). In the presence of 10 mM 
of MgATP, the intensity of the EcfA and EcfA’ bands was somewhat higher than in the 
absence of MgATP, but at the same time, the lower band of the two bands with a molecular 
weight of more than 97 kDa (indicated by the arrow in Figure 4D) disappears in case 
of the ECF FolT2 EcfA E169Q S172C EcfA’ E171Q G175C (E169Q S172C E’171Q 
G’175C) mutant. For the other mutant, the lower band becomes less intense as well, 
especially for the 15 minutes incubation. This might mean that the crosslinked protein can 
still adopt two conformations, of which one is preferred the presence of MgATP. This last 
conformation can be the closed conformation of the EcfAA’ dimer, which can convert to 
the open conformation upon ATP hydrolysis, but when ATP hydrolysis is abolished by the 
glutamate to glutamine mutation, this conformation becomes dominant.
ATPase activity of cross-linked ECF FolT2.
 To see the effect of cross-linking on the ATPase activity of the transporter, the 
cysteine mutants were reconstituted in nanodiscs and the ATPase activity was measured in 
the absence and presence of folate (Figure 5A). However, even without crosslinking, the 
mutants displayed the same activity as the background activity measured in the presence 
of empty nanodiscs, and thus turned out to be ATPase inactive. One explanation could 
be the requirement of the natural cysteine in EcfA’ near where the cysteine mutations 
for cross-linking were introduced. After bringing this cysteine back by introduction of 
the EcfA’ A’168C mutation, the new cysteine mutants were reconstituted into nanodisc 
and showed to cross-link upon treatment with Cu-phenanthroline (the bands of EcfA and 
EcfA’ disappear almost completely), while no crosslinking was observed for wild type 
ECF FolT2 reconstituted in nanodiscs (Figure 5B-C).
























































































Figure 5: ATPase activity of ECF FolT2 cysteine mutants, before and after cross-linking. A) 
ATPase activity of wild type ECF FolT2 (red) and the cysteine mutants S172C G’175C (blue) and 
M173C A’174C (green) reconstituted in nanodiscs, measured in the absence or presence of 100 
nM of folate. The background activity measured in the presence of empty nanodiscs is shown in 
yellow. The color code is maintained throughout the figure. B) SDS-PAGE gels of the purification 
of nanodiscs with wild type ECF FolT2 and the cysteine mutants with the EcfA’ A168C mutation, 
as well as the analysis of cross-linking with 5 mM of Cu-phenanthroline of the transporters while 
being reconstituted in the nanodiscs. C) SEC profile of the purification of nanodiscs with wild type 
ECF FolT2 and the cysteine mutants with the EcfA’ A168C mutation. The colored bars indicate 
the fractions used for the activity assay. D) The ATPase activity of wild type ECF FolT2 and the 
cysteine mutants reconstituted in nanodiscs, with the EcfA’ A168C mutation introduced in the 
cysteine mutants. The asterisks indicate the conditions after treatment with Cu-phenanthroline. The 
errors in all graphs represent the standard deviation from three experiments. 
this was only 20-35 % of the activity observed for wild type ECF FolT2 (Figure 5D). 
This would indicate that one or more of the other three natural cysteines have a role in 
functionality too.  After cross-linking, the ATPase activity of the S172C A’168C G’175C 
mutant dropped by 31 and 61 % in the presence and absence of folate, while the M173C 
A’168C A’174C mutant did not show any ATPase activity anymore. For wild type ECF 
FolT2, the activity was decreased by 10 and 33 %, respectively, showing that the treatment 
with Cu-phenanthroline is not entirely harmless to the protein.
Crystallization of ECF FolT2 in a nucleotide-bound state.
 Using wild type ECF FolT2 and several mutants acquired in this Chapter, several 
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approaches were taken to crystallize the transporter in a different conformational state than 
the apo and AMP-PNP bound structures described in Chapter 5. The goal was to crystallize 
the transporter in an ATP-bound state, in order to see which conformational changes the 
coupling helices of EcfT undergo upon closure of the EcfAA’ heterodimer, and if this 
would affect the conformation of the S-component in complex with the ECF module. 
Therefore, the ATPase inactive mutant E168Q E’171Q was crystallized in the presence 
of 8.5 mM of MgATP and the first crystals diffracted up to 8 Å resolution. Subsequent 
optimization using the AdditiveTM screen from Hampton Research and 10 mM of MgATP 
did not improve the resolution of diffraction for crystals of this mutant. Simultaneously, 
the cysteine mutants S172C G’175C and M173C A’174C were crosslinked in the presence 
of Cu-phenanthroline and MgATP, and from the first crystallization trials, initial crystals 
diffracting up to 12.8 Å resolution were obtained.
 In order to follow what happens structurally at the step of ATP hydrolysis, wild 
type ECF FolT2 was set up for crystallization in the presence of MgATP, folate and 
vanadate. In case of the maltose transporter from E. coli, this strategy has been used to 
crystallize the transporter in the transition state during ATP hydrolysis.10 However, for 
ECF FolT2, no conditions have been found to date to crystallize the transporter under 
these conditions.
Discussion
 In order to dissociate FolT2 from the ECF module, the presence of both MgATP 
and folate were required. Besides, ATP needed to be hydrolyzed, since dissociation of 
the S-component in the presence of both MgATP and folate was not observed for the 
ATPase inactive mutant E169Q E’171Q. When characterizing ECF FolT2 biochemically 
and determining the Hill coefficient for ATP hydrolysis, this Hill coefficient implied more 
than one molecule of ATP being cooperatively involved in folate transport. With two ATP-
binding and -hydrolysis sites present per ECF transporter, we assume two molecules of 
ATP being hydrolyzed per molecule of folate being transported. This assumption became 
even more plausible by the activity assays performed with the single E’171Q mutant. 
The ATPase activity of this mutant was lowered by 71-78 % compared to the wild type 
transporter, while the transport rate was lowered by 96 %. In case of non-cooperative 
hydrolysis, the transport activity would not have been affected to such a large extent.
 Upon substitution of the aspartate in the D-loop by an alanine, transport activity 
has been observed for the double mutant in the absence of a measurable value of ATP 
hydrolysis, although additional experiments need to be performed to exclude the presence 
of any ATP hydrolysis completely. In case of the single D’177A mutant, both transport 
activity and ATPase activity were observed with values of 23 % and 38-53 % of what 
has been measured for the wild type transporter, which are higher than measured for the 
E’171Q mutant. This implies that the aspartate in the D-loop plays a role in the cooperative 
ATP hydrolysis, but this role is not as crucial as for the glutamate of the Walker B motif.
 Based on this new information, the working model of the transport mechanism 
proposed in Chapter 5 is adjusted (Figure 6). Continuing from the state in which the 
substrate has been released into the cytosol and the S-component is associated with the 
ECF module in a toppled conformation, then next step would indeed be binding of two 
molecules of ATP (Step (1)). Since the C-termini of the coupling helices CH2 and CH3 in 
EcfT are anchored into EcfA’ and EcfA, respectively, closure of the EcfAA’ heterodimer
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Figure 6: Working model of the transport mechanism of ECF transporters. The ECF 
transporter subunits are colored as in Chapter 5. Continuing from the state in which the substrate 
has just been released into the cytoplasm, two molecules of ATP will bind to the ATPases (step 
(1)). Binding of ATP will push CH1 and the N-terminal part of CH2 of EcfT up into the membrane, 
thereby accommodating the S-component to topple back, and this will disrupt the hydrophobic 
interaction (red) of the S-component with CH3 of EcfT, which will retain in the cytoplasm. Upon 
ATP hydrolysis (step (2)), the interactions between the S-component and the ECF module are 
weakened even more and the S-component will dissociate (step (3)). This step is driven by the 
favorable binding of substrate on the extracytoplasmic side of the membrane (step (4)), after which 
the S-component topples in the membrane (step (5)), possibly with the help of the ECF module. 
After dissociation of the S-component, the ECF module will release the molecules of ADP and 
inorganic phosphate and regenerates the binding platform for the S-component (step (6)). Futile 
cycles of ATP hydrolysis can take place at this stage to make sure that the ECF module is free 
of ATP and ready to bind the next substrate-bound S-component (step (7)). Upon binding, the 
substrate binding site is disrupted and the substrate is released into the cytosol.
upon ATP binding will bring the C-termini of the helices closer together. Simultaneous, 
the N-terminal parts will be pushed in the upward direction. In case of CH3, the movement 
of the N-terminal part is restricted by the connection to the C-terminal part of CH2. 
On the other hand, the N-terminal part of CH2 could insert into the membrane together 
with coupling helix CH1, and with that, accommodating the S-component to topple 
back into the membrane. This is in agreement with the shift of CH2 from BioMNY from 
Rhodobacter capsulatus to a more hydrophobic environment in the presence of ATP, as 
well as spontaneous cross-linking of CH2 and the transmembrane helix 1 of BioY in the 
presence of ATP and biotin.13 In the next step, both molecules of ATP will be hydrolyzed 
in a cooperative manner before the S-component will dissociate from the ECF module 
(Step (2)). Toppling of the S-component back in the membrane might have weakened the 
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interaction with EcfT, and the subsequent hydrolysis event could make the interaction 
even less favorable. Besides, the high affinity of the S-component for the substrate will 
make the S-component preferring the substrate-bound conformation. In complex of the 
ECF module, obtaining this state might be impossible, and therefore dissociation from the 
ECF module is triggered (Step (3)). After dissociation of the S-component, the couplin 
helices CH1 and CH2 will be allowed to move back while ADP and inorganic phosphate 
are released and the EcfAA’ heterodimer converts back to the nucleotide-free, open 
conformation (Step (6)). In this state, the ECF module is ready to accept another toppled, 
substrate-bound S-component (Step (7)).
In order to validate this proposed model with structural data, attempts were 
made to crystallize ECF FolT2 in a nucleotide-bound state, which will give insight in 
the conformation and/or orientation of the S-component. The uptake experiments in the 
presence of AMP-PNP have shown that AMP-PNP functions as a competitive inhibitor 
for the EcfAA’ dimer. However, binding of AMP-PNP did not lead to crystallization of 
the EcfAA’ heterodimer in a closed conformation within the complete transporter (see 
Chapter 5). Vanadate showed to inhibit folate uptake by ECF FolT2 as well, and will be 
a potential candidate in trapping ECF FolT2 in a post-hydrolysis state in which ATP has 
been hydrolyzed, but where ADP has not left the hydrolysis site yet. It will be interesting 
to see if at this stage, the S-component has already dissociated form the ECF module. 
To date, ECF FolT2 in the presence of MgATP, vanadate and folate, has not crystallized.
Other approaches to trap ECF FolT2 in a nucleotide-bound state, were the 
introduction of the ATPase inactivating mutations and cross-linking of the D-loops. The 
cross-linking experiments showed a higher yield of cross-linking for the S172 G’175C 
mutant compared to the M173C A’174C mutant, which could be explained by a more 
optimal distance of the cysteines for the cross-linking reaction. For both mutants, the 
presence of MgATP did not influence the degree of cross-linking, probably because 
the D-loops are already in proper distance to accommodate cross-linking, as shown in 
the previously reported crystal structures of ECF FolT2. When combining the cysteine 
mutations with the ATPase inactivating mutations, the presence of MgATP did cause the 
disappearance of the lower cross-linked band on the SDS-PAGE gel. However, ATPase 
activity assays showed that the cysteine mutants were ATPase inactive also without the 
introduction of the ATPase inactivating mutations, making it difficult to reason the effect 
of MgATP on the cross-linking.
Bringing back the natural cysteine (EcfA’ C168) near the Walker B motif of EcfA’ 
partially restored the ATPase activity, implying that the other natural cysteines are also 
important for functionality. Upon crosslinking, the ATPase activity of the S172 A’168C 
G’175C mutant dropped significantly, while the activity for the M173C A’168C A’174C 
mutant was completely abolished, making this cross-linking mutant the most promising 
one to trap ECF FolT2 in a nucleotide-bound state. Unfortunately, no success in getting a 
crystal structure of ECF FolT2 in a nucleotide-bound conformation was obtained yet. For 
both the ATPase inactive mutant and the cysteine mutants after cross-linking, diffraction 
was observed, but only to low resolution. However, crystallization of these mutants was 
still in an early stage and there are many more possibilities to improve the diffraction in 
the future.
To conclude, the information obtained from the biochemical characterization, 
mutagenesis and the dissociation experiments by size-exclusion chromatography have 
led to an updated version of the working model on the transport mechanism of ECF 
transporters. To validate this model in terms of structural information, attempts to trap 
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ECF FolT2 in a nucleotide-bound state with the EcfAA’ heterodimer adopting a closed 
conformation, have been made, and initial crystals hold positive perspectives for the 
future.
Experimental section
Mutagenesis of ECF FolT2.
In order to introduce mutations in the EcfA and EcfA’ subunits of ECF FolT2, 
the p2BAD His10-ECF FolT2-STREPII plasmid was mutated by quick change PCR using 
the primers given in Table 1. The introduction of cysteines for the generation of cross-
linking mutants was performed in a version of ECF FolT2 in which all natural cysteines 
were removed (cysteine-less ECF FolT2). After mutagenesis, the mutated plasmids were 
transformed to Ca2+-competent E. coli MC1061 cells and the mutations were verified 
by DNA sequencing (Seqlab and GATC, Germany). In case of introducing multiple 
mutations, transformation to Ca2+-competent E. coli MC1061 cells was performed 
after each round of mutagenesis in order to prevent recombination of the plasmid. The 
lone ECF module was cloned behind the arabinose promotor of the pBAD plasmid and 
proceeded by the sequence for a His10-tag and TEV cleavage site, and this plasmid too 
was transformed to Ca2+-competent E. coli MC1061 cells.
Expression and purification of wild type ECF FolT2, the ECF FolT2 mutants and the 
lone ECF module.
 The expression and purification of wild type ECF FolT2, its mutants and the 
lone ECF module was performed as described in Chapter 5 using buffer A (50 mM KPi, 
pH 7.5, 150 mM NaCl, 0.05 % (w/v) DDM) for size-exclusion chromatography.14 In case 
of purification for crystallization, buffer A was replaced by buffer B (20 mM Tris-HCl, 
pH 8.0, 150 mM NaCl, 0.05 % (w/v) DDM). For the purification of the ECF module, the 
imidazole concentration for the elution from the Ni2+-Sepharose column was lowered to 
150 mM.
 When trying to dissociate the S-component from the ECF module on the gel 
filtration column, no EDTA was added to the second elution fraction from the Ni2+-
Sepharose column. The elution fraction was split into four equal fractions and the fraction 
to which nothing was added, was loaded immediately on the gel filtration column. In 
case of addition of 5 mM of MgATP, 100 µM of folate or 5 mM of MgATP plus 100 µM 
of folate, the protein was first incubated with these additives for one hour on ice before 
loading it on the gel filtration column. The subsequent size-exclusion chromatography 
was performed using buffer A and the contents of the peaks in the size-exclusion 
chromatography profile were analyzed on SDS-PAGE gels.
Reconstitution in proteoliposomes and radiolabeled uptake assays.
 Purified wild type ECF FolT2 and the E171Q, E169Q E’171Q, D’177A and 
D175A  D’177A mutants were reconstituted in proteoliposomes as described in Chapter 
5.14 The radiolabeled uptake assay too was performed as described in Chapter 5, with 
loading the proteoliposomes with 5 mM of MgATP. For the efflux experiments, uptake 
of radiolabeled folate was allowed for 16 or 55 minutes, after which 5 mM of MgATP or
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Table 1. Primers for mutagenesis of EcfA and EcfA’ in ECF FolT2, with the mutations underlined.






































100 µM of non-radiolabeled folate was added to follow efflux for an additional 7 or 15 
minutes, respectively.
 When determining the KM and Vmax of ECF FolT2 for folate and MgATP, as well 
as the nH for ATP hydrolysis, the initial folate uptake rates were determined under different 
folate or MgATP concentrations (in the assay buffer or enclosed in the proteoliposomes, 
respectively) by allowing uptake for 5 minutes. The slopes of these uptake curves were 
determined by fitting with a linear function in Sigmaplot version 11 and subsequently, 
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these initial uptake rates were plotted against the folate or MgATP concentrations. The KM 
and Vmax for folate were determined by fitting the data to the Michaelis-Menten equation 
in Sigmaplot version 11, while the KM, Vmax and nH for MgATP and ATP hydrolysis were 
determined by fitting the data to the 3-parameter Hill equation of the software.
 When determining the apparent Ki for MgAMP-PNP, the initial folate uptake 
rates were determined in the presence of 5 mM of MgATP plus various concentrations 
of MgAMP-PNP enclosed in the proteoliposomes. Next, the rates were converted to 
percentages of inhibition, taking the initial uptake rate in the absence of MgAMP-PNP 
as 0 % of inhibition and the initial uptake rate in the presence of 40 mM of MgAMP-
PNP as 100 % of inhibition. These percentages were plotted against the MgAMP-
PNP concentration and fitted to the Michaelis-Menten equation in SigmaPlot version 
11, in which KM now represented the apparent Ki. To study the inhibition by vanadate, 
proteoliposomes were loaded with 5 mM of MgATP without ortho-vanadate, with 10 mM 
of ortho-vanadate or 25 mM of ortho-vanadate (purchased in the activated form, New 
England BioLabs Inc.), and uptake of radiolabeled folate was followed for 16 minutes.
Cross-linking.
When purifying the cysteine mutants for cross-linking, 1 mM of freshly prepared 
DTT was added to the second elution fraction from the Ni2+-Sepharose column and 
incubated for 5 minutes on ice, before loading it on the gel filtration column. After size-
exclusion chromatography, the protein was incubated with 1 mM of HgCl2 or various 
concentrations of Cu-phenanthroline, using a stock of 100 mM of Cu-phenanthroline that 
was prepared freshly by combining 100 mM of CuSO
4
 and 100 mM of freshly prepared 
1,10-phenanthroline (dissolved in methanol) in a 1:3 ratio. The incubation was performed 
in the presence or absence of MgATP, on ice or at room temperature and for various time 
frames. To analyze the degree of cross-linking, samples were analyzed on SDS-PAGE 
gels using non-reducing 5x loading dye without β-mercaptoethanol.
Reconstitution in nanodiscs and ATPase activity assay.
Purified wild type ECF FolT2 and its mutants were reconstituted in nanodiscs 
as described in Chapter 6, using the larger MSP2N2, the lipid composition of E.coli lipid 
to egg PC of 3:1 and the protein to MSP to lipid ratio of 1:5:1500. The concentrations 
of protein used in the reconstitution mixtures were 2.86 and 5.00 µM for wild type 
ECF FolT2 (first preparation used in the comparison with the mutations of the Walker 
B glutamate, the aspartate of the D-loop and the cross-linking mutants in cysteine-less 
ECF FolT2, the second in the second comparison with the cross-linking mutants with 
the EcfA’ A168C mutation), 1.43 µM for the  E’171Q,  D’177A, S172C G’175C, S172C 
A’168C G’175C and M173C A’168C A’174C mutants, 1.86 µM for the E169Q E’171Q 
mutant and 2.14 µM for the D175A D’177A and M173C A’168C A’174C mutants. In case 
of cross-linking the ECF FolT2 transporters while being reconstituted in nanodiscs, 1 
mM of DTT was added to the nanodisc preparation before purification by size-exclusion 
chromatography. Subsequently, the fractions containing the nanodiscs with protein were 
combined and concentrated using a Vivaspin 500 concentrating device with a molecular 
weight cut-off of 100 kDa (Sartorius stedim). The concentrated nanodiscs were incubated 
with 5 mM of Cu-phenantroline for 50 minutes on ice and then purified over a NAP5 
column (GE Healthcare) to remove the Cu-phenantroline. The ATPase activity assay was 
performed and analyzed as described in Chapter 6, with the concentrations of folate being 
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0 or 100 nM.
Crystallization.
For the crystallization of the ATPase inactive mutant E169Q E’171Q, the protein 
was concentrated to a final concentration of 6.6 mg/mL after the addition of 8.5 mM of 
MgATP. Elongated crystals appeared from the F5 condition (100 mM Tris-HCl, pH 8.0, 
100 mM NaCl, 325 mM Na-acetate, 21 % (v/v) PEG400) of the Memgold HT-96 screen 
(Molecular Dimensions) and diffracted to 8 Å resolution. Optimization of this condition 
using the AdditiveTM screen (Hampton research) and 10 mM of MgATP, while keeping 
the final protein concentration at 6.6 mg/mL, resulted in crystal formation in the presence 
of 100 mM of Na-citrate tribasic dihydrate, 3 % (w/v) of trimethylamine N-oxide hydrate, 
3 % (v/v) of ethanol, 3 % (v/v) of 2-propanol or 3 % (v/v) of methanol. However, addition 
of none of these additives improved the resolution of diffraction.
For the crystallization of crosslinked ECF FolT2, the S172C G’175C and M173C 
A’174C mutants were concentrated to about 7 mg/mL after cross-linking in the presence 
of 5 mM of Cu-phenantroline and 4.6 mM MgATP for one hour at room temperature. 
Rectangular crystals appeared from the C4 condition (100 mM Na-citrate, pH 6.0, 50 
mM NaCl, 20 mM MgCl2, 22 % (v/v) PEG400) of the Memgold HT-96 screen (Molecular 
Dimensions) and diffracted to 12.8 Å resolution.
Wild type ECF FolT2 has been used for crystallization in the presence of 
5 mM of MgATP, 10 mM of ortho-vanadate and 937.5 µM of folate at a final protein 
concentration of 7.5 mg/mL, but did not yield crystals using the Memgold and Memgold 
2 HT-96 screens (Molecular Dimensions).
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Chapter 8
Identification of an inhibitor specific for the ECF 
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In the search for novel antibiotics, ECF transporters form an interesting target, 
since there are many pathogenic bacteria that rely on the ECF transporters for the 
uptake of vitamins. In this chapter, druggable pockets on the surface of ECF FolT2 
from L. delbrueckii were identified and potential small-molecules binders were 
found by virtual screening. Of the three molecules tested, one showed inhibition of 
folate transport by ECF FolT2. When testing with another ECF transporter from 
L. delbrueckii, the ECF PanT transporter for pantothenate, inhibition of transport 
by this compound was observed too, while it did not inhibit transport by the ABC 
transporter OpuA for glycine betaine from L. lactis, indicating specificity for the 
ECF module from L. delbrueckii. An attempt was made to crystallize ECF FolT2 in 
complex with the compound to localize its exact binding-site and to obtain knowledge 
on its mechanism of inhibition, but no crystals have appeared to date. Nevertheless, 
the identification of this inhibiting compound could be a first step in the development 





 As mentioned already in Chapters 2-4, ECF transporters form an interesting 
target for the development of novel antibiotic against pathogenic bacteria, which 
lack biosynthetic pathways for the production of vitamins and therefore rely on ECF 
transporters for the uptake of these micronutrients.1 The fact that ECF transporters have 
been identified in prokaryotes only, lowers the risk of side effects on human transporters. 
In Chapters 2-4, small-molecule binders were designed with the goal to bind to the 
S-component ThiT from L. lactis in order to obtain knowledge on substrate binding, 
as well as on the transport mechanism by trapping the S-component in previously 
undetected conformational states. The latter goal has not been reached, and although the 
research in these Chapters has led to a good understanding of which functional groups 
are most important for the high-affinity binding of thiamine to ThiT, no compound has 
been obtained that could be a promising candidate for starting the development of a new 
antibiotic.
 Moving away from the substrate-binding pocket of ThiT, in this Chapter we 
look for small-molecule binders that bind in a specific pocket on the surface of the full 
ECF FolT2 complex. Such small-molecule binders could be used to trap the transporter 
in a certain state during the transport cycle, thereby providing knowledge on the transport 
mechanism of the ECF transporters. Besides, if those molecules would bind to the EcfT 
subunit, which is characteristic for the ECF transporters, the chances of being specific 
for these proteins increases. In that way, such small-molecules binders would form an 
interesting scaffold for the development of novel antibiotics.
Results
Virtual screening for potential small-molecule binders of ECF FolT2.
 With the goal to lock ECF FolT2 in a particular state of the transport cycle 
by the binding of a small molecule, we first used the DoGSiteScorer2,3 server to find 
potential pockets on the surface of the transporter. Next, we let the server predict the 
change to be able to find a molecule that would bind in these pockets, returned in the form 
of a druggability score with values ranging between 0 and 1 (with 1 being the highest 
probability of finding a molecule that would bind in the corresponding pocket). Eleven 
pockets were found, scattered over the whole surface of the transporter (Figure 1A), with 
a druggability score varying from 0.85 to 0.50 (Table 1). From these eleven pockets, 
pocket P4 (pale yellow pocket, indicated by the arrow in Figure 1A) was chosen to be the 
most interesting and promising pocket, with a druggability score of 0.81. This pocket is 
located in EcfT and lined by residues from coupling helix 1 (CH1), the N-terminal part 
of coupling helix 2 (CH2) of EcfT and the loop L7 connecting coupling helix 3 (CH3) 
of EcfT with the final transmembrane helix of this protein. If a small molecule can be 
found to bind in this pocket, movement of the coupling helices could be inhibited and this 
might abolish transport activity. Other interesting pockets were pockets P5 (dark green), 
P6 (orange) and P7 (purple) with druggability scores of 0.78, 0.76 and 0.67, respectively. 
These pockets are located at interfaces between EcfT and FolT2. Binding of a small-
molecule in these pockets could prevent FolT2 from dissociating from the ECF module. 
However, since both the druggability score and the volume of these pockets were lower
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Figure 1: Virtual screening for small molecule inhibitors for ECF FolT2. A) Cartoon 
representation of ECF FolT2 in the apo state, colored as in Chapter 5, with the eleven predicted 
pockets calculated by DoGSiteScorer shown as meshes colored in pink (P1), red (P2), dark blue 
(P3), pale yellow (P4), dark green (P5), orange (P6), purple (P7), brown (P8), light green (P9), 
light blue (P10) and gray (P11). B) The chemical structure of compounds 1 and 2. C) Surface 
representation of EcfA and EcfT, of which the last is shown in cartoon representation as well. 
The three coupling helices of EcfT are indicated by CH1-3, and the loop L7 connecting the third 
coupling helix with the last transmembrane helix, is indicated by L7. Compounds 1-2 are shown 
in sticks in their predicted binding mode, with their carbon atoms colored purple and orange, 
respectively. Compound 3 is predicted to bind in the same pocket. D) Same as in panel C, but after 
rotation of 90 degrees.
than for pocket P4, we decided to focus on pocket P4.
 Having found a potential pocket, compounds from the Express Collection of 
Princeton BioMolecular Research, Inc. (http://www.princetonbio.com/, downloaded 
in May 2015) were filtered and the resulting library was used for virtual screening and 
docking. This resulted in a top 12 of compounds, of which only three could be used in KPi 
buffer without precipitating. The chemical structures of two of the three compounds is 
given in Figure 1B, and the predicted binding poses of the small-molecules are shown in 
Figure 1C and 1D. The identity of the third molecule cannot be disclosed at this moment 
because it may be patented.
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Table 1: Predicted druggable pockets by DoGSiteScorer. Main shape descriptors for the eleven 












P1 443.79 471.01 259.24 0.55 23.00 0.85
P2 703.87 820.63 722.60 0.88 20.53 0.84
P3 940.08 1164.56 647.25 0.56 26.40 0.83
P4 1027.85 1114.93 713.60 0.64 18.51 0.81
P5 639.34 1019.34 731.11 0.72 15.22 0.78
P6 500.80 666.87 557.25 0.84 16.02 0.76
P7 292.13 459.96 350.91 0.76 16.00 0.67
P8 287.19 387.58 365.53 0.94 15.28 0.64
P9 431.10 786.14 436.96 0.56 13.57 0.63
P10 330.43 367.11 177.61 0.48 13.81 0.58
P11 220.28 539.77 301.01 0.56 13.45 0.50
ATPase activity of ECF FolT2 in the presence of small molecules.
 We tested the effect of compounds 1-3 on the ATPase activity of ECF FolT2 
reconstituted in nanodiscs (see Chapter 6). We used a reconstitution ratio of 1:5:1500 (ECF 
FolT2:MSP:lipid molar ratio), and used a concentration of 5 mM of each compound. The 
compounds were solubilized in DMSO and the final DMSO concentration in the assay 
was 5 % (v/v). As control experiments, the ATPase activity of ECF FolT2 in nanodiscs 
in the absence and presence of 5 % (v/v) of DMSO was measured. It turned out that 
the addition of DMSO did not decrease the ATPase activity, but rather increased it by 
roughly 20 % (Figure 2A). In case of the background activity measured in the presence 
of empty liposomes, the increase in the presence of DMSO was even 40 %. Apparently, 
a lower concentration of DSMO stimulates one or multiple reactions in the assay. When 
measuring the ATPase activity of ECF FolT2 reconstituted in nanodiscs in the presence of 
5 mM of compound 1 or 3, the signal was disturbed by the absorbance of the compounds 
at 340 nm where the assay is performed. In the presence of 5 mM of compound 2 or 0.25 
mM of compound 3, reliable data could be obtained. Compound 2 inhibited the ATP 
hydrolysis to the same levels as measured in the presence of empty nanodiscs. However, 
from control experiments with the PK/LDH enzyme mixture of the coupled enzyme 
assay, it was unclear if this compound would actually inhibit the activity of these enzymes 
rather than the activity of ECF FolT2. At 0.25 mM of compound 3, the ATPase activity of 
ECF FolT2 was lowered by roughly 65 % (after subtraction of the background activity).
Transport activity in the presence of small molecules.
 Since no conclusive data could be obtained from the ATPase activity assay, the 
effect of the compounds was also tested with ECF FolT2 reconstituted in proteoliposomes 
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A B
C D
Figure 2: Effect of the small-molecule compounds on the activity of ECF FolT2. A) ATPase 
activity of ECF FolT2 reconstituted in nanodiscs measured under various conditions, as indicated 
on the x-axis. The concentration of DMSO was 5 % (v/v) in all conditions except for the - DMSO 
conditions. The conditions Empty, -/+ DMSO indicated the background activity measured in the 
presence of empty nanodiscs. B) Transport activity of ECF FolT2 in proteoliposomes filled with 5 % 
(v/v) DMSO (black) or 5 mM of compound 1 (blue), compound 2 (green) or compound 3 (red) with 
a final DMSO concentration of 5 % (v/v). C) Transport activity of ECF PanT in proteoliposomes 
without additive (gray), filled with 5 % (v/v) DMSO (black), with 5 mM of compound 3 (red) with 
a final DMSO concentration of 5 % (v/v) or with 5 mM of MgADP instead of 5 mM of MgATP 
(purple). D) Same as in panel C for the transport activity of OpuA. The errors represented the 
standard deviation of three measurements, except for the data in panel C, where they represent the 
spread of the data from two measurements.
in the uptake assay with radiolabeled substrates. This assay was performed in the 
presence of 5 mM of each compound with a final DMSO concentration of 5 % (v/v), or 
in the presence of only DMSO at the same concentration (Figure 2B). In the presence 
of 5 mM of compound 2, the transport activity was not significantly different from the 
control curve with DMSO only. For compound 1, a slightly higher transport activity was 
observed, but compound 3 inhibited transport; the transport rate was lowered by 80 %.
ECF FolT2 from L. delbrueckii belongs to the group II ECF transporters, 
meaning that its ECF module is shared among different S-components. Besides FolT2, 
L. delbrueckii has seven other S-components, one of which is PanT, the S-component for 
pantothenate (vitamin B5). Since compound 3 is predicted to bind in a pocket located in 
EcfT, its inhibitory effect should be generic for all ECF transporters from L. delbrueckii 
that use the same ECF module. To test this prediction, pantothenate uptake by ECF PanT 
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was measured in the absence and in the presence of 5 % (v/v) of DMSO or 5 mM of 
compound 3 in a final DMSO concentration of 5 % (v/v) (Figure 2C). Upon addition 
of DMSO, the uptake activity of ECF PanT was increased by about 26 %. A similar 
effect was seen in the ATPase activity assay with ECF FolT2, implying that DMSO has 
a stimulating affect, of which the mechanism of action is unknown. In the presence of 5 
mM of compound 3, the uptake activity of ECF PanT was inhibited and did not differ from 
negative control in which proteoliposomes were loaded with 5 mM of MgADP instead 
of MgATP, indicating that the compound inhibited transport of pantothenate completely 
at this concentration. The fact that compound 3 inhibits the uptake activity of both ECF 
FolT2 and ECF PanT from the same organism, suggests specificity of this compound for 
the ECF module. However, the compound could also interfere with the assay by making 
the proteoliposomes leaky, which would disable uptake of the radiolabeled folate and 
radiolabeled pantothenate.
In order to test whether the inhibition by compound 3 was specific for the ECF 
transporters from L. delbrueckii, the uptake of glycine betaine by the ABC transporter 
OpuA from L. lactis was measured in the absence and in the presence of 5 % (v/v) of 
DMSO or 5 mM of compound 3 in a final DMSO concentration of 5 % (v/v) (Figure 2D). 
Neither the presence of compound 3, nor the presence of DMSO affected the transport by 
OpuA significantly, which not only strengthens the assumption of specificity of compound 
3 for the ECF transporters from L. delbrueckii, but also showed that the compound did not 
provide false positive results by causing leakiness of the proteoliposomes.
Crystallization of ECF FolT2 in complex with compound 3.
 In order to find out the exact binding site of compound 3 in ECF FolT2, an 
attempt has been made to crystallize ECF FolT2 in the presence of 5 mM of compound 3 
under the same condition as the crystals of the apo and AMP-PNP bound transporter were 
obtained. However, this did not yield any crystals to date.
Discussion
The search for druggable pockets on the surface of ECF FolT2 and the subsequent 
virtual screening, resulted in the identification of compound 3. This molecule specifically 
inhibited folate transport by ECF FolT2 and pantothenate transport by ECF PanT, while 
it did not have any effect on the transport activity of OpuA. Compound 3 is predicted to 
bind in a pocket in EcfT, located between the coupling helix CH1, the N-terminal end of 
coupling helix CH2 and the loop L7, which connects the coupling helix CH3 with the last 
transmembrane helix of EcfT. During the transport cycle, EcfA and EcfA’ are predicted 
to close upon ATP binding and hydrolysis, thereby bringing the C-terminal ends of CH2 
and CH3, with which these helices are anchored in the nucleotide binding domains, closer 
towards each other. This movement might cause the N-terminal part of CH2, together with 
the coupling helix 1, to move back into the membrane, thereby pushing the S-component 
to topple back up in the membrane and dissociate from the ECF module. With compound 
3 bound in this pocket, coupling helices CH1 and CH2 would not be able to push out the 
S-component, thereby interrupting the transport cycle.
Attempts to crystallize ECF FolT2 in complex with compound 3 were 
unsuccessful. Also, under seeding conditions in which apo and AMP-PNP bound ECF 
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FolT2 crystallized, we did not find evidence that binding of compound 3 could force the 
transporter in a different conformation. Nevertheless, the identification of this compound 
as a specific inhibitor for the ECF module from L. delbrueckii is a very interesting result, 
since this compound may be used for the development of antibiotics against pathogenic 
bacteria that rely on ECF transporters for their survival.
Experimental section
Identification of druggable pockets in ECF FolT2.
 The DoGSiteScorer2,3,4 server was used to find pockets on the surface of ECF 
FolT2 and predict their druggability. The crystal structure of the transporter in the apo 
state (PDB ID: 5D7T)5 was used, selecting the chains A, B, C and D from the PDB 
file. DoGSiteScorer was customized to work on the pocket level, with the druggability 
estimation for pockets option switched on. Geometric and physicochemical properties 
of eleven predicted pockets were calculated by DoGSiteScorer, such as volume, surface, 
lipophilic surface and depth (Table 1), and a druggability score from 0 (undruggable) to 1 
(druggable) was given. Detailed descriptor information for the most promising pocket P4 
is shown in Table 2.
Virtual screening for potential small-molecule inhibitors of ECF FolT2.
 The Express Collection of Princeton BioMolecular Research, Inc. (http://www.
princetonbio.com/, downloaded in May 2015) was used for the virtual screening and was 
filtered first in MONA6,7 according to the following criteria: molecular weight 250–500 
g/mol, aromatic fused tricyclic (or bigger) compounds and esters were removed. Virtual 
screening was done using the KNIME Analytics Platform8 and the interfaces for KNIME 
available from BioSolveIT.9 After generation of the 3D-coodinates by the 3D generator 
interface9 from BioSolveIT, the library was docked as follows: the crystal structure of 
ECF FolT2 in the apo state (PDB ID: 5D7T)5 was used for docking by using LeadIT 
(version 2.1.8) from BioSolveIT.10 The receptor was defined by manual selection and 
included the following amino acid residues: F97–P118 and E140–S142 from EcfA; L69, 
V70, V73 and I74 from FolT2; P132–T169 and L218–L239 from EcfT. The default 
settings were used for docking. Ten poses of each molecule were generated, filtered upon 
calculated [Total Score] (–25 kJ/mol was used as cutoff, poses with a higher [Total Score] 
were discarded) and promiscuous and toxic compounds were removed using the PAINS-
filter11 and Eli Lilly-rules.12,13 The resultant poses were scored with HYDE in SeeSAR 
(version 3.2)14 and all poses with red flagged torsions and compounds with only one pose 
were removed. From the best 1000 poses according to the estimated affinity, the best 
100 compounds were visually inspected in SeeSAR.14 The ones with at least two similar 
poses were selected as potential candidates for screening. The best representative of each 
cluster of structurally similar compounds were ordered from Princeton BioMolecular 
Research, Inc. and tested, of which only three (compounds 1-3) appeared to be soluble in 
the buffers used in the activity assays.
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Table 2: Descriptor information for pocket P4.
Descriptor Value Descriptor Value
Size and shape descriptors Amino acid descriptors
Volume (Å3) 1027.85 # Ala 2
Surface (Å2) 1114.93 # Arg 5
Lipophilic surface (Å2) 713.60 # Asn 0
Depth (Å) 18.51 # Asp 2
Ellipsoid main axis ratio c/a 0.23 # Cys 0
Ellipsoid main axis ratio b/a 0.59 # Gln 0
Enclosure 0.11 # Glu 3
Functional group descriptors # Gly 2
# Hydrogen-bond donors 21 # His 0
# Hydrogen-bond acceptors 61 # Ile 4
# Metals 0 # Leu 6
# Hydrophobic interactions 28 # Lys 0
Hydrophobicity ratio 0.25 # Met 2
Element descriptors # Phe 3
# Pocket atoms 204 # Pro 3
# Carbons 139 # Ser 3
# Nitrogens 30 # Thr 1
# Oxygens 34 # Trp 1
# Sulfurs 1 # Tyr 2
# Other elements 0 # Val 3
Amino acid composition # special amino acids 0
Apolar amino acid ratio 0.57
Polar amino acid ratio 0.19
Positive amino acid ratio 0.12
Negative amino acid ratio 0.12
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Expression, purification and reconstitution of ECF FolT2 in nanodiscs and 
proteoliposomes.
The expression and purification of ECF FolT2 was performed as described in 
Chapter 5, using buffer A (50 mM KPi, pH 7.5, 150 mM NaCl, 0.05 % (w/v) DDM) 
for size-exclusion chromatography.5 The reconstitution in nanodiscs was performed as 
described in Chapter 6, using the larger MSP2N2, the lipid composition of E.coli lipid 
to egg PC of 3:1 and the protein to MSP to lipid reconstitution ratio of 1:5:1500. The 
reconstitution in proteoliposomes was performed as described in Chapter 5. 
ATPase activity assay and radiolabeled uptake assay with ECF FolT2.
The ATPase activity of the ECF FolT2 reconstituted in nanodiscs was measured 
by using the coupled enzyme assay described in Chapter 6. The reaction solutions 
were supplemented with 5 % (v/v) of DMSO or different concentrations of compounds 
in DMSO (with a final DMSO concentration of 5 % (v/v)) as indicated in the figure 
legends. The ATPase activity was expressed in µmol of ATP hydrolyzed/(min*mg of ECF 
transporter) and bar charts were prepared using SigmaPlot version 11 software.
The radiolabeled uptake assay was performed as described in Chapter 5, with 
loading the proteoliposomes with 5 mM of MgATP, as well as 5 % (v/v) of DMSO or 5 
mM of compound 1-3 in DMSO with a final DMSO concentration of 5 % (v/v). 
Crystallization of ECF FolT2 in complex with compound 3.
 ECF FolT2 was purified as described in Chapter 5, using buffer B (20 mM Tris, 
pH 8.0, 150 mM NaCl, 0.03 % (w/v) DDM) for size-exclusion chromatography. The 
purified protein was incubated with 5 mM of compound 3 (in a final DMSO concentration 
of 5 % (v/v)) for 30 minutes on ice, and subsequently concentrated to a final concentration 
of about 8 mg/mL using a Vivaspin 500 concentrating device with a molecular weight 
cut-off of 100 kDa (Sartorius stedim). The concentrated protein was used at four different 
concentrations (8, 6, 4 and 2 mg/mL) to set up four different conditions in a 24 well 
hanging drop crystallization plate. A reservoir solution of 50 mM Tris, pH 7.5, 17 % (v/v) 
PEG350 MME, 10 mM spermidine, 2 % (w/v) NG was used, and the crystallization drops 
were prepared in duplo by adding 1 µL of protein solution to 1 µL of reservoir solution. 
Half of the drops were provided with seeds from old apo ECF FolT2 crystals.
Expression, purification and reconstitution of ECF PanT in proteoliposomes, and 
radiolabeled uptake assay.
 The genes encoding ECF PanT from L. delbrueckii subsp. bulgaricus (LDB_
RS01805, ecfA; LDB_RS01810, ecfA’; LDB_RS01815, ecfT; LDB_RS01970, panT) 
were cloned in the p2BAD vector in the same way as described for ECF FolT2,5,15 and 
this vector was transformed into Ca2+-competent cells of the E. coli strain MC1061. 
The expression, purification and reconstitution of ECF PanT in proteoliposomes was 
performed as described for ECF Fol2, with the only differences being the concentration 
of L-arabinose used for induction (1.0*10-3 % (v/v) of L-arabinose for expression of ECF 
PanT instead of 1.0*10-2 % (v/v) of L-arabinose) and the protein to lipid reconstitution ratio 
(1:1000 for ECF PanT instead of 1:250). The radiolabeled uptake assay was performed 
as described for ECF FolT2, with 5 nm of d-[2,3-3H]pantothenic acid and 95 nm of non-
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radiolabeled pantothenic acid present in the assay buffer instead of the radiolabeled and 
non-radiolabeled folate. The reaction was started by addition of 0.25 µg of ECF PanT 
(instead of 1 µg of ECF FolT2) and uptake was followed for 8 minutes. 
Expression, purification and reconstitution of OpuA in proteoliposomes, and 
radiolabeled uptake assay.
 The expression, purification and reconstitution of OpuA in proteoliposomes 
was performed as described elsewhere, using a protein to lipid reconstitution ratio of 
1:100.16,17 The radiolabeled uptake assay was performed as described previously,18 hereby 
loading the proteoliposomes with 5 mM of MgATP instead of the ATP-regenerating 
system. Additionally, the proteoliposomes were loaded with 5 % (v/v) of DMSO, 5 mM 
of compound 3 in DMSO with a final DMSO concentration of 5 % (v/v), or an equivalent 
volume of buffer. Encapsulation of the chemicals was achieved by performing five freeze-
thaw cycles, followed by two washing steps with 50 mm KPi, pH 7.0, after which the 
proteoliposomes were resuspended to a final OpuA concentration of about 80 mg/mL. For 
the uptake assay, the proteoliposomes were diluted to a final OpuA concentration of 5 mg/
mL in 46.9 mm KPi, pH 7.0, 499.7 mm KCl, 4.8 µm of [14C]-glycine betaine, 14.9 µm of 
non-radiolabeled glycine betaine, and the reaction was followed for five minutes.
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Summary and future perspectives
At the start of my PhD studeies, only the crystal structures of the substrate-bound 
S-components RibU from S. aureus, ThiT and BioY from L. lactis were solved,1–3 there 
was a debate on the stoichiometry of the ECF transporters,4–6 and no initial model for 
the transport mechanism was proposed. The goal of the research project was then set 
to unravel this transport mechanism, by making use of structure-based design to obtain 
small molecules that would trap a model ECF transporter in intermediate states of the 
transport cycle. This would not only help to get insight in the transport mechanism, but 
the small molecules could also turn out to be potent inhibitors of the ECF transporters, 
and thereby becoming the basis of new antimicrobial drugs. 
With the crystal structure of ThiT being available, structure-based design was 
initially used to synthesize thiamine derivatives to study the high-affinity binding to ThiT 
and identify the contribution of individual interactions between substrate and protein 
(Chapter 2). This was combined with mutagenesis of binding-site residues (Chapter 4), 
and resulted in identification of the electrostatic interaction between the positive charge 
nitrogen in the thiazolium ring of thiamine and E84 from ThiT as the main contributor 
for the picomolar affinity. Next, additional sub-pockets in the substrate-binding pocket 
were explored and extended thiamine derivatives were synthesized, which still bound 
to ThiT with affinities in the nanomolar range (Chapters 3 and 4). Based on molecular 
dynamics simulations, we could not observed any big conformational changes of the 
transmembrane helices or the L1 loop of ThiT upon binding of two extended thiamine 
derivatives (Chapter 4), implying that these derivatives would still allow ThiT to associate 
with the ECF module and allow subsequent substrate transport. For one of the extended 
thiamine derivatives, we observed an effect on cell growth in bacterial growth assays, but 
we have not been able to pinpoint the actual cause of this effect. Overall, the work on the 
thiamine derivatives did not result in the identification of a small molecule that could trap 
the complete transporter in an intermediate state of the transport cycle, but it has allowed 
us to develop a smooth-running pipeline of design, synthesis and testing of compounds to 
obtain derivatives that still bound to ThiT with high affinity and gave us information on 
the interactions involved in substrate binding.
When the crystal structures of ECF FolT and ECF HmpT from L. brevis 
were published, the stoichiometry of two NBDs, one EcfT and one S-component 
per transporter, which our laboratory had previously determined by light scattering 
techniques, was confirmed. In both structures, the substrate-free S-component adopted a 
toppled conformation, with its helical axis lying almost perpendicular to the plane of the 
membrane. In order to start structure-based design of molecules that could trap the ECF 
FolT transporter from L. brevis in a different state than the one that was published, various 
attempts were made to express this protein in our lab, but high yields were never obtained. 
Therefore, we moved to the ECF transporter for folate from L. delbrueckii, which we 
were able to purify with high purity and useful yields. The organism L. delbrueckii has 
two S-components for folate, called FolT1 and FolT2, which are 93 % identical and have 
a similar affinity for folate (1.0 ± 0.24 nM and 3.1 ± 1.4 nM, respectively, Chapter 5). 
Both S-component interact with the same ECF module and belong to the group II ECF 
transporters.
Working on both S-components and the complete ECF FolT1 and ECF FolT2 
proteins, resulted in one crystal structure of folate-bound FolT1 (for FolT2, we have 
not succeeded in obtaining a crystal structure) and two crystal structures of ECF FolT2 
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in the apo state and AMP-PNP bound state (Chapter 5). The structure of folate-bound 
FolT1 identified the residues involved in high-affinity binding of folate, while the two 
highly similar apo and AMP-PNP bound ECF FolT2 structures showed the S-component 
in the same toppled orientation as in the crystal structures of the ECF transporters from 
L. brevis published earlier. Despite the presence of AMP-PNP, the ATPase dimer was still 
in its open conformation in the AMP-PNP bound ECF FolT2 structure, indicating that 
AMP-PNP is not able to cause closure of the two ATPase subunits. By comparing the 
structures of folate-bound FolT1 and the substrate-free FolT2 in the two structures of the 
complete transporter, we were able to reveal how interaction of the S-component with 
EcfT disrupts of the substrate-binding site, thereby causing release of the substrate in the 
cytosol. Using radiolabeled uptake assays, we have also shown in Chapter 5 that only in 
the presence of MgATP, folate transport could be achieved. Combining the information 
from our crystal structures with all the available data on ECF transporters till then, we 
proposed a new working model for the transport mechanism of ECF transporter that was 
consistent with all the data.
Subsequently, we obtained more biochemical data on ECF FolT2 by assaying 
both uptake of radiolabeled folate in proteoliposomes and ATPase activity in phospholipid 
bilayer nanodiscs (Chapters 6 and 7). The optimization of reconstitution of two ECF 
transporters, ECF NiaX for niacin from L. lactis and ECF FolT2 from L. delbrueckii, in 
phospholipid nanodiscs was described in Chapter 6. In Chapter 7, we discovered that only 
in the presence of both MgATP and substrate, dissociation of the S-component from the 
ECF module could be achieved. Performing the same experiment with an ATPase-inactive 
mutant suggested that ATP also needs to be hydrolyzed in order for the S-component to 
dissociate. These results led to an updated version of our working model for the transport 
mechanism, which we then tried to verify by obtained crystal structures of ECF FolT2 in 
a nucleotide-bound state. To this purpose, we made different mutants; one double mutant 
that showed to abolish the ATPase activity of the ATPase subunits, two double mutants 
that could be used in cross-linking experiments to lock the ATPase subunits in a closed 
conformation, and combinations of these two variants. Unfortunately, no crystal structure 
has been obtained so far.
In order to trap an ECF transporter in intermediate states of the transport cycle, 
it might be more efficient to look for a small-molecule that interferes with complex 
formation or disallows conformational changes to occur, rather than trying to find a 
substrate derivative that inhibits substrate transportation at an intermediate step. Focusing 
on the ECF module in the search of inhibiting compounds rather than on the S-component, 
will create a higher specificity for the ECF transporters, since substrate derivatives could 
also bind to substrate binding proteins or enzymes with a comparable substrate-binding 
site. Besides, common information on the transport mechanism could be obtained, as 
the ECF module forms the general part of the transporter. Therefore, we searched for 
druggable pockets on the surface of ECF FolT2 and found an interesting pocket located 
between the coupling helices of EcfT (Chapter 8). Virtual screening and testing of the 
top-12 hits yielded one molecule, which did not only inhibit the transport activity of ECF 
FolT2, but also the transport activity of the ECF transporter ECF PanT for pantothenate 
from the same organism, while no inhibition was observed in case of the classical ABC 
transporter OpuA for glycine betaine from L. lactis. As discussed in Chapter 8 already, 
the next step in this project will be to determine the exact binding site of the inhibiting 
compound and see if it inhibits transport by the other ECF transporters of L. delbrueckii 
besides ECF FolT2 and ECF PanT, both in vitro and in vivo. If that is the case, testing of 
the inhibiting effect of the compound on ECF transporters from pathogenic bacteria could 
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be started as a first step in the development of antimicrobial drugs against these bacteria, 
for example by expressing these ECF transporters in knock-out strains to restore vitamin 
uptake, and then following the effect of adding the compound.
Remaining questions
After finishing this thesis, there are still many remaining questions regarding 
the transport mechanism of ECF transporters. One of them concerns the toppling of the 
S-component; is the protein able to topple on its own, or does it need the EcfT to provide 
a platform along which it can topple? In the substrate-free state, the L1 loop and L3 
loop open up the substrate-binding pocket to the extracytoplasmic space (Chapter 5). 
Upon substrate-binding, these loops close over the substrate, and charged and hydrophilic 
residues within the binding pocket get excluded from the external solution, resulting in a 
more compact structure which should be able to topple over within the membrane more 
easily than the substrate-free S-component.
For three S-components of the group I ECF transporters, substrate transport has 
been reported in the absence of an ECF module (although the level of uptake was significant 
lower compared to transport performed by the complete transporters), implying that they 
are able to topple by themselves. These S-components are BioY from various bacteria,7,8 
and CbiMN and NikMN from R. capsulatus.9 Genomic context analyses have shown 
that only 1/3 of the bioY genes are linked to genes encoding the BioM and BioN proteins 
that form the ECF module in the group I ECF transporters, and on the phylogenetic tree, 
these BioY proteins form a separate branch that is very diverged from the other BioY 
proteins which are not linked to the BioM and BioN proteins.7,10 It could be that this last 
group of BioY proteins have a lower affinity for biotin compared to the other group, and 
that when it topples in the membrane, it is occasionally able to release biotin into the 
cytoplasm. The S-components CbiMN and NikMN actually consist of two proteins, the 
M- and N-protein. The M-protein forms the actual S-component, with a structure that 
resembles the structure of the other S-components,11 while the N-protein is predicted to 
consist of two transmembrane helices, which showed to be only loosely bound to the 
rest of the ECF transporter, but is required for transport activity.12 It is possible that this 
N-protein provides a platform along which the M-protein can topple, after which the 
M-protein is in a conformation in which it occasionally releases its substrate. In complex 
with the ECF module, the release of the substrate into the cytoplasm gets more efficient, 
probably because the interaction with the EcfT subunit disrupts the substrate-binding site. 
One way to study the toppling of the S-component in complex with the ECF 
module, is by performing single molecule FRET or EPR studies. Both require the 
introduction of cysteine mutations in order to label the transporter. The removal of native 
cysteines and the introduction of new cysteines have shown to be problematic, in the 
sense that the activity of the transporter was affected drastically. However, lately some 
promising new mutants have been obtained that still show transport activity after being 
labeled and give initial FRET signals. Another possibility to label the ECF transporter 
would be to introduce non-natural amino acids. Toppling of the lone S-component 
could be studied by making use of environment-sensitive labels, which can discriminate 
between the exterior and interior of proteoliposomes, or between a hydrophilic and a 
hydrophobic environment.
Another big question is the order of events after substrate release into the cytosol. 
As discussed in Chapters 5 and 7, binding and hydrolysis of ATP is a logical next step, 
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and attempts have been made to crystallize ECF FolT2 in a nucleotide-bound state. By 
obtaining a crystal structure in the nucleotide-bound state, we hope to see if the expected 
closure of the ATPase subunits causes movement of the coupling helices of EcfT, and if 
this will accommodate the S-component in toppling back in the membrane and dissociate 
from the ECF module, or if the dissociation will required the subsequent step of ATP 
hydrolysis. In this perspective, it would be interested to obtain a crystal structure of an 
intermediate step or post-hydrolysis state too. Besides, it would be interesting to see what 
the role of the substrate will be in the dissociation of the S-component. In Chapter 7, it 
was shown that in detergent solution, both ATP and the substrate needed to be present in 
order for the S-component to dissociate. It seems logical that the presence of the substrate 
stimulates dissociation of the S-component in order to capture the substrate and then 
start a new cycle of substrate transport, but how is the presence of the substrate sensed? 
Besides, the detergent micelle does not mimic the natural environment of membrane 
proteins well, and follow-up experiments in proteoliposomes need to be performed.
To conclude, the work described in this thesis did not unravel the complete 
transport mechanism of the ECF transporters, but has resulted in a new working model 
that is in agreement will the data on ECF transporter available to date.
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De context van het onderzoek.
 Alle levende wezens zijn opgebouwd uit cellen, of dat er nu één is zoals bij 
bacteriën, of ongeveer 1014 in het geval van de mens. Een cel wordt omgeven door een 
celmembraan, die de inhoud van de cel (het cytoplasma) afschermt van de omgeving. 
In dit membraan bevinden zich tal van eiwitten, die allerlei functies hebben. Zo zijn er 
eiwitten die energie genereren, eiwitten die betrokken zijn bij de communicatie tussen 
de cel en de buitenwereld, en eiwitten die moleculen naar binnen of naar buiten kunnen 
transporteren. Deze laatste groep eiwitten is op te splitsen in verschillende klassen. Één 
daarvan is de klasse van de kanaaleiwitten, die kleine kanaaltjes in de membraan vormen 
waardoor moleculen de cel in of uit kunnen gaan. Voor dit transport is geen toevoeging 
van energie nodig; de moleculen gaan die kant op waar hun concentratie het laagst is. 
Daarnaast zijn er verschillende klassen waarbij wel toevoeging van energie nodig is om het 
transport mogelijk te maken. Deze energie kan een gradiënt van ionen (electrochemische 
gradiënt) of protonen (proton gedreven kracht) zijn, maar kan ook verkregen worden 
door het molecuul adenosine trifosfaat (ATP, van adenosine triphosphate in het engels) te 
hydrolyseren. De klasse van eiwitten die ATP als energiebron gebruiken om moleculen 
over de membraan te transporteren, worden de ATP-binding cassette (ABC) transporters 
genoemd.
 De ABC transporters kunnen worden opgesplitst in ABC importeurs en ABC 
exporteurs. De ABC importeurs brengen moleculen de cel binnen, terwijl de ABC 
exporteurs moleculen naar buiten transporteren. Voor een lange tijd waren er twee 
klassen van ABC importeurs bekend, en één klasse van ABC exporteurs. In 2009 is er 
een derde klasse van ABC importeurs geïdentificeerd, de energy-coupling factor (ECF) 
transporters, die de opname van vitamines, enkele aminozuren en de ionen nikkel en 
cobalt verzorgen. Elke ECF transporter bestaat uit vier eiwitten, subunits genoemd, die 
elk een eigen functie hebben en samen de actieve transporter vormen (Figuur 1A). Twee 
van de vier eiwitten zijn de ATPase subunits (EcfA en EcfA’), die elk één molecuul ATP 
kunnen binden en hydrolyseren. Deze ATPases bevinden zich aan de binnenkant van 
de cel, waar ATP beschikbaar is. De ATPases hebben interactie met de derde subunit, 
EcfT, die zich in de celmembraan bevindt. De vierde subunit, de S-component, bevindt 
zich ook in de membraan. Dit subunit is verantwoordelijk voor de binding van een 
specifiek vitamine, aminozuur of één van de ionen nikkel of cobalt, dat het substraat 
van deze S-component wordt genoemd. Het hebben van een substraat-bindende subunit 
die zich in de celmembraan bevindt, is een unieke eigenschap van de ECF transporters. 
De andere ABC transporters hebben twee identieke of sterk op elkaar lijkende subunits 
in de membraan (transmembraan domeinen (TMDs) genoemd), en in het geval van de 
ABC importeurs, één of meerdere substraat-bindende eiwitten (SBP of SBD genoemd, 
van substrate-binding protein of substrate-binding domain in het engels) die zich aan de 
buitenkant van de celmembraan bevinden (Figuur 1B). In de ECF transporters vormen 
de drie subunits EcfA, EcfA’ en EcfT samen de energy-coupling factor (ECF) module, 
waaraan de ECF transporters hun naam te danken hebben. Deze ECF module is de 
energieleverancier voor de transporter en wanneer het vierde subunit zijn substraat heeft 
gebonden en interactie maakt met EcfT, kan het substraat getransporteerd worden. De 
ECF transporters zelf zijn ook weer op te splitsen in twee groepen. In de eerste groep 
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Figuur 1: De opbouw van ECF transporters en de andere ABC importeurs. De verschillende 
subunits waaruit de ECF transporters (A) en ABC importeurs (B) zijn opgebouwd, zijn schematisch 
weergegeven. De ATPase subunits zijn rood gekleurd, EcfT en de transmembraandomeinen blauw 
en de substraat-bindende subunits geel. Het grijze vlak stel de celmembraan voor en de buiten- 
en binnenkant (cytosol) van de cel zijn aangegeven. De ABC exporters zijn op dezelfde manier 
opgebouwd als de ABC importeurs, maar hebben geen SBP of SBD.
vormen alle vier subunits een transporter die toegewijd is aan het transport van één 
substraat, maar in de tweede groep kunnen verschillende S-componenten die verschillende 
substraten binden, interactie hebben met dezelfde ECF module om een functionele ECF 
transporter te vormen, die al die verschillende substraten kan transporteren.
De inhoud van mijn proefschrift.
 Mijn proefschrift is gericht op het mechanism van substraat binding aan de 
S-component en het daarop volgende transport, mogelijk gemaakt door de gehele ECF 
transporter. Ter inleiding worden in het eerste hoofdstuk de structurele eigenschappen 
van de drie klasse van ABC importeurs en de meest recente modelen voor de 
transportmechanismen beschreven.
In de hoofdstukken 2-4 wordt de binding van het substraat thiamine (vitamine 
B1) aan de S-component ThiT van de ECF transporter ECF ThiT uit het organisme 
Lactococcus lactis (de melkzuur-producerende bacterie die bij het maken van karnemelk 
en kaas wordt gebruikt) bestudeerd. ThiT bindt thiamine sterk, met een zeer hoge affiniteit. 
In 2010 is de kristalstructuur van thiamine-gebonden ThiT in onze onderzoeksgroep 
opgehelderd, waardoor we konden zien hoe thiamine in ThiT gebonden zit. Gebasseerd 
op deze informatie hebben we stukjes van het thiamine molecuul veranderd om zo meer 
informatie te verkrijgen over welke interacties tussen ThiT en het thiamine molecuul 
van belang zijn voor de sterke binding. Deze methode wordt structuur-gebaseerde design 
genoemd. Voor de nieuwe thiaminederivaten hebben we bepaald hoe goed ThiT ze bindt, 
en van de eerste generatie thiaminederivaten hebben we kristalstructuren verkregen van 
ThiT met deze gebonden derivaten. Met de verkregen informatie hebben we geprobeerd 
grotere thiaminederivaten te verkrijgen die een inhiberende rol kunnen spelen tijdens 
het transport van thiamine door de complete ECF ThiT transporter. Er zijn pathogene 
bacteriën (bacteriën die voor ziektes zorgen) die afhankelijk zijn van de ECF transporters 
voor de opname van vitamines, en zo’n inhiberende derivaat zou er dan voor kunnen 
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zorgen dat de pathogene bacteriën dood gaan. Mensen hebben geen ECF transporters, 
wat deze transporters een geschikt doel maakt voor de ontwikkeling van een nieuw 
soort antibioticum. Het ontdekken van een inhiberende vitamine derivaat zou een eerste 
stapje zijn in de ontwikkeling van zo’n nieuwe soort antibioticum tegen deze pathogene 
bacteriën. Helaas hebben wij nog geen inhiberend derivaat gevonden, maar wel een 
methode ontwikkeld die hiervoor gebruikt zou kunnen worden.
 De volgende drie hoofdstukken (hoofdstuk 5-7) richten zich op het onderzoeken 
van het transport mechanism van een andere ECF transporter, ECF FolT2 van het 
organisme Lactobacillus delbrueckii, dat het transport van folate (vitamine B11) verzorgt. 
In hoofdstuk 5 onthullen we de kristalstructuren van de folaat-gebonden S-component 
en de gehele ECF FolT2 transporter in twee verschillende toestanden, één zonder dat er 
iets is gebonden, en de ander met een langzaam hydrolyseerbare vorm van ATP (AMP-
PNP) gebonden in de ATPase subunits. Door de plek waar het folaat molecuul gebonden 
zit in de structuur van de folaat-gebonden S-component te vergelijken met de lege plek 
in de structuren van de complete transporter, konden we uitspraken doen over hoe de 
interactie tussen de substraat-gebonden S-component en de ECF module leidt tot het 
loslaten van het substraat in het cytosol van de cel nadat het substraat getransporteerd 
is. Samen met de informatie die er al beschikbaar was over de ECF transporters, heeft 
dit geleid tot een nieuw werkmodel voor het transportmechanism. Hoofdstuk 6 is een 
meer technisch hoofdstuk, waarin de optimalisatie van het gebruik van een redelijk 
nieuw modelmembraan voor het bestuderen van de ECF transporters wordt beschreven. 
In hoofdstuk 7 laten we zien dat wanneer er, in de aanwezigheid van het substraat, ATP 
hydrolyseerd kan worden, de S-component van de ECF module dissociëert. Dit leidde tot 
een nieuwe versie van het werkmodel voor het transportmechanisme. Om meer bewijs 
voor dit nieuwe model te leveren, werden er pogingen gedaan om de ECF transporter in 
een nieuwe toestand te kristalliseren om te zien of één van de toestanden voorgesteld in 
het nieuwe werkmodel, ook daadwerkelijke plaats vindt.
In hoofdstuk 8 gebruiken we een nieuwe methode om een molecuul te vinden 
die het transport van folaat door ECF transporter ECF FolT2 op een specifieke manier 
inhibeert. Het gevonden molecuul bleek ook de transportactiviteit van een andere ECF 
transporter van hetzelfde organisme, die gebruikt maakt van dezelfde ECF module, te 
inhiberen, terwijl het de transportactiviteit van een andere ABC importeur ongemoeid liet. 
Dit wees erop dat we een molecuul gevonden hadden, dat specifiek de ECF transporters 
van het organism Lactobacillus delbrueckii inhibeert.
Wat kunnen we met de resultaten uit dit proefschrift?
 Het onderzoek beschreven in dit proefschrift heeft allereerst nieuwe inzichten 
in het transport mechanism van de ECF transporters opgeleverd. Aan de hand van de 
kristalstructuren uit hoofdstuk 5 en alle informatie die op dat moment over de ECF 
transporters bekend was, hebben we een werkmodel voor het transportmechanisme 
opgesteld die alle observaties kon verklaren. Vervolgens hebben we het model nog een 
stapje uitgebreid naar aanleiding van de resultaten uit hoofdstuk 7. Deze nieuwste versie 
van het model kan nu gebruikt worden om nieuwe experimenten op te zetten, waarmee 
we onze ideëen over het transport mechanisme kunnen bevestigen of aanpassen.
Op het gebied van toepassingen beschrijft dit proefschrift in hoofdstukken 2-4 
een methode om substraat derivaten te ontwerpen, te synthetiseren en te testen. Het 
gebruik van deze methode heeft geresulteerd in een aantal thiaminederivaten die een stuk 
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groter zijn dan thiamine, maar nog steeds aan ThiT binden met een hoge affiniteit, wat ons 
informatie over de substraatbinding heeft opgeleverd. In combinatie met deze informatie 
kan de methode in de toekomst gebruikt worden om nog meer thiaminederivaten te 
maken, die misschien zelfs een hogere affiniteit hebben dan thiamine, of die het transport 
kunnen blokkeren. In dat geval zouden de derivaten een eerste stap kunnen zijn naar de 
ontwikkeling van nieuwe antibiotica, die aangrijpen op transporters voor thiamine. In 
hoofdstuk 8 hebben we een iets andere methode gebruikt voor het vinden van inhibitoren 
van ECF transporters, die meteen succesvol bleek te zijn. Het gevonden molecuul zal in de 
toekomst gebruikt gaan worden om zowel inzicht in het transportmechanism te verkrijgen 
door het molecuul te laten co-kristalliseren in complex met de ECF FolT2 transporter, als 
wel in experimenten om te testen of het werkelijk gebruikt kan gaan worden als een eerste 
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de resultaten lang niet altijd vrolijkmakend, en de ervaring om voor het eerst naar een 
internationaal congres te gaan, en dan ook meteen naar California! Buiten het lab hebben 
we ook vele leuke dingen samen beleefd en steun aan elkaar gehad, en ik hoop dat deze 
vriendschap er één is voor het leven! Weronika, you joined our office and the ECF team in 
the second year of my PhD, and from the start you brought laughter and joy in the group. 
Thank you for the great times together, as well as printing GE Healthcare trucks for our 
beamtimes, making me experienced in the isotope lab, discussing our understanding of 
the ECF transporters and fantasizing about this microscope of the future which will show 
us every detail of our proteins!
 Leticia, four years ago we started working together on the ThiT project, and 
it has been a warm and successful collaboration. Thank you for synthesizing all those 
molecules, and waiting patiently until I could provide you with the affinities. I am 
glad that we can continue our collaboration for now, and I hope that we will be able to 
characterize our special compound 3 and turn it into a great story. But for now, we first 
have to defend our thesis... Good luck, and let’s have a well-deserved party afterwards! I 





Besides Sonja and Weronika, I have shared office 16.133 with a couple of other 
people during the four years of my PhD. Hallie, you started your PhD one year after me, 
and together with Sonja and Weronika, we build up a nice friendship in our office. All 
of us were very sad when you had to leave us, but luckily you only moved to the green 
building, so we could still meet each other on regular basis and have our nice high teas 
and ladies nights with delicious food. You were also always willing to water my plants 
when I had to go abroad, and I hope we will stay in touch once you have finished your 
PhD too. Michael, you were the only guy in our girly office, thanks for being part of our 
Dirks Angels team. Marysia, only at the end of your postdoc you came in our office, but 
you have always been a very friendly and helpful person in sharing your knowledge on 
the ECF transporters, and a great cook! All the best to you, Maciej and the little Lena, 
and I hope you will find a nice job soon. Alisa, you are always happy and enthusiastic, 
and I really hope that you will soon have a crystal structure of your protein hanging on 
our wall of fame too! Inda, you just started your PhD and it is my pleasure to be your 
supervisor and teach you everything I know about the ECF transporters. Good luck with 
your research and take care of my beloved proteins! Joris, succes met jouw postdoc, ik 
hoop dat er vele mooie FRET signalen op jouw computerscherm gaan verschijnen.
 Besides my office mates, I would also like to thank the other members of Dirks 
group; Raj, who help me with cloning in L. lactis and can also cook delicious Indian food, 
Joana, who bought me a big chocolate-chip cookie and cheered me up after I found out 
that I had been scooped, Valentina, with whom I had a great beamtime trip to the SLS, 
Stephan and Gianluca, who always make a joyful time out of lunch, Artem, with whom 
I ate delicious rösti in Geneva, but also Dorith, Cristiane and Nynke. And special thanks 
to Albert, who taught me the tips and tricks in protein crystallography, data collection 
and solving crystal structures, and helped me with the struggle that the work on the ECF 
FolT2 and FolT1 structures was. It costed a lot of time and energy, but in the end we got 
a fantastic article out of it!
 During my PhD, I also had help from four enthusiastic students. Aisyah, Tobias, 
Ruben and Eefke, thank you a lot for all the work you have perform on the ThiT project! 
I would not have managed to get all those KD values without you.
 My place in the lab would not have been the same without my fellow lab 
members in 16.112. Ruslan, you were always in for a nice chat and we often met in the 
coffee corner waiting for the water to boil in order to make a cup of  tea. Rianne, bedankt 
dat jij samen met mij drie jaar lang de verjaardagscommissie hebt willen vormen; we 
hadden de versieringen toch altijd mooi voor elkaar! Lukasz, you were always prepared to 
make jokes, helping me a hand or letting me pass when I was walking around in a hurry. 
Hendrik, bedankt dat jij het effect van compound 3 op OpuA voor mij hebt getest, dat was 
toch wel een doorslaggevend resultaat! And let’s not forget Arnold and Boqun.
 Gea en Ria, zonder jullie als ordebewaaksters van het lab zou het er allemaal niet 
zo gesmeerd bijlopen. Ik wil Gea in het bijzonder ook bedanken voor haar begeleiding 
tijdens mijn allereerste weken in het lab als Bachelors student, en ook voor al haar 
technische kennis en de gezellige praatjes die we zo nu en dan op het lab hebben. 
Daarnaast wil ik graag Margriet bedanken voor alle secretariële ondersteuning.
 Besides the people from Dirks group and my fellow lab members, I would also 
like to thank Bauke, Franz, Jelger, Jonas, Joury, Marina, Matteo, Michiel, Patricia, 
Paul, Ryan, Tjeerd and Wojtek, and all the people who have left the group already.
 Het doen van een PhD is niet monotoom, het bestaat uit hoogte- en dieptepunten, 
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uit tijden waarin je ontzettend enthousiast bent over waar je mee bezig bent, maar ook 
uit tijden waarin je onzekerheid of terleurstelling voelt en met stress te maken hebt. Dit 
soort gevoelens blijven niet binnen de muren van de universiteit, maar neem je mee in je 
privéleven. Buiten het lab heb ik enorm veel steun en liefde gehad van een aantal mensen, 
die ik bij deze ook wil bedanken.
Papa en Mama, jullie hebben altijd achter mij gestaan en mij altijd gesteund, 
vanaf de lagere school tot aan dit moment. Het is dan ook niet voor niets dat ik mijn 
proefschrift aan jullie op draag. Jullie hebben mijn interesse voor allerlei dingen 
aangewakkerd, mij gestimuleerd om te doen wat ik leuk vind en daar dan ook echt voor 
te gaan, en jullie hebben mij geleerd om nooit op te geven, wat er ook gebeurd, want het 
belangrijkste, je familie, staat altijd voor je klaar. In het kader daarvan wil ik ook mijn 
broertje Henk-Pieter, Tata en Oma bedanken, die mij ook altijd gesteund hebben en aan 
mij dachten als ik naar het buitenland ging, een interessant experiment ging doen of een 
presentatie moest houden.
 Naast mijn eigen familie wil ik ook Alexanders ouders, Joke en Koos, en Martijn 
bedanken. Jullie zijn ook altijd even geïnteresseerd in mijn werk en leven met me mee. 
Ik weet nog goed dat ik na een lange treinreis vanuit Zwitserland op weg naar Groningen 
was, en dat er toen bij jullie een warme maaltijd op mij stond te wachten.
 Tot slot wil ik eindigen met degene die tijdens mijn promotie de belangrijkste 
persoon in mijn leven is geworden. Wie had kunnen denken dat er uit het geven van een 
eerstejaars computerpracticum zoiets moois zou ontstaan? Lieve Alexander, vanaf onze 
eerste date had jij interesse in mijn onderzoek, en die interesse heb je altijd gehouden. 
Je wilt altijd begrijpen wat ik doe, en denkt serieus met me mee als ik met vragen zit. 
Bedankt dat je altijd voor mij klaar staat, of het nu gaat om mijn enthousiasme te delen, 
me op te vrolijken, te kalmeren of af te remmen. Bedankt dat je het eten klaar hebt staan 
als ik wat langer door ga, en dat je met me mee gaat als ik ’s avonds of in het weekend 
naar het lab ga, en dat je dan mee helpt om dingen schoon te maken. Met jou kan ik alles 
aan, en nu dat mijn promotie erop zit, kijk ik uit naar een prachtige toekomst die wij 
samen tegemoet gaan!
